Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020630	s-prot	g/l (g/l)	27931	71494	0.02%
3020630	s-prot	— (—)	4097	5741	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Certain infectious and parasitic diseases

4161

10619

2.04

322.83

2.7

2.1

66.03

67.36

g/l

20.30

3833

9602

Pain, not elsewhere classified

1746

6618

2.85

322.70

2.6

2.4

66.24

67.07

g/l

4.30

1611

5973

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2148

5356

2.66

321.87

2.7

2.5

66.22

67.79

g/l

14.43

2003

4904

Lower back pain or/and sciatica

6197

24029

1.75

317.62

2.6

2.5

66.71

66.51

g/l

1.25

5583

21918

Complications of medical and surgical care

4605

23661

1.89

313.29

2.6

2.5

65.73

66.60

g/l

10.81

4199

21470

Coagulation defects, purpura and other haemorrhagic conditions

1539

5662

3.07

309.01

3.0

2.5

65.72

66.45

g/l

2.71

1444

5125

Glomerulonephritis

965

2725

4.30

308.00

3.1

2.7

62.45

66.57

g/l

31.69

927

2500

Nephropathy related operations

1615

3533

6.23

307.65

4.1

2.5

62.51

66.53

g/l

60.92

1552

3213

Cerebrovascular diseases (FINNGEN)

1957

4337

3.46

307.65

2.3

2.5

65.99

67.73

g/l

15.67

1814

3960

Acute tubulo-interstitial nephritis

4145

16494

2.32

307.65

2.5

65.30

66.85

g/l

26.30

3728

14823

Other pleural conditions

1342

3142

5.71

307.65

2.7

2.6

63.28

66.23

g/l

28.01

1274

2782

Dialysis

536

862

9.01

307.65

3.9

2.6

62.62

66.98

g/l

25.80

519

797

Pain in limb

5443

16973

2.28

307.65

2.4

2.6

66.35

66.54

g/l

1.02

4954

15415

Gout

2624

7975

3.34

307.65

3.4

2.7

65.60

65.95

g/l

1.31

2427

7190

L04AD Calcineurin inhibitors

1161

2546

5.78

307.65

3.7

2.8

63.16

67.01

g/l

39.02

1116

2349

Any reimbursement code in KELA

2631

4943

2.78

307.65

2.8

1.5

66.81

68.09

g/l

11.83

2466

4457

Viral Sepsis

1763

5916

3.42

307.65

3.6

2.3

64.22

66.73

g/l

27.86

1632

5276

Osteopathies and chondropathies

4533

17079

2.73

307.65

3.1

2.5

66.11

66.49

g/l

2.54

4026

15486

Neurological diseases, wide definition

1386

1883

3.87

307.65

2.4

2.8

67.11

66.04

g/l

3.83

1288

1740

Unspecified kidney failure

1258

2899

5.67

307.65

3.1

2.4

64.49

66.25

g/l

9.67

1169

2557

Low back pain

4646

16703

2.10

307.65

2.6

2.5

66.64

66.36

g/l

1.58

4174

15258

Osteoporosis

2633

8202

3.56

307.65

2.6

2.5

66.01

66.04

g/l

0.04

2271

7305

Heart failure, strict

5267

15096

2.77

307.65

2.4

2.6

64.56

66.68

g/l

59.22

4838

13521

Septicaemia

3744

12687

3.12

307.65

3.4

2.3

64.40

66.91

g/l

53.01

3434

11359

All chronic kidney diseases

6606

13412

4.88

307.65

2.8

2.4

65.17

66.81

g/l

41.09

6144

12034

Polymyalgia rheumatica

1388

4511

3.76

307.65

2.1

2.6

66.13

65.95

g/l

0.37

1246

3996

Other pulmonary diagnosis

4548

10673

2.24

307.65

2.8

2.2

66.14

67.52

g/l

23.76

4206

9642

Metabolic disorders

6488

18410

2.29

307.65

2.8

2.5

65.92

66.91

g/l

18.26

5955

16723

Heart failure and coronary heart disease

3535

11450

2.43

307.65

2.3

2.7

64.62

66.30

g/l

26.86

3249

10186

Implicit viral Sepsis

2441

8908

3.09

307.65

3.2

2.4

64.52

66.79

g/l

33.36

2246

7981

Codeine

5608

14453

2.22

307.65

2.3

2.2

66.57

66.84

g/l

1.64

5121

13178

Dorsalgia

5765

17003

1.89

307.65

2.5

66.86

66.37

g/l

4.56

5231

15517

Codeine or tramadol medication

6865

21292

1.84

307.65

2.4

2.5

66.57

66.55

g/l

0.06

6267

19362

Asthma (only as main-diagnosis), excluding more controls

3747

9281

2.42

307.65

2.2

66.45

67.84

g/l

22.27

3435

8384

Oral corticosteroids

8522

19333

2.84

307.65

2.3

2.6

66.12

66.78

g/l

10.33

7834

17493

Erysipelas

3911

15956

2.34

307.65

2.5

2.3

65.46

67.08

g/l

28.90

3565

14379

L04AA Selective immunosuppressants

1859

6114

3.48

307.65

2.7

2.5

64.85

66.79

g/l

19.74

1771

5610

Asthma, excluding more controls

4189

9281

2.48

307.65

2.2

66.58

67.84

g/l

19.66

3855

8384

Kidney transplant status

611

1169

7.02

307.65

3.7

2.9

62.73

66.82

g/l

25.53

588

1081

Systemic connective tissue disorders

3374

11186

3.50

307.65

2.1

2.6

66.65

66.28

g/l

1.79

3076

10034

Bacterial Sepsis

4533

13470

3.29

307.65

3.1

2.4

64.25

66.90

g/l

72.92

4131

12109

Multiple myeloma

697

677

32.04

307.65

22.1

1.6

67.41

66.78

g/l

0.71

682

595

Other and unspecified polyneuropathies, also in other diseases

2642

6254

5.71

307.65

2.3

2.5

67.26

66.08

g/l

12.18

2439

5618

Opioids

5883

14568

2.20

307.65

2.6

2.2

66.53

66.86

g/l

2.23

5378

13279

Other disorders of skin and subcutaneous tissue

4601

21945

1.98

307.65

2.5

2.6

65.69

66.55

g/l

10.40

4166

19870

Spondylopathies

5097

15904

2.02

307.65

2.6

2.5

66.78

66.29

g/l

4.37

4634

14476

Parasetamol

4073

9543

2.26

307.65

2.6

2.2

66.51

66.93

g/l

2.43

3746

8756

Diabetic nephropathy, excluding more controls

1416

3528

3.99

307.65

2.6

2.3

65.20

67.06

g/l

13.86

1324

3159

Explicit Sepsis

3827

13268

3.02

307.65

3.4

2.4

64.39

66.89

g/l

53.87

3512

11935

Other heart diseases

2799

5651

3.47

307.65

2.6

2.4

65.62

67.81

g/l

33.56

2618

5186

Covid-19 confirmed case

2845

12319

2.55

307.65

3.2

2.4

64.79

66.40

g/l

21.71

2635

11067

Acute renal failure

2624

6659

4.99

307.65

3.1

2.4

63.43

66.40

g/l

48.87

2455

5892

Type 2 diabetes, wide definition

5287

17739

2.02

307.65

2.4

2.7

66.33

66.41

g/l

0.28

4825

16077

All kidney diseases

8545

19405

3.33

307.65

2.8

2.4

65.38

67.12

g/l

61.53

7898

17563

Tramadol

5513

14002

2.59

307.65

2.7

2.2

66.26

66.80

g/l

4.80

4983

12743

COPD/asthma/ILD related infections

6085

16356

1.95

307.65

3.1

2.2

65.76

67.21

g/l

34.25

5623

14825

Oxycodone

3420

10765

3.25

307.65

4.6

2.3

65.05

66.50

g/l

18.66

3107

9725

Liquid cancers, helper endpoint

5313

10042

5.99

307.65

6.8

1.5

66.69

66.74

g/l

0.14

5049

8918

Oedema, not elsewhere classified

2463

8831

3.05

307.65

2.5

2.4

65.25

66.85

g/l

16.97

2256

7908

All pneumoniae

7410

20692

2.58

307.65

3.2

2.3

65.01

67.25

g/l

91.92

6863

18782

Abnormalities of breathing

5672

15264

2.28

307.65

2.5

66.13

66.77

g/l

7.17

5187

13952

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1264

2391

7.99

307.65

3.5

2.5

68.92

66.06

g/l

22.73

1156

2145

Other arthritis (FG)

2195

8331

2.89

307.65

2.4

2.7

66.90

66.39

g/l

2.46

2032

7611

Abnormal findings on diagnostic imaging of lung

3554

17192

2.15

307.65

2.5

2.6

65.98

66.37

g/l

2.04

3261

15488

Other septicaemia

3329

11678

3.10

307.65

3.2

2.3

64.10

66.86

g/l

57.53

3048

10430

Autoimmune diseases excluding thyroid diseases, strict definition

6913

17415

2.31

307.65

2.2

2.6

66.65

66.57

g/l

0.33

6405

15763

Erysipelas

5067

17348

2.40

307.65

2.4

2.3

65.62

67.16

g/l

33.14

4619

15652

Abnormal findings on examination of blood, without diagnosis

3716

15286

2.46

307.65

2.9

2.5

66.85

66.32

g/l

3.38

3422

13897

Other bacterial diseases

8070

19680

3.04

307.65

3.2

2.3

65.03

67.21

g/l

88.77

7450

17808

Headache

3756

13329

2.37

307.65

2.2

2.3

66.80

67.15

g/l

2.17

3453

12061

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1733

2841

3.19

307.65

2.6

2.3

66.84

67.47

g/l

2.24

1610

2592

Condition for Implicit Sepsis (Organ dysfunction codes)

6605

18781

2.62

307.65

2.6

2.4

65.37

67.19

g/l

55.83

6059

17053

Implicit bacterial Sepsis

4319

13159

3.25

307.65

2.9

2.4

64.13

66.88

g/l

76.67

3925

11813

Pain in throat and chest

4735

15045

1.97

307.65

2.5

66.60

66.78

g/l

0.88

4296

13745

Cardiovascular diseases (excluding rheumatic etc)

3136

6539

2.90

307.65

2.6

2.3

66.52

67.86

g/l

15.07

2940

6021

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6647

16355

2.65

307.65

3.2

2.2

65.06

67.21

g/l

74.95

6159

14824

Hypothyroidism, levothyroxine purchases

1038

1318

4.67

307.65

2.8

1.3

66.53

68.67

g/l

11.87

967

1229

Hypertension

4579

11966

2.28

307.65

2.4

2.6

66.38

66.88

g/l

3.70

4268

10891

Other systemic involvement of connective tissue

2548

8583

3.44

307.65

2.1

2.6

67.39

66.23

g/l

10.72

2315

7697

Enlarged lymph nodes

1213

3619

3.78

307.65

2.5

2.4

66.62

67.06

g/l

1.04

1145

3275

Nutritional anaemias

3974

16665

2.53

307.65

2.3

2.5

65.60

66.35

g/l

6.68

3570

14964

Anaemias

2030

1266

12.05

307.65

3.0

1.4

65.89

68.64

g/l

26.19

1899

1180

Malaise and fatigue

4095

11790

3.08

307.65

2.4

65.32

66.94

g/l

27.57

3692

10582

Dental caries

2009

6714

3.21

307.65

4.0

2.3

64.63

66.60

g/l

18.90

1881

6143

Reimbursement for rheumatic diseases

3965

18543

2.29

307.65

1.9

2.7

66.83

66.45

g/l

2.16

3693

16710

Autoimmune diseases

6738

18037

1.99

307.65

2.4

2.6

66.58

66.54

g/l

0.12

6214

16335

Finngen Rheumatological endpoints

5863

16087

2.18

307.65

2.2

2.6

66.99

66.48

g/l

4.97

5360

14686

Implicit bacterial Sepsis

4027

12371

3.32

307.65

2.9

2.4

63.99

66.83

g/l

76.05

3659

11096

Other anaemias

5141

13883

4.29

307.65

2.8

2.4

65.59

66.28

g/l

6.72

4679

12383

Pneumonias (Asthma/COPD co-morbidities)

7391

20645

2.59

307.65

3.2

2.3

65.02

67.26

g/l

92.36

6843

18739

Asthma, unspecified (mode)

3433

10142

2.73

307.65

2.3

2.2

66.20

67.50

g/l

18.23

3126

9149

Implicit Sepsis

6358

18317

2.89

307.65

2.7

2.4

64.87

67.06

g/l

74.48

5759

16594

Influenza and pneumonia

7560

20338

2.54

307.65

3.3

2.2

65.13

67.28

g/l

86.07

7002

18468

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6039

20553

2.01

307.65

3.0

2.4

65.72

66.85

g/l

22.15

5553

18720

Malignant neoplasm

4964

15655

1.97

307.65

4.2

1.6

65.93

67.12

g/l

19.50

4638

14126

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1431

1286

44.75

307.65

8.3

1.4

69.55

66.59

g/l

23.69

1360

1141

Autoimmune diseases excluding thyroid diseases

7156

17971

2.31

307.65

2.2

2.6

66.65

66.54

g/l

0.47

6633

16275

Implicit viral Sepsis

1759

5907

3.41

307.65

3.6

2.3

64.21

66.72

g/l

27.92

1628

5268

Caries of dentine

1803

5988

3.28

307.65

4.0

2.3

64.57

66.67

g/l

19.03

1683

5486

Certain infectious and parasitic diseases

5920

14321

2.17

307.65

2.8

2.1

65.88

67.39

g/l

35.29

5463

12951

Polyneuropathies and other disorders of the peripheral nervous system

2877

7129

5.31

307.65

2.5

2.6

67.13

66.11

g/l

10.12

2661

6400

Asthma (mode)

4279

10660

2.25

307.65

2.2

66.57

67.52

g/l

12.06

3935

9629

Hypertension, essential

4595

11811

2.33

307.65

2.5

2.6

66.53

66.88

g/l

2.06

4276

10747

Condition for Implicit Sepsis (Organ dysfunction codes)

6578

18984

2.66

307.65

2.6

2.4

65.14

67.14

g/l

65.76

6003

17221

Non-Hodgkin lymphoma, all, including Hilmo

1261

3858

3.91

307.65

3.1

1.6

64.60

66.76

g/l

13.80

1202

3398

Malignant neoplasm, wide definition for exclusion

5027

15874

1.94

307.65

4.0

1.6

65.94

67.13

g/l

20.02

4701

14331

Other diseases of intestines

5931

19275

1.82

307.65

2.5

66.41

66.76

g/l

2.55

5403

17636

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7251

20822

2.56

307.65

3.2

2.3

65.04

67.20

g/l

84.79

6709

18907

Excluding asthma or asthma-COPD overlap

4500

10673

2.21

307.65

2.7

2.2

66.15

67.52

g/l

23.04

4169

9642

Hypertensive diseases (excluding secondary)

2901

5640

3.18

307.65

2.6

2.4

66.47

67.84

g/l

14.89

2719

5171

ILD medications: immunosuppressive drugs

5786

15162

4.01

307.65

4.8

2.0

65.88

67.01

g/l

19.96

5455

13736

Other heart diseases, wide

5401

15857

2.19

307.65

2.6

2.5

65.91

67.33

g/l

30.33

4982

14500

Autoimmune diseases related-to ILD

5474

23913

2.07

307.65

2.1

2.6

66.89

66.48

g/l

3.22

5050

21684

Multiple myeloma and malignant plasma cell neoplasms

1149

1450

20.34

307.65

19.4

1.9

67.48

66.26

g/l

3.20

1128

1310

Complications of surgical and medical care, not elsewhere classified

6349

23533

1.95

307.65

2.6

2.5

65.86

66.69

g/l

12.84

5780

21375

Pneumonia, organism unspecified

6914

19629

2.68

307.65

3.2

2.2

64.99

67.23

g/l

87.29

6391

17802

COPD/asthma related infections

6085

16356

1.95

307.65

3.1

2.2

65.76

67.21

g/l

34.25

5623

14825

General symptoms and signs

7293

14950

2.60

307.65

2.6

2.3

66.23

67.16

g/l

16.40

6736

13535

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

866

1221

5.74

307.65

2.3

3.1

66.12

65.56

g/l

0.89

814

1111

ILD medications: prednisolone, methylprednisolone, prednisone

8661

17301

3.05

307.65

2.5

2.0

66.05

66.93

g/l

17.04

7969

15599

6647

16355

2.65

307.65

3.2

2.2

65.06

67.21

g/l

74.95

6159

14824

COPD differential diagnosis

4474

10662

2.20

307.65

2.7

2.2

66.15

67.52

g/l

23.09

4149

9631

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4890

21147

2.24

307.65

2.6

66.11

66.46

g/l

2.27

4501

19089

Bacterial infection, other or unspecified

5676

15573

3.53

307.65

3.4

2.3

64.47

67.05

g/l

86.95

5219

13991

Implicit Sepsis

6615

18954

2.79

307.65

2.7

2.4

65.03

67.12

g/l

71.34

6013

17189

Infections, IBD-co-morbidities

1259

1534

6.63

307.65

4.0

3.0

64.40

65.86

g/l

5.45

1162

1414

ILD differential diagnosis

4474

10660

2.20

307.65

2.7

2.2

66.15

67.52

g/l

23.05

4149

9629

Heart failure,strict

4861

12068

3.25

307.65

2.4

2.6

64.62

67.16

g/l

75.19

4478

10828

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9834

19400

3.98

307.65

2.8

2.4

65.83

66.86

g/l

25.25

9062

17537

Primary_lymphoid and hematopoietic malignant neoplasms

3309

7838

5.61

307.65

8.7

1.8

66.04

66.25

g/l

0.58

3187

6962

Asthma (only as main-diagnosis)

3901

10569

2.24

307.65

2.2

66.36

67.53

g/l

16.62

3565

9547

Inflammatory bowel disease treatment related agents

8666

19545

2.67

307.65

2.3

2.6

66.21

66.79

g/l

8.03

7985

17689

Asthma

4386

10569

2.28

307.65

2.2

66.51

67.53

g/l

13.79

4034

9547

ILD medications

8947

17401

3.03

307.65

3.2

2.0

66.11

66.94

g/l

15.55

8262

15696

Hypothyroidism (congenital or acquired)

1055

1322

4.73

307.65

2.8

1.3

66.44

68.67

g/l

12.85

983

1233

Glomerular disorders in diseases classified elsewhere

1491

3330

5.99

307.65

3.4

2.5

64.48

66.50

g/l

14.58

1404

3035

Bacterial infection, other or unspecified

5358

14980

3.58

307.65

3.5

2.3

64.38

66.99

g/l

84.94

4919

13448

Multiple myeloma, including Hilmo

1125

1209

24.75

307.65

19.6

1.6

67.49

66.74

g/l

1.39

1103

1074

Other disorders of fluid, electrolyte and acid-base balance

2670

9724

2.95

307.65

2.7

2.5

64.68

66.58

g/l

24.52

2424

8687

Non-rheumatic valve diseases

3264

10559

2.41

307.65

2.6

2.7

65.69

67.07

g/l

17.83

2988

9536

Provisional assignment of new diseases of uncertain etiology

3602

17013

2.27

307.65

3.0

2.4

65.24

66.61

g/l

20.48

3344

15395

Codes for special purposes

3606

17038

2.27

307.65

3.1

2.4

65.25

66.61

g/l

20.33

3347

15419

Diseases of oesophagus, stomach and duodenum

6551

21612

1.90

307.65

2.4

2.6

66.30

66.63

g/l

2.52

5966

19700

Other and unspecified anaemias

5111

13794

4.31

307.65

2.8

2.4

65.60

66.28

g/l

6.61

4650

12305

Osteoporosis with pathological fracture (FG)

792

1872

5.45

307.65

2.2

2.8

65.90

65.50

g/l

0.64

659

1631

Atrial fibrillation and flutter with reimbursement

1632

3481

3.25

307.65

2.7

65.69

67.58

g/l

15.57

1518

3154

Second line medication for Crohn's disease

4510

17417

2.86

307.65

5.3

2.1

66.42

66.65

g/l

1.07

4233

15846

Diseases of arteries, arterioles and capillaries (FINNGEN)

1741

3431

3.90

307.65

2.6

65.39

67.63

g/l

21.61

1612

3113

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

697

677

32.04

307.65

22.1

1.6

67.41

66.78

g/l

0.71

682

595

Other systemic involvement of connective tissue (FG)

2503

6915

4.18

307.65

2.0

2.7

67.39

66.12

g/l

11.83

2274

6198

Chronic kidney disease

4652

9770

6.34

307.65

2.7

2.4

65.32

66.33

g/l

12.18

4334

8625

First line medication for Crohn's disease

8446

16695

2.96

307.65

3.2

1.8

66.01

67.10

g/l

24.72

7827

15025

Atrial fibrillation and flutter

1893

4120

3.21

307.65

2.8

2.6

65.62

67.71

g/l

21.43

1768

3753

Heart failure and bmi 25plus

2868

7704

2.83

307.65

2.4

2.8

65.22

66.98

g/l

23.87

2616

6890

Polyarthropathies

5553

13116

3.03

307.65

2.6

2.7

66.40

66.32

g/l

0.26

5164

11948

Extracorporeal dialysis

772

1663

6.43

307.65

3.5

2.7

62.03

66.60

g/l

39.14

735

1536

Renal failure

6345

13608

5.29

307.65

2.9

2.5

64.90

66.52

g/l

37.91

5899

12114

Disorders of lipoprotein metabolism and other lipidaemias

5237

17119

2.00

307.65

2.6

2.5

66.09

66.85

g/l

9.59

4787

15508

Dialysis, with operation codes

1733

3285

7.30

307.65

4.1

2.4

62.75

66.70

g/l

60.00

1658

2970

Aplastic and other anaemias

5463

14591

4.24

307.65

2.9

2.5

65.51

66.33

g/l

9.64

4984

13040

Heart failure and antihypertensive medication

2341

3680

4.85

307.65

2.5

2.9

64.57

66.82

g/l

25.83

2191

3337

Other and unspecified iron deficiency

2789

10863

2.87

307.65

2.2

2.5

65.77

66.31

g/l

2.88

2509

9725

All-cause Heart Failure

5136

14910

2.73

307.65

2.4

2.6

64.56

66.69

g/l

57.87

4712

13346

Endocrine, nutritional and metabolic diseases

4121

10420

2.08

307.65

2.5

2.6

66.26

67.04

g/l

7.47

3814

9536

Other diseases of blood and blood-forming organs, wide

1918

6799

3.25

307.65

3.3

2.6

65.61

66.51

g/l

4.59

1793

6168

Other specified/unspecified arthritis

1940

7469

2.85

307.65

2.4

2.7

67.05

66.25

g/l

4.70

1792

6813

Renal tubulo-interstitial diseases

8281

19488

3.57

307.65

2.8

2.5

65.31

66.98

g/l

55.94

7619

17624

Heart failure, not strict

6947

15678

3.42

307.65

2.7

2.6

64.73

67.34

g/l

109.34

6432

14202

Cardiovascular diseases

2712

5414

2.81

307.65

2.5

2.3

66.75

67.92

g/l

10.00

2545

5001

Hypertensive diseases

4588

11970

2.28

307.65

2.4

2.6

66.39

66.87

g/l

3.65

4276

10894

Hypothyroidism and >3 levothyroxin purchases

1038

1318

4.67

307.65

2.8

1.3

66.53

68.67

g/l

11.87

967

1229

GASTRO-related operations

4643

8840

2.77

307.65

2.6

1.9

66.19

67.72

g/l

27.24

4282

7984

Examination and observation for other reasons

3897

9596

2.50

307.65

2.6

2.3

66.34

66.52

g/l

0.66

3583

8806

Valvular heart disease excluding rheumatic fever

3281

10597

2.42

307.65

2.6

2.7

65.65

67.07

g/l

18.65

3005

9572

Medical observation and evaluation for suspected diseases and conditions

3970

9716

2.19

307.65

2.5

2.3

66.71

66.51

g/l

0.80

3570

8895

Iron deficiency anaemia

3487

14199

2.68

307.65

2.3

2.5

65.55

66.33

g/l

6.41

3126

12739

Hypertensive heart and/or renal disease

2099

6094

2.86

307.65

2.4

2.7

65.43

66.26

g/l

4.29

1918

5424

Any gastric operation

4643

8840

2.77

307.65

2.6

1.9

66.19

67.72

g/l

27.24

4282

7984

Other bacterial diseases

8100

19227

2.92

307.65

3.0

2.3

65.24

67.26

g/l

78.60

7488

17398

Fever of other and unknown origin

5012

13287

3.77

307.65

4.0

2.4

65.33

67.07

g/l

36.92

4679

11991

Pleural effusion

2316

5021

6.46

307.65

2.4

2.5

64.10

66.34

g/l

28.11

2231

4455

Other medical care

3705

13959

2.63

307.65

3.6

2.3

64.50

66.81

g/l

50.22

3469

12447

Gout, FINNGEN

2624

10243

2.92

307.65

3.4

2.5

65.60

66.20

g/l

3.30

2427

9162

Used for control exclusion in common control thyroid runs

6299

16659

2.00

307.65

2.3

2.7

66.50

66.58

g/l

0.29

5807

15082

Cardiac arrhythmias

3109

9024

2.35

307.65

2.6

2.7

66.42

67.40

g/l

9.45

2868

8297

L04AX Other immunosuppressants

4440

16984

2.89

307.65

5.3

2.1

66.40

66.64

g/l

1.20

4167

15449

Non-ischemic cardiomyopathy

2604

8417

2.81

307.65

2.4

2.7

64.32

66.66

g/l

34.75

2377

7476

Secondary hypertension

760

1352

6.74

307.65

3.6

2.5

64.51

67.42

g/l

15.92

726

1218

Glomerular diseases

2169

5408

5.11

307.65

3.3

2.5

63.77

66.59

g/l

36.93

2058

4916

Bleeding

5368

21344

1.89

307.65

2.4

2.6

65.67

66.59

g/l

13.29

4875

19358

Persons encountering health services for specific procedures and health care

7238

20160

2.28

307.65

3.0

2.3

65.48

67.14

g/l

51.99

6728

18211

Other diseases of pleura

4546

14301

3.23

307.65

2.4

2.6

64.50

66.53

g/l

48.02

4247

12797

Care involving dialysis

1135

2052

7.93

307.65

3.2

2.4

62.65

66.88

g/l

49.38

1082

1863

Transplanted organ and tissue status

1246

2411

6.97

307.65

6.3

2.5

63.33

66.83

g/l

36.28

1199

2202

Other soft tissue disorders, not elsewhere classified

6141

17255

2.21

307.65

2.5

2.6

66.49

66.57

g/l

0.34

5633

15673

Dyspnoea

6522

22451

2.30

307.65

2.6

2.5

65.81

66.69

g/l

15.45

5945

20376

Asthma, unspecified (mode), excluding more controls

3300

8914

2.97

307.65

2.3

2.2

66.27

67.81

g/l

24.03

3015

8043

Any death

4295

16790

1.97

307.41

3.3

2.5

63.68

67.10

g/l

110.40

3951

15210

Insulin medication

3886

17375

1.99

305.96

2.5

2.7

65.83

66.33

g/l

3.36

3565

15759

Gout, idiopatic and unspecified

2103

9097

2.62

305.26

2.3

2.6

65.63

66.21

g/l

2.81

1938

8181

Diseases of arteries, arterioles and capillaries

4550

18715

1.91

304.91

2.2

2.7

65.41

66.48

g/l

15.79

4114

16903

Pain in joint

3358

10624

2.11

299.74

2.2

2.5

67.30

66.49

g/l

7.43

3056

9698

Symptoms and signs involving the circulatory and respiratory systems

5370

15285

1.82

299.23

2.5

66.55

66.77

g/l

1.20

4929

13973

Neurological diseases

4569

12424

1.92

297.22

2.3

2.8

66.79

66.37

g/l

2.78

4192

11380

Disorders of other endocrine glands

2775

13176

2.21

295.65

2.6

2.5

65.97

66.44

g/l

2.54

2507

11908

Rheumatoid arthritis

2210

8686

2.47

295.46

1.9

2.8

66.24

66.21

g/l

0.06

2052

7840

Depression medications

1076

1369

4.11

295.20

2.0

1.3

67.23

68.81

g/l

7.37

1012

1279

Other CVD (FINNGEN)

925

1895

4.35

294.71

2.9

2.6

65.02

67.34

g/l

13.40

827

1685

Symptoms and signs involving cognition, perception, emotional state and behaviour

5682

23000

1.75

293.89

2.1

2.6

66.38

66.58

g/l

1.07

5109

21033

Syncope and collapse

2752

11249

2.22

292.15

2.3

2.4

65.76

66.93

g/l

11.72

2461

10102

Other dorsopathies, not elsewhere classified

5575

17023

1.78

287.63

2.4

2.5

66.93

66.38

g/l

5.84

5047

15536

Diverticular disease of intestine

4567

16355

1.88

287.00

2.7

2.6

66.21

66.62

g/l

2.83

4124

14884

Disorders of thyroid, IBD co-morbidities

907

1614

4.21

286.84

2.3

2.9

65.93

65.96

g/l

0.02

828

1486

Neoplasms

3663

9895

2.03

286.50

3.1

1.4

66.51

67.29

g/l

6.82

3424

8996

Other specific joint derangements/joint disorders

3884

13338

1.96

285.19

2.3

2.6

67.25

66.41

g/l

9.46

3549

12221

Complications of procedures, not elsewhere classified

4808

22997

1.81

284.93

2.5

65.98

66.68

g/l

7.54

4390

20888

Pure hypercholesterolaemia

4499

16452

1.88

284.41

2.5

66.03

66.81

g/l

8.77

4099

14889

Gout, unspecified

1757

7248

2.77

284.12

2.3

2.5

65.68

66.15

g/l

1.64

1628

6510

Disorders of calcium metabolism

694

1646

5.37

284.06

3.9

2.5

65.02

66.60

g/l

4.72

629

1504

Dermatitis

3778

20487

1.94

283.87

2.5

2.6

66.77

66.41

g/l

2.03

3493

18576

Diseases of the skin and subcutaneous tissue

5645

16602

1.77

283.18

2.5

66.42

66.63

g/l

1.06

5153

15056

Disorders of mineral metabolism

811

2158

4.57

281.36

3.7

2.5

65.32

66.73

g/l

4.64

736

1968

Small fibre neuropathy

452

769

9.50

280.33

2.4

2.8

67.40

66.18

g/l

2.54

414

699

Gout, strict definition

1600

6382

2.90

279.01

2.3

2.6

65.42

66.12

g/l

2.95

1482

5746

Purpura and other haemorrhagic conditions

1154

3854

3.48

278.74

3.1

2.6

65.76

66.33

g/l

1.44

1084

3505

Other and unspecified dermatitis

3218

16738

2.04

278.71

2.5

2.6

66.77

66.44

g/l

1.55

2983

15169

Symptoms and signs involving the nervous and musculoskeletal systems

3659

19881

1.95

277.32

2.2

2.6

66.94

66.36

g/l

4.99

3365

17999

Diabetes mellitus

5699

19965

1.73

274.65

2.3

2.7

66.53

66.54

g/l

0.04

5215

18148

Diabetes, varying definitions

5678

19956

1.73

273.60

2.2

2.7

66.53

66.55

g/l

0.06

5193

18138

Hard cardiovascular diseases

4863

16726

1.81

272.58

2.5

2.7

65.96

66.88

g/l

12.33

4497

15186

STROKE

3269

11407

2.06

272.10

2.5

2.8

65.92

67.02

g/l

12.00

2993

10341

Any event in cancer register

5011

17130

1.79

271.52

3.8

1.8

65.84

67.10

g/l

22.44

4666

15513

Persons encountering health services in other circumstances, wide

6695

21450

1.66

270.96

2.5

66.36

66.62

g/l

1.76

6207

19374

Diabetic nephropathy

1428

5414

3.08

270.69

2.6

2.3

65.18

66.59

g/l

9.15

1335

4897

Ulcer of lower limb, not elsewhere classified

1300

4747

3.20

269.55

2.5

64.30

66.19

g/l

12.66

1191

4238

Antihypertensive medication - note that there are other indications

2553

6152

2.28

266.36

2.3

2.5

66.75

67.42

g/l

3.66

2372

5658

Symptoms and signs concerning food and fluid intake

859

2439

4.05

265.85

2.1

2.4

66.19

66.73

g/l

1.06

782

2189

Disorders resulting from impaired renal tubular function

490

940

7.60

264.35

4.6

2.8

64.45

66.65

g/l

6.91

474

866

Haemorrhage from respiratory passages

2369

10108

2.27

262.94

2.5

66.30

66.42

g/l

0.29

2149

9115

Symptoms and signs involving the urinary system

4721

21114

1.79

262.30

2.5

2.6

66.07

66.50

g/l

3.23

4232

19165

Type 2 diabetes

5519

19531

1.71

255.97

2.2

2.7

66.60

66.52

g/l

0.27

5040

17738

Constipation

5314

22313

1.72

255.55

2.8

2.5

65.98

66.55

g/l

6.03

4749

20353

Symptoms and signs involving the skin and subcutaneous tissue

4156

23463

1.82

255.37

2.6

2.5

66.67

66.49

g/l

0.80

3820

21302

ILD medications: azathioprine

940

2887

3.60

254.14

2.0

1.9

65.82

67.08

g/l

4.37

881

2632

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3773

16907

1.91

253.73

2.4

2.7

66.52

66.12

g/l

2.31

3401

15276

Insulin, combination of fast acting with intermediate-acting or long-acting

3891

20146

1.86

253.33

2.5

65.83

66.46

g/l

5.27

3568

18248

Hyperlipidaemia, other/unspecified

2682

12481

2.13

252.09

2.8

2.5

66.08

66.59

g/l

2.79

2448

11220

Continuous positive airway pressure

1237

3691

3.08

251.10

2.3

3.0

65.98

67.19

g/l

5.16

1093

3382

Preparatory care for dialysis

548

1216

6.31

249.49

2.3

2.9

63.56

66.57

g/l

14.58

516

1118

Intracranial trauma

2889

10290

2.05

247.27

2.4

2.8

66.58

66.51

g/l

0.16

2604

9446

Fall on same level

6196

21235

1.65

244.70

2.4

2.6

66.26

66.80

g/l

5.77

5569

19592

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5292

19383

1.71

243.79

2.2

2.7

66.59

66.51

g/l

0.27

4818

17606

Insulin, intermediate and long-acting

3486

18870

1.90

243.46

2.4

2.6

66.00

66.44

g/l

2.64

3189

17121

Hypo-osmolality and hyponatraemia

1379

5391

2.86

243.05

2.7

2.4

64.76

66.35

g/l

9.38

1243

4755

Intestinal infectious diseases

5298

24742

1.69

242.99

3.1

2.4

65.52

66.74

g/l

23.35

4834

22485

Other necrotizing vasculopathies (FG)

618

1511

5.13

242.48

1.7

3.0

64.73

66.03

g/l

3.33

569

1369

Other special examinations and investigations of persons without complaint or reported diagnosis

3584

9716

1.94

241.81

2.6

2.3

66.63

66.51

g/l

0.40

3284

8895

Ascites

750

2110

4.36

241.66

2.8

2.5

62.84

66.54

g/l

22.19

709

1900

Diarrhoea and gastroenteritis of presumed infectious origin

3990

20711

1.81

241.17

3.0

2.3

65.53

66.72

g/l

17.12

3638

18790

Persons encountering health services for other counselling and medical advice, not elsewhere classified

6203

21320

1.64

238.07

2.5

66.30

66.63

g/l

2.58

5753

19282

Genitourinary diseases

3009

7631

2.05

237.75

2.6

2.4

66.21

67.40

g/l

12.35

2806

7011

Percutaneous Coronary Intervention

4646

16902

1.76

237.50

2.5

2.7

65.89

66.73

g/l

10.23

4321

15280

Asthma-related infections

3462

18951

1.88

236.73

2.4

2.6

65.83

66.46

g/l

5.03

3163

17126

Asthma, hospital admission 2, infections

3462

18951

1.88

236.73

2.4

2.6

65.83

66.46

g/l

5.03

3163

17126

Emergency coronary revascularization (for ACS)

5118

18966

1.71

236.20

2.4

2.7

65.88

66.62

g/l

8.64

4728

17092

Ischemic heart diseases

4790

17242

1.74

234.60

2.6

2.7

65.99

66.76

g/l

9.02

4443

15601

Diseases of the musculoskeletal system and connective tissue

2562

6129

2.17

234.51

2.5

66.85

66.17

g/l

3.66

2375

5601

Nerve, nerve root and plexus disorders

6037

23499

1.63

233.64

2.4

2.6

66.67

66.47

g/l

1.20

5508

21345

COPD (mode)

1942

6906

2.37

233.53

2.1

2.3

65.12

67.22

g/l

24.60

1751

6162

Soft tissue disorders

5497

17379

1.68

233.47

2.3

2.6

66.66

66.58

g/l

0.34

5024

15778

Disorders of parathyroid gland

1604

6840

2.58

231.04

2.7

2.5

65.67

66.09

g/l

1.43

1419

6079

Certain disorders involving the immune mechanism

1371

5500

2.78

231.01

2.9

2.5

65.62

66.56

g/l

4.00

1306

5029

Diseases of liver

2261

11151

2.19

230.48

2.1

2.6

66.70

66.49

g/l

0.54

2056

10168

Hypothyroidism, drug reimbursement

606

931

4.87

230.34

2.7

1.3

66.72

68.53

g/l

5.80

562

863

Pain (limb, back, neck, head abdominally)

3989

11241

1.84

229.94

2.5

2.4

66.52

66.44

g/l

0.26

3660

10223

Coronary revascularization (ANGIO or CABG)

4617

16904

1.75

229.40

2.5

2.7

65.88

66.73

g/l

10.40

4304

15282

Dermatitis and eczema

6118

24304

1.61

228.26

2.5

66.86

66.46

g/l

3.58

5619

22055

Diseases of the respiratory system

3398

9120

1.94

228.23

2.7

2.2

66.25

67.47

g/l

14.89

3129

8219

Diabetes, insulin treatment (Kela reimbursement)

5671

21560

1.65

227.95

2.2

2.7

66.55

66.46

g/l

0.39

5172

19570

Spinal stenosis

3289

13775

1.92

227.73

2.5

2.6

66.33

66.16

g/l

0.64

2940

12482

Asthma (diagnoses ohter than nonallergic)

4885

24954

1.69

227.31

2.2

2.6

66.21

66.58

g/l

2.85

4450

22673

Spondylosis

3275

14773

1.91

225.81

2.2

2.5

66.85

66.28

g/l

4.42

2976

13456

Other necrotizing vasculopathies

717

2062

4.31

224.84

1.8

2.8

64.44

66.27

g/l

6.98

658

1869

Other dialysis

405

760

7.77

223.60

3.0

62.51

66.54

g/l

18.36

389

696

Disorders of lens

4042

14680

1.80

223.26

2.7

2.6

66.01

66.65

g/l

5.58

3693

13471

Paroxysmal tachycardia

1169

3570

2.92

221.66

2.3

2.6

65.98

67.62

g/l

9.81

1064

3240

Other arrhythmias

3350

14065

1.87

220.64

2.3

2.6

66.20

67.25

g/l

12.78

3027

12815

Azathioprine

940

3153

3.28

219.56

2.0

2.7

65.82

66.82

g/l

2.96

881

2881

Dorsopathies

5410

17065

1.66

219.51

2.4

2.5

66.92

66.37

g/l

5.38

4908

15577

Hypertensive Heart Disease

1686

5802

2.48

219.49

2.3

2.7

65.56

66.23

g/l

2.57

1523

5162

Seropositive rheumatoid arthritis

1605

7014

2.47

218.62

1.9

2.8

66.33

66.15

g/l

0.36

1500

6298

Other antidepressants

5802

18823

1.63

218.46

2.3

2.6

66.67

66.57

g/l

0.40

5233

17248

Hernia of abdominal wall, postoperative

1069

3850

3.01

218.17

2.4

2.0

65.85

67.70

g/l

11.22

973

3476

Nephrotic syndrome

388

711

7.61

217.43

3.0

2.9

59.18

66.29

g/l

28.13

379

655

Symptoms and signs involving the digestive system and abdomen

5521

17317

1.65

216.20

2.6

2.5

66.26

66.79

g/l

5.06

5071

15723

6326

21180

1.59

216.07

3.2

2.3

66.10

66.70

g/l

7.11

5753

19210

Disturbances of skin sensation

1637

7279

2.42

215.09

2.1

2.5

67.73

66.75

g/l

6.85

1523

6660

Cardiomyopathy

1238

4914

2.79

212.34

2.7

2.5

64.54

66.97

g/l

21.57

1151

4422

Myelodysplastic syndrome, including Hilmo

402

786

7.36

212.05

2.8

1.5

66.95

66.48

g/l

0.53

376

688

Benign neoplasm of colon, rectum, anus and anal canal

4039

21096

1.75

211.95

2.5

2.6

66.06

66.40

g/l

1.91

3652

19083

Asthma-related pneumonia

2397

12415

2.06

210.70

2.5

65.19

66.22

g/l

8.09

2186

11097

Asthma-related pneumonia or sepsis

2400

12444

2.06

210.25

2.5

65.19

66.22

g/l

8.20

2189

11125

Asthma, hospital admissions 3, pneumonia

2400

12444

2.06

210.25

2.5

65.19

66.22

g/l

8.20

2189

11125

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3657

21259

1.78

209.87

2.4

2.5

65.83

66.56

g/l

6.60

3340

19252

Non-follicular lymphoma

892

3059

3.50

209.50

2.7

2.6

64.24

66.16

g/l

8.18

847

2764

Care involving use of rehabilitation procedures

3488

18553

1.80

209.11

2.5

2.3

66.01

67.06

g/l

12.91

3271

16729

Major coronary heart disease event

4858

18192

1.68

208.56

2.5

2.7

65.85

66.70

g/l

10.78

4510

16444

Thrombocytopenia, unspecified

680

1985

4.17

207.24

2.9

2.6

65.62

66.43

g/l

1.51

635

1819

Insulin, fast-acting

2235

11392

2.09

206.01

2.4

2.5

65.37

66.54

g/l

10.10

2074

10336

Other disorders of urethra and urinary system

3984

17149

1.75

205.39

2.5

2.6

65.88

66.61

g/l

7.05

3626

15565

Chronic lower respiratory diseases

6435

22576

1.56

205.06

2.2

2.6

66.37

66.67

g/l

2.34

5898

20546

Nausea and vomiting

1724

7818

2.31

204.70

2.9

2.5

65.03

66.42

g/l

9.46

1581

6950

Hypertensive Renal Disease

440

945

6.11

204.66

2.9

2.7

65.19

66.14

g/l

1.49

422

841

Bacterial pneumoniae

2488

11544

2.01

203.67

3.5

2.3

64.56

67.08

g/l

40.83

2306

10366

Disorders of choroid and retina

4837

21629

1.66

202.97

2.6

66.06

66.45

g/l

2.92

4351

19627

Venous thromboembolism

3433

19399

1.81

202.68

3.0

2.5

65.15

66.49

g/l

19.23

3150

17431

General examination and investigation of persons without complaint and reported diagnosis

3336

9692

1.86

200.95

2.6

2.3

66.21

66.50

g/l

1.23

3055

8879

Diabetes medication

5565

21269

1.60

200.58

2.2

2.6

66.52

66.51

g/l

0.04

5059

19337

Other nutritional deficiencies

3478

19170

1.78

200.50

2.1

2.6

66.70

66.69

g/l

0.03

3164

17594

Hyperkalaemia

587

1594

4.56

199.59

3.1

2.4

63.59

66.33

g/l

12.98

546

1420

Concussion

2416

10222

2.00

199.55

2.3

2.8

66.67

66.50

g/l

0.49

2169

9382

Pulmonary heart disease, diseases of pulmonary circulation

2219

11526

2.08

196.51

2.8

2.5

64.93

66.25

g/l

12.05

2047

10295

Rheumatoid arthritis, including avohilmo

2411

12859

2.00

195.57

1.9

2.6

66.41

66.36

g/l

0.10

2235

11537

Arthropathies

4495

13874

1.69

195.36

2.2

2.6

66.89

66.40

g/l

3.76

4121

12673

Episodal and paroxysmal disorders

5800

19225

1.58

192.31

2.2

2.7

66.76

66.41

g/l

2.77

5276

17503

Exposure to unspecified factor

5362

25155

1.58

190.79

2.4

2.5

66.16

66.62

g/l

4.14

4809

22974

Dizziness and giddiness

4288

21156

1.67

190.69

2.2

2.7

66.46

66.51

g/l

0.16

3855

19295

Intestinal infectious diseases

6235

23766

1.54

190.36

2.9

2.4

65.67

66.76

g/l

21.56

5686

21604

All influenza

1545

7059

2.35

190.34

4.9

2.2

65.29

67.10

g/l

14.71

1412

6323

Lung cancer and mesothelioma

1308

4729

2.59

189.74

1.9

2.3

64.77

67.09

g/l

19.92

1226

4192

DVT of lower extremities and pulmonary embolism

2729

15261

1.90

187.77

3.2

2.5

64.99

66.41

g/l

17.27

2492

13695

Bacterial pneumonia, not elsewhere classified

2357

11034

1.99

187.30

3.4

2.2

64.45

67.05

g/l

42.10

2193

9892

Solid cancers, helper endpoint

4282

15550

1.68

187.27

2.9

1.6

65.81

67.12

g/l

21.23

3964

14028

Gastrointestinal diseases

2740

7302

1.94

186.61

2.7

2.2

66.64

67.23

g/l

3.11

2524

6700

Other intervertebral disc disorders

4394

16409

1.67

186.59

2.4

2.5

66.97

66.32

g/l

6.55

3986

14956

Streptococcal septicaemia

716

2291

3.62

185.62

4.2

2.3

65.69

66.74

g/l

2.26

664

2055

Hypercalcemia

492

1260

5.18

185.25

4.3

2.8

64.93

66.48

g/l

3.53

453

1137

Other functional intestinal disorders

2662

13712

1.89

185.16

2.6

2.5

66.07

66.51

g/l

2.11

2398

12398

Explicit bacterial Sepsis

811

2784

3.30

184.98

4.2

2.3

65.56

66.74

g/l

3.04

754

2505

Diseases of the digestive system

2891

16482

1.85

184.61

2.5

65.58

66.34

g/l

5.25

2644

14842

Cerebrovascular diseases

4504

20070

1.65

183.59

2.3

2.7

65.66

66.50

g/l

9.94

4046

18200

Infections of the skin and subcutaneous tissue

3134

18168

1.78

182.48

2.8

2.5

65.78

66.71

g/l

8.75

2912

16586

Persons encountering health services for examination and investigation

3375

9716

1.80

181.48

2.5

2.3

66.70

66.51

g/l

0.69

3088

8895

Type 2 diabetes, definitions combined

5059

19178

1.60

180.87

2.2

2.7

66.79

66.49

g/l

1.77

4604

17398

Gastro-oesophageal reflux disease

3776

20000

1.70

179.93

2.3

2.6

66.66

66.58

g/l

0.25

3400

18236

Insulin, fast-acting or short human

2240

11981

1.98

178.80

2.4

2.5

65.36

66.52

g/l

9.88

2079

10866

Other disorders involving the immune mechanism, not elsewhere classified

348

687

6.73

178.48

3.6

2.8

65.39

66.79

g/l

1.99

334

632

Other diseases of pericardium

438

1039

5.24

178.20

2.5

2.6

63.45

66.95

g/l

13.58

417

941

Other diseases of urinary system

5405

19930

1.57

178.19

2.5

2.6

66.19

66.67

g/l

4.37

4918

18206

Amyloidosis

315

581

8.09

177.99

7.2

2.6

63.01

66.25

g/l

6.96

301

529

Secondary and unspecified malignant neoplasm of lymph nodes

680

2169

3.66

177.92

2.6

1.6

64.03

66.88

g/l

12.82

652

1934

Use of hypnotics and sedatives

5745

21965

1.55

177.62

2.8

2.5

66.27

66.67

g/l

3.35

5210

20055

Type 2 diabetes, strict (exclude DM1)

5071

19333

1.59

176.88

2.2

2.7

66.80

66.49

g/l

2.00

4616

17540

Senile cataract

3689

13666

1.73

176.83

2.8

2.6

66.04

66.57

g/l

3.65

3347

12513

Other disorders of kidney and ureter

1023

4091

2.85

176.11

3.6

2.6

65.26

66.28

g/l

3.93

973

3706

Sulfasalazine

1562

7391

2.24

174.94

1.9

2.7

67.06

66.82

g/l

0.59

1454

6700

Presence of cardiac and vascular implants and grafts

2932

12584

1.84

174.63

2.1

2.5

65.45

66.36

g/l

7.80

2649

11324

Anaemia in chronic diseases classified elsewhere

312

579

7.76

173.93

5.4

2.8

63.25

66.47

g/l

7.83

295

524

Presence of other functional implants

3621

15309

1.72

172.96

2.5

66.22

66.49

g/l

1.20

3224

13804

Secondary uncertain malignant neoplasm

965

3775

2.87

172.01

2.6

1.6

64.19

66.68

g/l

14.31

909

3323

Viral pneumonia

890

3329

2.97

171.87

4.7

2.2

64.71

67.00

g/l

13.05

822

2981

Conduction disorders

1837

7459

2.13

171.70

2.3

2.6

65.53

66.95

g/l

11.61

1643

6690

Bronchitis

5725

24247

1.53

171.64

3.4

2.3

65.97

66.67

g/l

9.07

5229

22009

Amyloidosis, other/unspecified

280

483

9.27

171.25

7.8

2.7

62.86

66.16

g/l

6.46

270

438

Benzodiazepine use

5399

24816

1.54

170.63

2.4

2.5

66.23

66.60

g/l

2.79

4817

22668

Abdominal and pelvic pain

5266

17316

1.57

170.22

2.6

2.5

66.39

66.79

g/l

3.03

4812

15722

Disorders of gallbladder, biliary tract and pancreas

5443

22929

1.55

169.45

2.6

2.5

66.07

66.61

g/l

5.14

4967

20837

Lymphoid leukaemia

556

1635

4.24

169.27

3.2

2.8

64.49

66.18

g/l

4.40

527

1499

Other/unspecified dorsalgia

2077

10908

1.99

168.99

2.9

2.5

66.88

66.29

g/l

3.07

1868

9891

Pulmonary embolism

1984

10448

2.04

168.59

2.8

2.5

64.91

66.29

g/l

12.00

1832

9327

Suppurative and necrotic conditions of lower respiratory tract

547

1594

4.23

168.21

2.7

61.94

66.46

g/l

26.85

521

1458

Agranulocytosis

838

3102

3.08

167.52

4.0

2.6

65.12

66.49

g/l

4.61

804

2837

Sicca syndrome [Sjögren]

675

2227

3.52

166.72

1.9

2.7

69.59

66.50

g/l

17.30

614

2017

2355

12929

1.89

166.45

2.6

2.5

66.11

66.50

g/l

1.72

2155

11712

Other retinal disorders

3877

19004

1.66

166.33

2.6

65.93

66.34

g/l

2.62

3472

17154

Pulmonary heart disease

1984

10498

2.03

166.21

2.8

2.5

64.91

66.29

g/l

11.86

1832

9372

Cough

2223

11421

1.93

165.98

2.6

66.85

66.62

g/l

0.75

2019

10370

Hyperparathyroidism

1330

6033

2.40

165.54

2.8

2.5

65.69

66.10

g/l

1.18

1179

5349

Obesity and other hyperalimentation

3208

18655

1.72

165.53

2.0

2.6

66.82

66.68

g/l

0.47

2921

17122

Obesity

3190

18569

1.72

164.90

2.0

2.6

66.83

66.68

g/l

0.54

2905

17045

Type 2 diabetes, definitions combined, including avohilmo

4994

19105

1.57

164.87

2.2

2.7

66.85

66.49

g/l

2.54

4542

17347

Benign neoplasm: Colon

3393

19979

1.71

164.50

2.5

2.6

66.08

66.36

g/l

1.27

3062

18074

Pyothorax

455

1192

4.88

164.39

2.8

61.78

66.35

g/l

22.59

433

1089

Other joint disorders

4187

13849

1.64

163.70

2.2

2.6

67.10

66.40

g/l

7.00

3825

12650

Implicit fungal Sepsis

574

1744

3.89

163.05

2.8

2.5

64.45

66.91

g/l

8.72

515

1588

Other disorders of white blood cells

507

1430

4.33

162.78

2.3

2.9

66.10

66.40

g/l

0.34

468

1311

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1044

4367

2.65

161.13

3.2

1.6

64.51

66.91

g/l

16.05

999

3883

Isolated proteinuria

318

637

6.65

160.66

3.4

2.8

64.65

66.56

g/l

3.27

310

577

Postmenopausal osteoporosis with pathological fracture

611

1973

3.82

160.59

2.2

2.4

66.50

66.15

g/l

0.50

499

1742

Vocal cord dysfunction

696

2069

3.22

159.57

2.5

3.1

66.14

67.20

g/l

2.76

629

1933

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

314

625

6.61

159.28

3.4

2.8

65.09

66.98

g/l

3.13

300

574

Peripheral artery disease

2913

13786

1.79

158.94

2.3

2.6

64.96

66.29

g/l

15.33

2627

12358

Other cataract

2662

11632

1.83

157.92

2.7

2.6

66.07

66.50

g/l

2.08

2427

10609

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5225

22509

1.53

157.71

2.6

2.5

66.05

66.63

g/l

5.90

4747

20486

Sciatica+with lumbago

2676

14319

1.79

157.54

2.4

2.5

67.04

66.38

g/l

4.82

2436

13082

Factors influencing health status and contact with health services

1547

3558

2.27

156.95

2.7

2.0

66.63

67.09

g/l

1.26

1413

3224

Coxarthrosis [arthrosis of hip](FG)

3033

12721

1.75

156.62

2.3

2.8

66.45

66.28

g/l

0.59

2724

11529

Obesity related asthma

1966

10529

1.98

156.50

2.1

2.6

66.76

66.58

g/l

0.50

1786

9628

Injuries to the head

5776

24359

1.50

155.88

2.4

2.6

66.21

66.63

g/l

3.62

5192

22244

Non-invasive ventilation

1156

4472

2.43

155.70

2.9

3.0

64.71

67.27

g/l

20.59

1068

4106

Iron deficiency anaemia secondary to blood loss (chronic)

1141

5053

2.49

154.57

2.3

2.5

64.95

66.13

g/l

4.67

1016

4505

Acute myeloid leukaemia and myelodysplastic syndromes

265

471

7.99

153.92

2.3

1.5

65.91

66.75

g/l

0.87

252

414

Other bacterial intestinal infections

1228

5606

2.39

153.79

3.8

2.4

64.06

66.42

g/l

18.29

1111

5001

Fracture of lumbar spine and pelvis

1512

7502

2.19

152.37

2.6

2.5

65.20

66.05

g/l

3.51

1273

6675

AV-block

1223

4848

2.40

152.28

2.3

2.5

65.61

66.83

g/l

6.27

1088

4289

Disorders of eyelid, lacrimal system and orbit

4661

23612

1.55

151.32

2.7

2.5

66.50

66.46

g/l

0.12

4227

21447

Diseases of the eye and adnexa

3706

11505

1.66

149.83

2.6

2.4

66.86

66.79

g/l

0.21

3435

10616

Injuries to the abdomen, lower back, lumbar spine and pelvis

2329

13155

1.84

149.82

2.6

2.5

65.58

66.36

g/l

4.73

2005

11869

Other acute lower respiratory infections

2933

16947

1.72

149.13

3.4

2.4

65.76

66.46

g/l

4.96

2681

15299

Bacterial pneumonia (organism specified)

2699

14535

1.77

148.90

3.7

2.4

64.50

66.55

g/l

29.65

2505

13041

Sleep apnoea

5015

21931

1.53

148.88

2.2

2.6

67.12

66.40

g/l

9.52

4560

20067

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3273

20475

1.67

148.15

2.3

2.6

65.92

66.48

g/l

3.87

2985

18557

Obesity due to excess calories

2364

13571

1.82

147.96

2.0

2.6

66.98

66.72

g/l

0.90

2148

12491

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1066

4693

2.53

147.78

1.8

2.6

66.05

66.33

g/l

0.46

983

4289

Enterocolitis due to Clostridium difficile

833

3284

2.86

147.00

4.0

2.4

63.48

66.18

g/l

15.50

759

2940

Unspecified haematuria

2622

12827

1.79

146.78

2.6

65.97

66.43

g/l

2.12

2368

11630

Volume depletion

728

2677

3.07

146.67

2.5

2.4

63.68

66.13

g/l

11.27

656

2357

Chronic lymphocytic leukaemia

330

744

6.00

146.46

2.2

1.6

64.14

66.82

g/l

5.71

314

660

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

330

744

6.00

146.46

2.2

1.6

64.14

66.82

g/l

5.71

314

660

Chronic lymphocytic leukaemia, helper endpoint

330

744

6.00

146.46

2.2

1.6

64.14

66.82

g/l

5.71

314

660

Abnormalities of gait and mobility

936

3919

2.71

146.39

1.9

2.6

66.58

66.01

g/l

1.46

857

3541

Other bacterial intestinal infections

1442

7125

2.17

146.13

3.6

2.4

64.35

66.49

g/l

18.38

1299

6390

Myalgia

1274

5992

2.26

145.14

2.4

2.6

66.80

66.59

g/l

0.46

1159

5455

ILD, hospital admission 2, with pulmonary infections

747

2807

3.02

144.98

2.3

2.1

65.72

66.73

g/l

2.60

693

2486

Adjustment and management of implanted device

1300

6237

2.28

144.55

2.4

2.3

65.56

66.39

g/l

3.60

1185

5461

Gonarthrosis [arthrosis of knee](FG)

3836

14244

1.62

143.54

2.3

2.7

66.78

66.38

g/l

2.44

3498

12951

Viral infections characterized by skin and mucous membrane lesions

4424

25314

1.54

143.24

3.0

2.5

66.20

66.60

g/l

2.79

4051

23042

Polyarthrosis

1292

5724

2.26

142.20

2.2

2.9

66.72

65.92

g/l

3.18

1150

5118

Later onset COPD, excluding more controls

1346

4981

2.26

141.91

2.1

2.3

65.05

66.91

g/l

13.82

1192

4367

Other (not insulin) diabetes medications

5090

20574

1.51

141.85

2.2

2.7

66.88

66.46

g/l

3.28

4610

18682

Type 1 diabetes

1345

6506

2.18

141.61

2.4

2.6

65.08

66.59

g/l

10.10

1247

5941

Other neurological diseases

4153

21614

1.57

141.56

2.4

2.6

66.08

66.42

g/l

2.14

3753

19545

Bacterial intestinal infections, IBD co-morbidities

1230

5816

2.30

141.25

3.8

2.4

64.10

66.26

g/l

15.53

1115

5204

Persons encountering health services in other circumstances

2100

11762

1.86

140.36

2.6

2.5

66.42

66.61

g/l

0.53

1953

10627

Coronary atherosclerosis

3696

15005

1.62

140.23

2.4

2.7

65.79

66.63

g/l

8.59

3421

13502

Ischaemic heart disease, wide definition

4299

17686

1.56

138.61

2.5

2.7

66.01

66.62

g/l

5.51

3964

16007

Fibrosis and cirrhosis of liver

626

2220

3.29

137.19

1.9

2.8

66.73

66.38

g/l

0.44

585

2027

Benign neoplasms

4888

18254

1.51

137.01

2.6

2.4

66.42

66.73

g/l

1.86

4463

16705

Atherosclerosis, excluding cerebral and coronary sclerosis

2712

13054

1.74

136.04

2.2

2.7

65.00

66.24

g/l

12.39

2439

11684

Abnormal findings on examination of urine, without diagnosis

403

1108

4.44

134.26

3.3

2.9

65.27

66.40

g/l

1.82

390

1013

GI-bleeding

2062

11778

1.86

134.18

2.3

2.5

65.33

66.15

g/l

4.43

1888

10522

Chronic apical periodontitis

5764

23141

1.45

132.83

2.7

2.5

66.45

66.61

g/l

0.78

5233

21084

Other diseases of the digestive system

2054

11769

1.85

132.32

2.4

2.5

65.30

66.16

g/l

4.75

1880

10518

Cardiomyopathies, Primary/intrinsic

807

3284

2.71

131.59

2.1

2.6

64.30

67.07

g/l

18.10

754

2951

Abnormalities of heart beat

1875

10194

1.89

131.58

2.3

2.5

66.29

66.57

g/l

0.85

1679

9193

Diarrhoea and gastroenteritis of presumed infectious origin

5166

23686

1.47

131.46

2.8

2.4

65.79

66.74

g/l

14.46

4701

21536

Diabetic retinopathy, excluding more controls

1546

4380

2.13

131.42

2.4

2.2

65.84

67.12

g/l

7.65

1423

3937

Falls/tendency to fall

5344

18528

1.48

131.30

2.4

2.6

66.39

66.81

g/l

3.38

4824

17140

Undetermined asthma, excluding more controls

688

2568

2.88

130.98

2.3

2.0

66.33

67.65

g/l

4.42

630

2278

Weight loss

741

2924

2.87

130.79

2.2

2.6

66.38

66.30

g/l

0.10

670

2662

Other and unspecified disorders of white blood cells

382

1035

4.56

130.55

2.3

2.9

66.41

66.39

g/l

0.02

356

944

Non-Hodgkin lymphoma, all

412

1176

4.30

130.43

3.7

1.6

63.68

66.46

g/l

6.48

398

1041

Pacemaker

2217

12517

1.81

129.94

2.2

2.6

65.40

65.99

g/l

2.93

1984

11118

Diffuse large B-cell lymphoma, helper endpoint

419

1215

4.23

129.72

2.2

1.6

62.67

66.79

g/l

16.06

396

1093

Diffuse large B-cell lymphoma

419

1215

4.23

129.72

2.2

1.6

62.67

66.79

g/l

16.06

396

1093

Diffuse large B-cell lymphoma, including Hilmo

419

1215

4.23

129.72

2.2

1.6

62.67

66.79

g/l

16.06

396

1093

Hypothyroidism, strict autoimmune

3545

15055

1.59

129.11

2.4

2.7

66.57

66.50

g/l

0.17

3215

13567

Abnormal weight loss

702

2720

2.95

129.11

2.0

2.6

66.53

66.27

g/l

0.37

633

2479

Other symptoms and signs involving the nervous and musculoskeletal systems

2246

13228

1.78

129.02

2.2

2.6

67.22

66.43

g/l

5.90

2080

12012

Any mental disorder

5702

20093

1.46

128.94

2.3

2.7

66.31

66.64

g/l

2.35

5132

18445

Type 1 diabetes, wide definition, subgroup 1

1075

4948

2.30

128.78

2.6

64.88

66.72

g/l

12.15

993

4557

Hernia

4839

22402

1.49

128.61

2.5

66.13

66.64

g/l

4.30

4359

20367

Early onset COPD, excluding more controls

1070

4934

2.31

128.11

2.0

2.2

65.11

67.47

g/l

17.55

987

4482

Shoulder lesions

3968

15915

1.56

127.85

2.3

2.7

66.58

66.51

g/l

0.21

3646

14444

Cardiomyopathy (excluding other)

826

3443

2.64

127.85

2.1

2.5

64.36

67.07

g/l

17.91

770

3088

Sleep apnoea, including avohilmo

5140

22222

1.47

127.54

2.2

2.6

67.14

66.39

g/l

10.56

4670

20324

Chronic nephritic syndrome

362

962

4.63

126.82

3.2

2.8

64.10

66.57

g/l

6.38

349

880

Arthrosis

3583

12683

1.60

126.60

2.2

2.7

66.92

66.29

g/l

5.04

3258

11540

Asthma, hospital admissions , main diagnosis only

4148

24822

1.52

126.20

2.2

2.6

66.30

66.57

g/l

1.56

3785

22554

Dysphagia

1511

7983

2.02

126.18

2.4

2.5

65.65

66.46

g/l

3.51

1358

7160

Other external causes of accidental injury

4121

13675

1.55

125.92

2.4

2.6

66.38

66.83

g/l

3.05

3724

12638

Viral infections characterized by skin and mucous membrane lesions

2222

13123

1.77

125.91

3.5

2.4

65.73

66.55

g/l

5.19

2050

11917

Hypokalaemia

808

3365

2.65

125.63

2.6

2.4

64.90

66.54

g/l

5.96

728

2991

Calcific aortic valvular stenosis, operated

2017

11338

1.85

125.59

2.4

2.5

65.83

65.91

g/l

0.18

1832

10035

Calcific aortic valvular stenosis

2017

11338

1.85

125.59

2.4

2.5

65.83

65.91

g/l

0.18

1832

10035

Cirrhosis of liver, NAS

478

1539

3.76

125.41

2.0

2.8

66.27

66.33

g/l

0.05

451

1404

Operations 2 for CAVS

2013

11323

1.85

125.03

2.4

2.5

65.84

65.92

g/l

0.15

1828

10021

Calcific aortic valvular stenosis, diagnosis (helper)

2013

11323

1.85

125.03

2.4

2.5

65.84

65.92

g/l

0.15

1828

10021

Calcific aortic valvular stenosis, including rheumatic fever

2018

11360

1.84

124.53

2.4

2.5

65.85

65.91

g/l

0.11

1833

10053

Acquired haemolytic anaemia

280

632

5.96

124.02

3.4

2.7

65.57

66.40

g/l

0.76

266

573

Asthma, including avohilmo

5989

24143

1.43

123.97

2.2

2.6

66.48

66.58

g/l

0.45

5474

21944

Convulsions, not elsewhere classified

1099

5104

2.23

123.68

1.9

2.3

65.57

67.11

g/l

7.43

1002

4614

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1450

7525

2.04

123.66

3.7

1.7

64.48

66.83

g/l

21.92

1348

6741

Acute bronchitis

2289

13433

1.75

123.48

3.4

2.4

65.84

66.35

g/l

2.35

2078

12035

Failure and rejection of transplanted organs and tissues

174

252

10.09

122.97

6.1

3.1

63.41

67.19

g/l

6.46

169

236

SLE (Finngen)

286

644

5.33

122.94

2.0

3.0

66.12

67.24

g/l

1.38

267

586

Other respiratory diseases principally affecting the interstitium

1265

6397

2.16

122.68

2.4

2.5

65.86

66.03

g/l

0.29

1175

5708

Coxarthrosis

2753

11229

1.68

122.52

2.2

2.8

66.56

66.17

g/l

1.83

2471

10185

Haemolytic anaemias

333

859

4.82

121.86

3.3

2.7

65.83

66.14

g/l

0.24

317

779

Seronegative rheumatoid arthritis

728

2921

2.73

121.84

2.1

3.0

65.81

66.21

g/l

0.61

669

2641

Sleep disorders (combined)

5785

21688

1.43

121.65

2.2

2.6

66.98

66.36

g/l

7.73

5207

19783

Other headache syndromes

2067

12055

1.78

121.54

2.2

2.7

67.09

66.54

g/l

2.96

1895

10979

Diaphragmatic hernia

2169

12926

1.77

121.15

2.5

2.6

66.00

66.42

g/l

1.62

1940

11658

Mood disorders, excluding more controls

4709

19447

1.48

121.09

2.2

2.7

66.74

66.69

g/l

0.19

4228

17859

ILD, hospital admissions 3, with pneumonia sepsis

654

2531

2.94

120.41

2.3

2.2

65.36

66.69

g/l

3.78

609

2251

Vasculitis limited to skin, not elsewhere classified

281

651

5.61

119.53

2.3

3.0

67.19

66.56

g/l

0.59

263

588

Follow-up examination after treatment for conditions other than malignant neoplasms

2117

8103

1.79

118.90

2.4

66.44

66.49

g/l

0.10

1921

7428

Retention of urine

2148

10450

1.78

118.58

2.3

2.6

65.74

66.39

g/l

3.25

1935

9455

Other CVD

1373

7219

2.06

118.48

2.8

2.4

64.81

65.95

g/l

6.14

1209

6381

Biguanides

4939

21155

1.46

117.77

2.1

2.7

66.93

66.37

g/l

5.38

4470

19222

Seropositive rheumatoid arthritis, wide

1604

8849

1.93

117.52

1.9

2.6

66.33

66.29

g/l

0.07

1499

7936

743

3047

2.62

117.39

2.5

65.47

66.87

g/l

4.73

689

2775

Accidents

4064

13675

1.53

116.25

2.4

2.6

66.39

66.83

g/l

2.86

3673

12638

Fibromyalgia

519

1785

3.18

116.15

2.1

2.6

67.64

66.86

g/l

1.72

481

1639

Chronic gastritis

1698

9570

1.89

115.85

2.2

2.6

66.05

66.17

g/l

0.25

1500

8556

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1559

8571

1.94

115.58

1.9

2.6

66.36

66.29

g/l

0.12

1456

7695

Asthma/COPD (KELA code 203)

4692

22556

1.46

114.99

2.2

2.6

66.10

66.68

g/l

5.60

4267

20528

Statin medication

3086

11077

1.61

114.00

2.5

2.7

66.41

66.85

g/l

2.34

2839

10107

Other/unspecified seropositive rheumatoid arthritis

1578

8747

1.92

113.84

1.9

2.6

66.37

66.29

g/l

0.15

1473

7848

Giant cell arteritis

403

1249

4.01

113.57

1.7

2.9

65.22

66.11

g/l

1.36

364

1122

Other reaction to severe stress, and adjustment disorders

1579

8678

1.89

113.51

2.6

2.4

66.36

67.00

g/l

2.61

1466

8023

IgA nephropathy (IgA glomerulonephritis)

244

524

6.02

113.38

2.0

2.8

65.25

67.27

g/l

3.10

230

480

Pruritus

697

2857

2.68

111.80

2.1

2.6

66.61

66.38

g/l

0.33

644

2596

Major coronary heart disease event excluding revascularizations

3414

15126

1.56

111.59

2.4

2.7

65.56

66.55

g/l

10.67

3104

13584

Immunodeficiency with predominantly antibody defects

252

561

5.67

111.52

4.2

2.7

62.66

67.15

g/l

11.34

243

514

Other and unspecified vasculitis limited to skin

258

591

5.71

111.49

2.3

3.0

67.16

66.55

g/l

0.52

242

532

Other specified/unspecified systemic involvement of connective tissue

420

1326

3.64

111.27

2.0

3.0

67.91

66.69

g/l

2.26

395

1205

Type 1 diabetes, wide definition

1106

5447

2.14

110.98

2.6

2.5

64.82

66.63

g/l

12.20

1021

4989

Mixed connective tissue disease

463

1554

3.42

110.83

2.0

2.8

68.08

66.71

g/l

2.94

435

1414

Undetermined asthma

688

2797

2.63

110.27

2.3

2.0

66.33

67.33

g/l

2.79

630

2495

Immunodeficiencies

376

1119

3.95

110.19

3.8

2.8

63.53

66.69

g/l

9.40

362

1024

Hypotension

1208

6244

2.11

110.05

2.7

2.4

64.74

65.89

g/l

5.52

1055

5514

Non-allergic asthma (mode), excluding more controls

893

4018

2.32

109.99

2.2

66.00

67.56

g/l

7.25

820

3571

Fungal Sepsis

355

1025

4.17

109.90

3.3

2.5

63.08

67.01

g/l

11.82

325

941

Injuries to the hip and thigh

2752

16040

1.62

109.72

2.3

2.5

65.14

66.37

g/l

12.46

2359

14493

Drug-induced osteoporosis with pathological fracture

217

449

7.15

108.67

2.0

3.0

63.76

66.73

g/l

5.20

187

401

Other disorders of lacrimal gland

1896

11221

1.77

107.82

3.0

2.6

66.71

66.41

g/l

0.97

1718

10151

Other gastritis (incl. Duodenitis)

1358

7322

1.98

106.90

2.5

2.6

65.96

66.35

g/l

0.97

1224

6564

Depression or dysthymia

3506

12905

1.54

106.84

2.3

2.7

66.79

66.59

g/l

0.75

3134

11935

Lumbar disc prolapse

3074

15499

1.57

106.64

2.5

67.05

66.37

g/l

5.51

2815

14187

Anxiety disorders, excluding more controls

3919

17510

1.49

106.30

2.4

2.7

66.63

66.75

g/l

0.41

3559

16110

COPD

2678

14092

1.63

106.00

2.1

2.7

65.16

66.34

g/l

11.51

2409

12732

Implicit fungal Sepsis

332

941

4.28

105.85

3.3

2.5

63.31

67.02

g/l

10.33

304

862

Other arthrosis

2659

11706

1.63

105.78

2.3

2.8

66.77

66.26

g/l

2.96

2419

10668

Sequelae of external causes of morbidity and mortality

1503

8396

1.90

105.57

2.7

2.5

65.61

66.34

g/l

3.00

1399

7581

Injuries to the thorax

2506

15969

1.63

105.49

2.6

2.5

65.75

66.49

g/l

5.04

2233

14473

Other (seronegative) rheumatoid arthritis, wide

1162

6006

2.08

104.61

2.1

2.5

65.75

66.32

g/l

1.53

1065

5395

External causes of morbidity and mortality

3188

10418

1.57

104.49

2.5

66.40

66.96

g/l

3.63

2908

9606

Visual disturbances and blindness

2753

17948

1.59

104.43

2.5

66.52

66.38

g/l

0.45

2482

16228

Myelodysplastic syndrome

155

240

9.84

104.09

2.2

1.7

65.81

66.48

g/l

0.42

145

208

Fracture of rib(s), sternum and thoracic spine

1780

10490

1.79

103.61

2.7

2.5

65.77

66.40

g/l

2.78

1573

9472

Gonarthrosis

3238

12196

1.56

103.60

2.2

2.7

66.83

66.27

g/l

3.72

2957

11084

Mycoses

1477

8254

1.89

103.08

2.9

2.5

65.40

66.52

g/l

6.00

1352

7502

Idiopathic gout

694

2980

2.63

102.94

2.3

2.6

64.96

66.03

g/l

3.07

638

2692

Gastroduodenal ulcer

1613

9242

1.84

102.80

2.3

2.6

65.46

66.15

g/l

2.72

1477

8257

Psychiatric diseases

5032

18064

1.43

102.64

2.3

2.7

66.37

66.62

g/l

1.33

4528

16629

Cutaneous abscess, furuncle and carbuncle

1335

7234

1.94

102.09

2.5

2.4

65.82

66.72

g/l

4.00

1241

6618

Myocardial infarction

2776

12695

1.60

101.93

2.4

2.7

65.31

66.53

g/l

13.06

2520

11378

Viral hepatitis, IBD co-morbidity

230

494

4.99

101.03

2.1

2.9

67.58

66.58

g/l

0.87

211

465

Stroke, including SAH

3618

18102

1.50

100.31

2.3

2.7

65.48

66.45

g/l

10.67

3246

16369

ILD, hospital admissions

1043

5302

2.16

100.13

2.3

2.5

66.26

66.05

g/l

0.35

968

4749

Disorders of lacrimal system

2258

14202

1.65

99.59

2.9

2.5

66.73

66.35

g/l

1.57

2050

12813

Other respiratory disorders and diseases

1312

7176

1.96

99.57

2.2

2.5

64.96

66.04

g/l

4.85

1185

6407

Other diseases of the respiratory system

1312

7176

1.96

99.57

2.2

2.5

64.96

66.04

g/l

4.85

1185

6407

Other interstitial pulmonary diseases

1055

5394

2.14

99.55

2.3

2.5

66.28

66.04

g/l

0.43

979

4824

Interstitial lung disease endpoints

1055

5415

2.13

98.47

2.3

2.5

66.28

66.04

g/l

0.42

979

4843

Interstitial lung disease

1055

5415

2.13

98.47

2.3

2.5

66.28

66.04

g/l

0.42

979

4843

Endocarditis

298

820

4.32

98.44

2.5

2.6

64.86

67.14

g/l

4.49

283

744

Cystitis

4236

17762

1.45

98.39

2.4

2.6

66.46

66.63

g/l

0.72

3848

16149

Primary hyperparathyroidism

747

3367

2.47

98.25

2.8

2.7

66.35

66.33

g/l

0.03

660

3015

Other disorders of skin and subcutaneous tissue, not elsewhere classified

899

4337

2.25

98.15

2.6

2.5

65.47

66.37

g/l

2.59

794

3907

Other symptoms and signs involving cognitive functions and awareness

2609

15518

1.59

97.58

2.1

2.7

66.01

66.33

g/l

1.27

2279

14049

Methotrexate

768

3471

2.37

97.44

2.0

2.8

66.14

66.58

g/l

0.80

718

3129

Acute sinusitis

2329

13679

1.62

97.16

3.3

2.3

66.49

66.77

g/l

1.01

2122

12514

Systemic lupus erythematosus

286

772

4.40

97.04

2.0

2.9

66.12

66.96

g/l

0.91

267

709

Rare circulating lymphoid malignancy, including Hilmo

261

666

4.78

96.40

4.9

1.6

64.33

66.90

g/l

4.21

250

602

Temporal arteritis

347

1086

3.96

96.32

1.7

3.0

65.19

66.16

g/l

1.41

316

973

Cardiomyopathy, other and unspecified

512

1949

2.92

96.21

2.4

2.5

64.86

67.07

g/l

7.65

470

1747

Chronic ulcer of skin, not elsewhere classified

524

2035

2.93

96.06

2.5

64.98

66.23

g/l

2.85

475

1845

Other/unspecified cytomegaloviral diseases

198

412

6.30

95.78

6.5

2.9

61.99

67.06

g/l

11.94

189

382

Periodontitis

4884

23829

1.40

95.49

2.6

2.5

66.48

66.55

g/l

0.27

4427

21716

Cytomegalovirus infection, IBD co-morbidity

220

500

5.62

95.38

6.0

2.6

62.23

67.07

g/l

12.69

208

460

Myeloid leukaemia

272

730

4.74

95.26

2.3

3.1

65.39

66.40

g/l

1.31

264

663

Substance abuse, excluding more controls

2705

15196

1.56

94.48

1.8

2.7

66.15

66.75

g/l

3.22

2413

14072

Zoster [herpes zoster]

2696

17619

1.57

94.44

3.1

2.5

66.10

66.37

g/l

1.04

2443

15862

Other diseases of liver

1010

5141

2.10

94.40

2.1

2.6

67.22

66.53

g/l

1.90

915

4713

Chronic periodontitis, including avohilmo

4864

23823

1.40

94.17

2.6

2.5

66.49

66.55

g/l

0.22

4407

21712

Amputation

730

3316

2.44

94.13

2.7

2.5

63.57

66.15

g/l

13.14

661

2949

Cardiomyopathy in other diseases

109

131

17.09

93.75

8.3

2.3

63.45

66.62

g/l

2.70

101

115

Diseases of oral cavity, salivary glands and jaws

3270

11349

1.52

93.08

2.6

2.4

66.16

66.33

g/l

0.56

2921

10265

Other degenerative diseases of the nervous system

1528

6527

1.83

92.97

2.0

2.8

66.50

66.17

g/l

0.85

1325

5896

Cytomegaloviral disease

221

514

5.42

92.83

6.0

2.8

62.26

66.92

g/l

12.11

209

473

Stroke, excluding SAH

3451

17490

1.49

92.74

2.3

2.7

65.43

66.42

g/l

10.35

3098

15783

Noninfective enteritis and colitis

2278

14590

1.61

92.57

2.5

66.18

66.59

g/l

1.63

2090

13265

Diseases of the myoneural junction and muscle

789

3717

2.32

92.21

2.0

2.6

64.90

66.29

g/l

4.83

699

3367

Acute upper respiratory infections of multiple and unspecified sites

3531

18183

1.47

92.21

3.7

2.3

66.08

66.65

g/l

4.12

3237

16542

Visual disturbances

2499

16407

1.58

92.06

2.5

2.6

66.61

66.44

g/l

0.57

2270

14875

Dental operations

3433

12052

1.51

91.86

2.6

2.3

66.28

66.32

g/l

0.10

3084

10849

Rotator cuff syndrome

3116

15205

1.52

91.38

2.3

2.7

66.62

66.50

g/l

0.39

2862

13803

Cholelithiasis, broad definition with cholecystitis

4452

21715

1.41

90.83

2.6

66.16

66.58

g/l

2.98

4032

19689

Zoster [herpes zoster]

1129

6066

2.00

90.64

3.8

2.5

65.70

66.24

g/l

1.43

1033

5402

Cellulitis

1202

6564

1.94

90.39

3.0

2.4

65.38

66.55

g/l

5.15

1124

5977

Other abnormalities of plasma proteins

185

386

6.61

90.38

3.9

2.7

63.05

66.24

g/l

3.49

173

339

Other chronic obstructive pulmonary disease

2525

13714

1.58

90.02

2.1

2.7

65.08

66.35

g/l

12.44

2265

12380

Mood [affective] disorders

4899

23369

1.39

89.51

2.1

2.6

66.74

66.58

g/l

0.74

4408

21340

Mood disorders

4911

23398

1.39

89.46

2.1

2.6

66.74

66.57

g/l

0.80

4418

21366

Osteomyelitis

464

1755

3.00

89.32

2.9

2.5

64.97

66.40

g/l

3.27

421

1622

Urticaria and erythema

1696

10220

1.72

89.00

2.7

2.5

66.91

66.57

g/l

1.07

1552

9332

Osteonecrosis

440

1625

3.09

88.85

7.0

2.5

65.33

66.65

g/l

2.87

406

1505

Diabetic maculopathy, excluding more controls

654

2890

2.46

88.50

2.8

2.6

65.25

66.37

g/l

3.07

607

2627

Disorders of the thyroid gland

4669

22263

1.40

88.49

2.4

2.6

66.40

66.54

g/l

0.60

4256

20241

Other and unspecified types of non-Hodgkin lymphoma, hilmo

360

1205

3.57

88.46

3.2

2.9

63.80

66.17

g/l

5.46

340

1095

Obesity, other/unspecified

1539

9060

1.76

88.03

1.8

2.5

66.58

66.78

g/l

0.50

1423

8308

Fracture of femur

1670

9142

1.75

87.76

2.3

2.5

64.70

65.98

g/l

7.58

1370

8111

Hydronephrosis

677

3048

2.41

87.63

2.8

2.4

65.37

66.58

g/l

3.81

632

2745

SLE, ICD10

277

788

4.18

87.35

2.0

2.8

66.15

67.19

g/l

1.26

258

721

SLE, strict definition

277

788

4.18

87.35

2.0

2.8

66.15

67.19

g/l

1.26

258

721

Giant cell arteritis with polymyalgia rheumatica

347

1154

3.70

87.33

1.7

2.9

65.19

66.21

g/l

1.56

316

1038

Missing teeth due to accident, extraction or parodontitis

3192

20950

1.49

87.19

2.6

66.37

66.42

g/l

0.13

2789

19124

Hypoparathyroidism

309

952

3.91

86.91

2.3

2.8

65.52

66.50

g/l

1.39

271

858

Non-allergic asthma (mode)

893

4412

2.10

86.43

2.2

66.00

67.24

g/l

4.90

820

3945

Other autoimmune haemolytic anaemias

165

331

7.32

85.40

3.1

3.0

66.64

66.25

g/l

0.19

158

296

Migraine

1988

10097

1.64

85.31

2.2

2.7

67.07

66.70

g/l

1.52

1821

9276

Candidiasis

1425

8323

1.79

84.73

2.7

2.5

65.78

66.59

g/l

3.37

1277

7548

Other diseases of hard tissues of teeth

3163

11190

1.50

84.54

2.5

2.4

66.28

66.34

g/l

0.16

2829

10143

Depression

4445

22060

1.39

84.42

2.1

2.6

66.74

66.62

g/l

0.51

3998

20189

Acute peritonitis

460

1784

2.92

84.32

3.1

2.7

63.16

66.48

g/l

14.99

439

1626

Neurotic, stress-related and somatoform disorders

4018

20269

1.42

84.30

2.4

2.6

66.63

66.69

g/l

0.21

3654

18540

Anxiety disorders

4071

20505

1.41

84.12

2.4

2.6

66.64

66.68

g/l

0.11

3701

18756

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2514

11290

1.57

83.95

2.8

1.6

65.93

66.85

g/l

7.33

2266

10049

Diagnoses used for exclusion with ILD

1477

8774

1.78

83.57

2.2

2.4

66.11

66.32

g/l

0.44

1350

7909

ILD, hospital admissions 1, main diag only

919

4765

2.11

83.53

2.3

2.5

66.39

66.02

g/l

0.68

848

4270

Valvular operations

823

4073

2.17

83.36

1.9

2.6

65.47

66.89

g/l

5.52

763

3627

Respiratory insufficiency

500

2006

2.72

83.27

1.9

2.0

64.85

66.77

g/l

6.10

449

1752

2866

17774

1.50

83.15

1.8

2.6

66.08

66.69

g/l

3.48

2572

16378

malignant neoplasm of female genital organs

843

4194

2.15

83.01

4.9

1.5

64.93

66.73

g/l

9.90

785

3663

Abnormal findings on diagnostic imaging of other body structures

813

4025

2.18

82.82

2.9

2.6

65.99

66.52

g/l

1.08

756

3651

Mycoses

4058

25730

1.40

82.65

2.5

66.31

66.60

g/l

1.56

3650

23502

Ischaemic Stroke, excluding all haemorrhages

3236

16909

1.48

82.27

2.3

2.6

65.43

66.37

g/l

9.12

2910

15225

Other diseases of blood and blood-forming organs

468

1855

2.83

81.82

3.4

2.8

66.85

66.35

g/l

0.67

422

1703

Gastric ulcer

1087

5955

1.95

81.73

2.3

2.6

65.08

66.17

g/l

4.10

989

5279

Injury, poisoning and certain other consequences of external causes

2537

8334

1.56

81.46

2.5

2.6

66.51

67.00

g/l

2.34

2311

7669

2973

18153

1.48

81.38

1.8

2.6

66.10

66.70

g/l

3.48

2667

16735

Malignant neoplasm of skin

2539

11623

1.55

81.31

2.8

1.6

65.90

66.88

g/l

8.19

2282

10356

Peripheral artery operations in Hilmo

840

4242

2.14

81.23

2.6

2.5

64.17

66.14

g/l

9.17

758

3775

Alcohol use disorder, Swedish definition

2724

17068

1.51

81.04

1.8

2.6

66.03

66.68

g/l

3.63

2444

15725

Amputation of toe

536

2286

2.66

81.01

2.9

2.6

63.61

66.20

g/l

10.06

488

2071

Other general symptoms and signs

279

812

3.73

80.91

1.9

2.5

67.28

66.96

g/l

0.27

257

741

Diseases of pulp and periapical tissues and dental caries

3612

13081

1.45

80.73

2.4

2.5

66.18

66.33

g/l

0.51

3248

11804

Cholelithiasis

4234

21439

1.39

79.90

2.6

2.5

66.20

66.57

g/l

2.35

3830

19424

Sequelae with surgical and medical care as external cause

1180

6678

1.88

79.88

2.6

65.66

66.34

g/l

2.14

1097

6011

Anxiety (asthma-related co-morbidities)

2451

12618

1.54

79.75

2.1

2.6

66.80

66.92

g/l

0.31

2226

11688

Secondary right heart disease

351

1227

3.38

79.71

2.1

2.7

65.27

66.19

g/l

1.33

330

1103

Marginal zone B-cell lymphoma, including Hilmo

174

382

6.09

79.69

2.5

1.6

66.05

67.48

g/l

1.21

163

338

Other diseases of anus and rectum

1598

9772

1.70

79.33

2.7

2.5

65.87

66.45

g/l

2.15

1399

8817

Deforming dorsopathies

1341

7842

1.78

79.00

2.5

2.6

66.65

66.35

g/l

0.71

1220

7143

Malignant neoplasm of respiratory system and intrathoracic organs

1220

5766

1.87

78.87

1.9

1.6

64.84

66.72

g/l

13.40

1139

5101

Systemic lupus erythematosus, unspecified

240

665

4.31

78.75

1.8

2.7

66.19

67.25

g/l

1.19

224

611

Paralytic ileus and intestinal obstruction

1425

8500

1.76

78.70

2.7

2.5

65.26

66.36

g/l

5.35

1296

7649

Myocardial infarction, without ST-elevation

2399

14741

1.55

78.20

2.3

2.6

65.39

66.15

g/l

5.27

2147

13221

Acute upper respiratory infections

5114

23799

1.35

78.11

3.3

2.3

66.30

66.54

g/l

1.39

4656

21592

Other noninfective gastroenteritis and colitis

1273

7371

1.81

78.05

2.7

2.5

65.68

66.42

g/l

2.56

1169

6658

Caries of dentine, including avohilmo

4179

15568

1.40

77.91

2.5

66.20

66.42

g/l

0.92

3762

14111

Other and unspecified diseases of blood and blood-forming organs

237

661

4.41

77.90

4.2

2.9

66.88

66.70

g/l

0.12

223

607

Dental caries, including avohilmo

3964

14664

1.42

77.76

2.4

2.5

66.18

66.37

g/l

0.77

3563

13272

Fentanyl

634

2912

2.35

77.76

5.4

2.1

64.97

65.92

g/l

1.98

563

2573

Diseases of pulp and periapical tissues, including avohilmo

5205

20352

1.35

77.29

2.6

2.5

66.60

66.50

g/l

0.38

4726

18474

Rheumatism, unspecified

733

3578

2.19

76.81

2.0

2.8

66.89

66.49

g/l

0.82

679

3236

Nonischemic cardiomyopathy

622

2869

2.37

76.45

2.4

2.6

64.40

66.35

g/l

6.54

576

2564

Peripheral arterial reconstruction

1114

6317

1.90

75.89

2.2

2.5

64.60

65.95

g/l

6.40

1001

5603

Open wound of head

2742

18346

1.48

75.76

2.3

2.6

65.89

66.49

g/l

3.71

2443

16720

Disorders of continuity of bone

515

2196

2.53

75.28

3.3

2.5

66.52

66.71

g/l

0.22

473

2027

Decubitus ulcer and pressure area

455

1858

2.77

75.28

2.0

2.6

64.10

66.19

g/l

5.36

402

1677

Intracranial injury

2864

18962

1.47

75.15

2.3

2.5

66.47

66.53

g/l

0.16

2548

17251

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2354

10803

1.55

74.93

2.7

1.6

65.82

66.82

g/l

7.70

2113

9595

Other chronic obstructive pulmonary disease, including avohilmo

2995

17495

1.47

74.58

2.0

2.7

65.22

66.43

g/l

13.67

2688

15873

Other disorders of ear

4583

22519

1.36

74.46

2.6

2.5

66.41

66.49

g/l

0.32

4111

20557

Complications of internal orthopaedic prosthetic devices, implants and grafts

1329

7938

1.77

74.28

2.2

2.5

65.72

66.17

g/l

1.25

1177

7086

Arthropathies in other diseases classified elsewhere

265

810

3.78

74.24

3.0

65.70

66.38

g/l

0.70

240

741

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

528

2301

2.50

74.01

3.6

2.5

65.95

66.68

g/l

1.32

489

2114

Migraine without aura

727

3551

2.12

73.99

2.4

2.5

67.10

66.97

g/l

0.19

672

3300

Soft tissue disorders related to use, overuse and pressure

1373

8243

1.74

73.85

2.4

2.7

66.20

66.49

g/l

0.74

1238

7479

Spondyloarthritis

912

4857

1.98

73.76

2.4

2.5

66.88

66.45

g/l

0.89

843

4404

Seropositive rheumatoid arthritis, strict definition

851

4462

2.04

73.50

1.8

2.6

66.64

66.49

g/l

0.23

791

4053

Other and unspecified immunodeficiencies with predominantly antibody defects

133

246

7.22

73.45

4.4

2.7

61.38

67.14

g/l

10.37

128

227

Hypothyroidism, other/unspecified

4262

20850

1.37

73.27

2.5

2.6

66.51

66.53

g/l

0.05

3869

18933

All anxiety disorders

2473

13274

1.51

73.09

2.1

2.5

66.81

66.89

g/l

0.19

2248

12237

Other anxiety disorders

1781

9799

1.62

73.04

2.0

2.5

67.00

67.01

g/l

0.02

1627

9058

Pain in thoracic spine

747

3731

2.11

72.85

2.8

2.5

66.92

66.46

g/l

0.98

682

3419

Other viral diseases

1228

7142

1.78

72.44

3.7

2.4

65.43

66.84

g/l

7.90

1158

6591

Need for other prophylactic measures

386

1479

2.93

72.20

2.3

2.8

64.20

66.67

g/l

7.07

371

1355

Biological medication for rheuma

763

3849

2.08

72.13

1.9

2.6

67.73

66.96

g/l

1.90

711

3573

Malignant neoplasm of mesothelium and soft tissue

300

1012

3.44

71.91

3.5

1.6

64.46

67.09

g/l

6.39

291

907

Other pulmonary heart/vessel disease

366

1380

3.07

71.90

2.1

2.7

65.16

66.11

g/l

1.45

340

1246

Exclusions for E4_PCOS_BROAD

851

4471

2.01

71.85

2.8

2.5

65.73

66.72

g/l

3.27

793

4117

Alcoholic liver disease

630

3007

2.29

71.44

1.7

2.7

65.64

66.40

g/l

1.27

567

2760

Sub-endpoint used in defining T1D endpoints

1429

8580

1.70

71.41

2.4

65.03

66.45

g/l

9.74

1318

7740

Myocardial infarction, strict

2486

12132

1.51

71.17

2.3

2.7

65.49

66.50

g/l

8.59

2260

10854

Irritable bowel syndrome

1249

7372

1.76

70.97

2.4

2.5

66.67

66.76

g/l

0.16

1122

6715

Pericarditis

256

787

3.73

70.86

2.6

2.4

64.62

67.31

g/l

5.97

242

714

Unspecified fall

2521

17209

1.49

70.82

2.3

2.5

65.72

66.44

g/l

4.62

2199

15629

Polyuria

1267

7567

1.77

70.58

2.1

2.6

66.41

66.35

g/l

0.11

1126

6842

Angina pectoris

2979

14062

1.46

70.45

2.6

2.7

66.11

66.56

g/l

2.49

2735

12618

Other viral diseases

1504

9244

1.66

70.19

3.4

2.3

65.67

66.89

g/l

7.58

1417

8524

Adrenocortical insufficiency

262

828

3.66

69.77

2.5

3.0

64.53

66.80

g/l

4.44

246

759

Gingivitis and periodontal diseases

5078

20013

1.33

69.55

2.6

2.5

66.56

66.47

g/l

0.33

4608

18184

Haemorrhage, not elsewhere classified

279

916

3.48

69.46

2.3

2.4

64.28

66.41

g/l

3.87

259

821

Other disorders of veins

1998

13210

1.56

69.44

2.3

2.6

66.61

66.60

g/l

0.02

1762

11956

Idiopathic thrombocytopenic purpura

238

715

3.93

69.16

3.3

2.6

66.53

66.33

g/l

0.14

225

645

Allergic asthma (mode), excluding more controls

796

4023

1.99

68.64

2.0

66.88

67.89

g/l

3.78

739

3642

Hypothyreosis and Thyroxine purchase for inclusion criteria

4406

21823

1.35

68.52

2.5

66.51

66.50

g/l

0.04

4004

19817

Injuries to the shoulder and upper arm

4100

24826

1.36

68.13

2.6

2.5

66.44

66.51

g/l

0.24

3675

22623

Abnormal involuntary movements

741

3802

2.08

68.03

2.5

2.6

66.67

66.26

g/l

0.77

669

3455

Disorder of lipoprotein metabolism, unspecified

787

4139

2.04

67.53

2.1

2.4

66.01

66.44

g/l

0.76

715

3684

Basal cell carcinoma, including avohilmo

2309

10839

1.52

67.39

2.8

1.6

65.90

66.82

g/l

6.63

2067

9629

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

611

2948

2.25

67.09

2.9

1.6

65.53

66.69

g/l

2.98

570

2598

Other disorders of adrenal gland

295

1018

3.27

67.06

2.5

2.9

64.79

66.70

g/l

3.70

279

935

Other diseases of intestine

811

4311

2.01

67.06

2.5

65.01

66.35

g/l

4.91

765

3902

Viral pneumonia (unknown virus, not influenza)

408

1660

2.69

66.75

3.9

2.7

64.83

66.70

g/l

4.77

380

1529

Diabetic retinopathy

1957

8083

1.59

66.18

2.3

2.2

65.86

66.65

g/l

4.29

1790

7336

Malignant neoplasm of ovary, including Hilmo

392

1580

2.75

65.93

6.1

1.5

64.26

66.91

g/l

9.04

371

1381

Persons encountering health services for specific procedures, not carried out

436

1830

2.56

65.91

2.2

2.4

66.82

67.19

g/l

0.46

400

1679

Functional dyspepsia

1290

7848

1.71

65.84

2.5

2.6

66.65

66.53

g/l

0.22

1178

7119

Demyelinating diseases of the central nervous system

421

1741

2.60

65.66

1.6

2.5

68.35

67.06

g/l

3.08

397

1608

All influenza (not pneumonia)

709

3610

2.07

65.47

4.3

2.2

65.76

67.25

g/l

5.15

648

3271

Malignant neoplasm of bronchus and lung, including Hilmo

1200

5991

1.77

65.22

1.9

1.6

64.86

66.68

g/l

12.23

1117

5299

Mental and behavioural disorders due to psychoactive substance use

2794

18499

1.43

65.13

1.8

2.6

66.18

66.70

g/l

2.66

2492

17033

Other symptoms and signs involving the digestive system and abdomen

841

4549

1.94

64.99

3.5

2.5

65.84

66.56

g/l

2.05

756

4093

Urticaria

1289

7851

1.70

64.96

2.7

2.5

66.94

66.71

g/l

0.50

1178

7186

Spondylopathies (FG)

607

2927

2.18

64.88

2.0

2.8

67.80

66.72

g/l

2.72

559

2702

Selective serotonin reuptake inhibitors

4733

18871

1.33

64.77

2.3

2.7

66.64

66.56

g/l

0.27

4258

17293

Eosinophilic disease (BM)

131

265

6.06

64.41

2.2

2.1

65.25

66.71

g/l

1.01

118

238

Other complications of surgical and medical care, not elsewhere classified

543

2535

2.31

64.32

2.8

2.5

65.76

66.65

g/l

1.86

499

2322

Cardiodefibrillation

2054

13992

1.53

64.16

2.4

2.6

65.49

66.27

g/l

4.59

1873

12622

Other or unspecified ileus, impaction or obstruction

1028

5948

1.82

63.89

2.7

2.5

65.33

66.32

g/l

3.14

933

5322

Other and unspecified myopathies

553

2625

2.31

63.78

2.1

2.5

64.82

66.23

g/l

3.49

479

2369

Basal cell carcinoma

2225

10537

1.51

63.66

2.8

1.6

65.86

66.79

g/l

6.43

1989

9346

Diseases of peritoneum

609

2997

2.20

63.43

2.8

2.6

63.97

66.35

g/l

11.12

569

2724

Drug-induced neutropenia

453

1990

2.52

63.36

3.7

2.8

64.32

66.57

g/l

6.55

435

1815

Oesophageal varices

305

1118

3.14

63.02

1.7

2.8

65.06

66.65

g/l

2.16

285

1022

Spondylopathies in diseases classified elsewhere

138

305

6.12

63.00

16.5

2.2

64.66

66.47

g/l

1.81

130

280

Substance abuse

2705

18193

1.43

62.61

1.8

2.6

66.15

66.71

g/l

2.93

2413

16764

Pneumonia due to other infectious organisms, not elsewhere classified

237

753

3.62

62.47

5.3

2.3

62.80

66.88

g/l

8.69

230

673

Charcot foot

159

390

5.03

62.27

3.5

2.9

65.67

67.40

g/l

1.85

146

355

COPD related to multimorbidity

2278

13403

1.49

62.26

2.0

2.6

64.92

66.27

g/l

12.81

2027

12079

Renal tubulo-interstitial disorders in diseases classified elsewhere

112

210

7.36

61.51

5.7

2.4

63.89

66.81

g/l

2.97

105

193

Carpal tunnel syndrome

2900

18552

1.41

61.46

2.4

2.6

66.83

66.51

g/l

1.54

2660

16834

Other and unspecified drugs and medicaments

489

2236

2.38

61.40

3.5

2.6

65.95

66.56

g/l

0.95

454

2038

Myeloproliferative diseases

536

2558

2.30

61.25

2.7

2.6

66.62

66.33

g/l

0.38

490

2320

COPD, early/later onset

2549

15306

1.45

61.20

2.1

2.6

65.08

66.33

g/l

12.23

2283

13842

Personality disorders, excluding more controls

938

5311

1.82

61.06

1.9

2.5

66.69

67.20

g/l

1.31

854

4975

Meniscus derangement

2532

12014

1.45

60.94

2.6

2.7

66.81

66.26

g/l

3.24

2301

10957

Other abnormal findings of blood chemistry

301

1116

3.04

60.16

3.5

2.8

67.04

66.69

g/l

0.33

291

1022

COPD, hospital admissions

2520

15214

1.45

59.74

2.1

2.6

65.09

66.33

g/l

12.00

2260

13751

Disorders of synovium and tendon

2338

14386

1.46

59.36

2.3

2.7

66.45

66.60

g/l

0.45

2138

13088

Somatoform disorder

757

4091

1.94

58.61

2.3

2.6

66.80

66.85

g/l

0.08

683

3758

Other coagulation defects

409

1767

2.51

58.50

2.6

65.90

66.56

g/l

0.96

384

1617

Diabetic neuropathy

730

3938

2.02

58.48

2.4

2.3

65.91

66.49

g/l

1.23

668

3567

Exposure to other specified factors

3338

22918

1.36

58.15

2.4

2.5

66.32

66.68

g/l

2.01

3004

21007

Diseases of spleen

161

422

4.71

57.89

2.1

2.8

64.52

66.36

g/l

1.70

153

388

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

967

5674

1.80

57.56

3.5

1.6

64.41

66.82

g/l

17.07

911

5044

Pyogenic arthritis

389

1658

2.55

57.44

2.6

2.9

66.28

66.05

g/l

0.22

363

1506

Other infectious diseases

544

2665

2.21

57.40

3.2

2.5

64.65

66.33

g/l

5.20

506

2429

Cervicalgia

984

5785

1.77

57.24

2.2

2.6

67.07

66.30

g/l

2.70

877

5246

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1008

5909

1.75

57.20

2.0

2.5

66.29

67.05

g/l

2.48

922

5516

Elevated blood glucose level

466

2152

2.34

57.02

3.0

2.6

65.13

66.34

g/l

2.72

427

1974

Allergic asthma (mode)

796

4277

1.87

57.01

2.0

66.88

67.62

g/l

2.27

739

3885

Recurrent or chronic depression

1617

7419

1.57

57.01

2.2

2.7

67.06

67.01

g/l

0.10

1463

6939

Benign neoplasm of other and ill-defined parts of digestive system

994

5906

1.78

56.87

2.5

2.6

65.66

66.27

g/l

1.72

908

5326

Subjective visual disturbances

1229

7678

1.67

56.77

2.4

2.6

66.96

66.45

g/l

1.63

1108

6960

Hypothyroidism, strict autoimmune, 3 medication purchases required

3914

20180

1.34

56.65

2.5

66.65

66.48

g/l

0.67

3537

18287

Benign neoplasm: Colon, unspecified

1419

9210

1.62

56.60

2.5

66.06

66.17

g/l

0.20

1264

8290

Non-small cell lung cancer, including Hilmo

860

4614

1.86

56.41

1.8

1.6

65.03

66.71

g/l

7.96

800

4065

Cervical disc disorders

1698

11400

1.54

56.27

2.3

2.6

66.80

66.39

g/l

1.54

1556

10433

Artrosis, including avohilmo

3943

16425

1.34

56.14

2.1

2.7

66.91

66.35

g/l

4.66

3570

15036

L01XX Other antineoplastic agents

412

1845

2.52

55.96

4.4

2.7

65.25

66.40

g/l

2.08

381

1683

Sarcoidosis

707

3815

1.97

55.92

2.1

2.6

66.73

66.66

g/l

0.08

669

3497

Other diseases of arteries and capillaries

528

2583

2.21

55.89

2.3

2.6

65.61

66.47

g/l

1.71

471

2335

Lichen simplex chronicus and prurigo

384

1661

2.54

55.38

2.3

2.8

67.20

66.35

g/l

1.39

353

1506

Prurigo nodularis

200

624

3.82

55.18

2.1

3.3

67.49

66.48

g/l

1.03

184

564

Motor neuron disease

155

406

4.54

55.08

1.6

2.9

67.88

66.05

g/l

2.59

142

371

L01XE Protein kinase inhibitors

377

1637

2.61

55.01

3.9

2.9

64.21

66.48

g/l

5.93

361

1503

Other/unspecified rheumatoid arthritis

718

3925

1.96

54.94

2.0

2.5

65.59

66.27

g/l

1.34

654

3509

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

567

2867

2.13

54.86

3.1

2.6

65.08

66.38

g/l

3.37

529

2625

Motor neuron disease (with DMD)

157

416

4.46

54.81

1.6

2.9

67.85

66.00

g/l

2.69

144

381

Coxibs

1384

4576

1.64

54.76

2.1

2.4

66.64

65.79

g/l

3.25

1253

4166

Symptoms and signs involving speech and voice

1650

11099

1.54

54.71

2.4

2.5

66.33

66.36

g/l

0.06

1498

10028

Migraine with aura

894

5157

1.79

54.70

2.0

2.6

67.07

66.77

g/l

0.65

821

4744

Abnormal results of function studies

464

2175

2.29

54.47

2.7

2.8

66.41

66.78

g/l

0.44

429

2010

Persons with potential health hazards related to communicable diseases

1353

8599

1.60

54.45

2.4

2.3

65.73

67.00

g/l

7.51

1270

7988

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1452

9509

1.58

54.24

2.4

2.5

65.78

66.55

g/l

3.19

1293

8659

Phlebitis and thrombophlebitis (not including DVT)

1137

7054

1.68

54.23

3.2

2.5

65.27

66.46

g/l

5.38

1047

6382

Candidiasis

689

3720

1.96

54.11

3.3

2.5

64.79

66.59

g/l

6.66

622

3395

Other skin changes

997

6007

1.75

53.91

3.7

2.5

65.36

66.18

g/l

2.57

912

5392

Protozoal diseases

230

791

3.42

53.85

6.0

2.9

63.34

66.57

g/l

5.89

221

721

Gout due to impairment of renal function

122

279

5.97

53.73

3.0

2.9

63.68

65.99

g/l

2.07

113

254

Degeneration of macula and posterior pole

2656

15482

1.41

53.65

2.6

65.98

66.09

g/l

0.30

2350

13823

Conductive and sensorineural hearing loss

3992

20801

1.32

53.60

2.6

66.36

66.41

g/l

0.16

3542

18943

Problems related to lifestyle

475

2249

2.23

53.53

1.8

2.6

66.46

67.09

g/l

0.92

432

2063

DVT of lower extremities

1019

6183

1.73

53.42

3.7

2.5

65.23

66.30

g/l

4.21

913

5570

Chronic sinusitis

1925

13364

1.48

53.22

2.4

2.6

66.33

66.59

g/l

0.79

1759

12212

Serous carcinoma of ovary, including Hilmo

243

866

3.25

53.07

6.9

1.5

64.28

67.10

g/l

6.47

233

763

Non-selective monoamine reuptake inhibitors

1835

12191

1.50

53.02

2.3

2.7

66.25

66.45

g/l

0.55

1645

11071

Nonalcoholic fatty liver disease

497

2417

2.20

52.99

2.1

2.8

68.37

66.75

g/l

4.45

449

2228

Vascular disorders of the intestines

442

2071

2.34

52.73

2.4

2.3

65.54

66.11

g/l

0.72

408

1845

Cerebral palsy and other paralytic syndromes

587

3035

2.06

52.64

2.0

2.6

66.03

66.39

g/l

0.47

531

2780

Disorders of skin appendages

2004

14031

1.46

52.60

2.4

2.5

66.66

66.74

g/l

0.19

1856

12841

Psoriatic and enteropathic arthropathies

524

2593

2.13

52.60

1.9

2.9

67.65

66.56

g/l

2.81

485

2391

Discitis, unspecified

150

401

4.62

52.57

2.8

2.7

65.21

66.09

g/l

0.67

144

373

Papulosquamous disorders

1863

12923

1.49

52.53

2.2

2.6

67.02

66.53

g/l

1.98

1710

11800

Abnormal findings on diagnostic imaging of central nervous system

280

1068

2.89

52.51

2.1

3.0

67.41

66.80

g/l

0.64

260

981

Intestinal stricture

1644

11163

1.53

52.37

2.8

2.5

65.25

66.22

g/l

4.82

1502

10013

Injuries to the knee and lower leg

5509

24507

1.27

52.11

2.3

2.6

66.14

66.64

g/l

4.78

4974

22357

Other and unspecified aplastic anaemias

112

241

5.96

52.06

3.2

2.9

65.24

66.55

g/l

0.92

104

216

Sequelae of cerebrovascular disease

1999

12125

1.47

51.96

2.2

2.6

65.46

66.18

g/l

3.54

1752

10862

Disorders of sclera, cornea, iris and ciliary body

2499

18250

1.40

51.94

2.5

66.99

66.52

g/l

2.47

2282

16616

Other specified/unspecified necrotizing vasculopathies

129

312

5.20

51.85

2.0

3.1

64.69

66.53

g/l

1.58

123

286

Type of accident

1356

8850

1.59

51.56

2.4

2.5

65.87

66.54

g/l

2.36

1202

8066

COPD, hospital admission 2, with asthma infections

1805

10699

1.50

51.50

2.2

2.6

64.65

66.24

g/l

13.85

1612

9605

Insulin, fast-acting (human)

624

3305

1.97

51.26

2.7

2.3

64.26

66.87

g/l

14.83

581

3045

Sensorineural hearing loss

3854

20241

1.32

51.24

2.6

66.30

66.39

g/l

0.26

3412

18419

Heart failure and hypertrophic cardiomyopathy

170

508

4.18

51.12

3.0

64.15

66.14

g/l

2.45

160

458

Other metabolic disorders

596

3117

2.01

51.08

3.1

2.4

66.03

67.02

g/l

2.53

561

2841

Tumor necrosis factor alpha inhibitors

638

3407

1.96

51.08

1.9

2.6

67.92

67.09

g/l

1.91

593

3164

Misadventures to patients during surgical and medical care

743

4184

1.88

51.06

3.0

2.5

64.77

66.44

g/l

6.40

679

3798

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1544

10380

1.54

51.04

2.5

65.91

66.54

g/l

2.74

1415

9443

Hypocalcemia

180

553

3.88

50.92

4.0

3.0

64.43

66.97

g/l

3.32

159

509

Unspecified acute lower respiratory infection

741

4168

1.87

50.73

3.5

2.3

65.24

66.49

g/l

4.08

691

3814

Postprocedural disorders of nervous system

313

1272

2.62

50.52

2.0

2.4

67.90

67.76

g/l

0.14

294

1182

Unspecified privation

572

2978

2.05

50.47

2.4

2.5

65.34

66.51

g/l

3.20

522

2731

Fracture of shoulder and upper arm

1751

12083

1.49

50.41

2.8

2.5

66.09

66.35

g/l

0.65

1532

10903

Folate deficiency anaemia

106

227

6.29

50.21

2.4

2.8

64.31

66.33

g/l

1.39

100

204

Chronic periodontitis, complicated

2655

19532

1.38

50.12

2.6

66.20

66.54

g/l

1.47

2422

17877

Malignant neoplasm of urinary organs

545

2806

2.09

50.06

2.9

1.6

65.67

66.68

g/l

2.10

502

2478

Paracetamol or NSAID medication

690

1817

1.96

49.89

2.7

2.2

66.49

66.12

g/l

0.51

623

1689

Viral pneumonia (known virus, not influenza)

203

678

3.51

49.88

7.2

2.8

64.77

66.29

g/l

1.64

187

611

COPD, hospital admissions 3, with asthma pneumonia sepsis

1570

9090

1.54

49.80

2.2

2.6

64.39

66.12

g/l

13.95

1401

8128

Dilated cardiomyopathy

698

3910

1.92

49.69

2.0

2.6

64.20

66.21

g/l

8.96

650

3550

Asthma and allergy, excluding more controls

402

1796

2.28

49.57

2.1

67.01

68.08

g/l

2.42

371

1647

Other embolism and thrombosis

692

3854

1.90

49.45

3.3

2.5

64.70

66.30

g/l

5.25

641

3470

Other diseases of upper respiratory tract

5293

22135

1.27

49.13

2.5

66.49

66.45

g/l

0.12

4825

20096

Mental and behavioural disorders due to alcohol

2341

16392

1.41

49.11

1.8

2.6

66.12

66.69

g/l

2.61

2101

15129

Drug-induced adrenocortical insufficiency

151

425

4.31

48.97

2.6

64.13

66.91

g/l

3.65

141

391

Chronic rhinitis, nasopharyngitis and pharyngitis

1408

9359

1.55

48.88

2.3

2.6

66.91

66.64

g/l

0.80

1276

8560

Diseases of the ear and mastoid process

5244

21102

1.26

48.56

2.6

2.5

66.72

66.55

g/l

0.86

4752

19338

Malignant neoplasm of kidney, except renal pelvis

499

2520

2.13

48.48

2.9

1.6

65.54

66.75

g/l

2.69

465

2224

Invasive ventilation

428

2046

2.28

48.46

2.8

2.7

63.56

66.34

g/l

8.02

397

1872

Other disorders of bone

836

4917

1.77

48.45

4.0

2.3

66.52

66.87

g/l

0.70

768

4555

Malignant neoplasm of bronchus and lung

991

5048

1.71

48.35

1.8

1.6

64.85

66.70

g/l

10.30

917

4449

Reactive arthropathies

426

2020

2.24

48.23

2.7

2.9

66.85

66.38

g/l

0.64

392

1855

Other infectious diseases

457

2242

2.21

48.21

3.3

2.5

64.38

66.39

g/l

5.95

423

2043

Transient ischemic attack

2780

16868

1.37

48.19

2.3

2.6

65.74

66.39

g/l

4.57

2493

15175

Malignant neoplasm of ovary

288

1168

2.74

48.08

6.2

1.5

63.89

66.95

g/l

8.92

274

1025

Acute pancreatitis

998

6186

1.69

47.94

2.3

2.5

65.74

66.48

g/l

2.04

915

5585

Hodgkin lymphoma, hilmo

190

620

3.49

47.92

2.5

3.1

65.96

66.64

g/l

0.45

182

571

Nonorganic sleeping disorders, excluding more controls

755

4327

1.81

47.65

1.9

2.6

66.51

66.91

g/l

0.78

690

4014

Noninfectious colitis NAS

673

3753

1.89

47.54

2.8

2.5

65.48

66.56

g/l

2.87

624

3406

Open wound of lower leg

755

4363

1.82

47.25

2.4

2.5

64.54

66.51

g/l

9.26

677

3946

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

204

706

3.38

47.24

6.5

1.5

63.65

67.05

g/l

7.36

196

623

Other disorders of glucose regulation and pancreatic internal secretion

444

2164

2.20

47.12

2.3

2.6

64.60

66.46

g/l

4.63

407

1987

Vitreous haemorrhage

564

2999

2.02

47.10

2.6

64.91

66.37

g/l

4.65

519

2732

Other and unspecified coagulation defects

273

1086

2.75

46.94

2.7

66.19

67.00

g/l

0.97

259

1001

Myeloproliferative diseases (CML excluded)

464

2320

2.18

46.89

2.8

2.6

66.90

66.31

g/l

0.89

421

2109

Budesonide

580

3095

1.96

46.59

2.2

2.7

66.57

66.78

g/l

0.24

528

2819

Chronic tubulo-interstitial nephritis

235

873

2.99

46.59

2.4

2.5

64.67

67.17

g/l

4.03

211

788

Injuries to the elbow and forearm

3123

21020

1.33

46.12

2.4

2.6

66.07

66.60

g/l

3.56

2784

19107

Reactive arthropathies, FINNGEN

331

1442

2.45

46.08

2.7

3.0

67.03

66.45

g/l

0.75

303

1319

MS-disease / Multiple Sclerosis

324

1399

2.47

45.94

1.5

2.5

68.39

67.32

g/l

1.97

308

1295

Other extrapyramidal and movement disorders in other diseases

1195

7808

1.60

45.90

2.0

2.6

67.03

66.27

g/l

3.27

1072

7062

Glucagon-like peptide-1 (GLP-1) analogues

1292

8563

1.56

45.89

1.9

2.8

67.50

66.65

g/l

4.07

1185

7910

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1292

8563

1.56

45.89

1.9

2.8

67.50

66.65

g/l

4.07

1185

7910

Disorders of muscles

493

2514

2.07

45.82

2.0

2.6

66.32

66.49

g/l

0.20

455

2294

Other peripheral vascular diseases

432

2110

2.20

45.74

1.9

2.6

67.07

66.65

g/l

0.66

397

1928

Use of pramipexole

1157

7520

1.61

45.74

2.1

2.6

66.59

66.17

g/l

1.26

1026

6767

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

197

668

3.23

45.68

2.3

2.4

64.55

68.14

g/l

9.13

182

642

Congenital malformations, deformations and chromosomal abnormalities

2283

15927

1.39

45.66

2.2

2.5

66.27

66.81

g/l

2.81

2110

14599

Crystal arthropathies, rheuma endpoint

154

460

4.00

45.57

2.4

3.7

65.76

65.87

g/l

0.06

139

409

Chronic pancreatitis

655

3686

1.89

45.42

2.0

2.6

65.29

66.52

g/l

3.26

608

3355

Bipolar affective disorders

707

4040

1.81

45.07

1.9

2.6

66.38

67.03

g/l

1.38

642

3758

Gonarthrosis,primary

4459

21945

1.28

44.96

2.3

2.7

66.67

66.38

g/l

1.77

4031

19929

Diabetic retinopathy, strict definition

941

5163

1.71

44.96

2.6

2.2

65.31

66.72

g/l

6.34

857

4691

Covid-19 suspected case

858

5182

1.71

44.79

2.7

2.4

66.44

67.04

g/l

1.49

799

4765

Cystic kidney disease

218

798

3.07

44.78

2.5

2.9

64.12

66.76

g/l

5.22

207

731

Postprocedural endocrine and metabolic disorders, not elsewhere classified

541

2867

1.98

44.64

3.2

2.4

66.29

67.02

g/l

1.60

508

2621

Cystic kidney disease

207

740

3.16

44.52

2.5

2.9

64.14

66.82

g/l

5.13

197

679

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2029

14638

1.41

44.28

1.8

2.6

66.01

66.70

g/l

3.22

1819

13518

Extrapyramidal and movement disorders

1925

13871

1.43

44.27

2.0

2.6

66.59

66.23

g/l

1.31

1706

12495

Polyarthritis, unspecified

221

818

3.00

44.17

2.3

3.0

65.85

66.08

g/l

0.15

205

749

Epilepsy

1392

9399

1.52

44.12

2.2

2.6

66.03

66.30

g/l

0.57

1251

8525

Phobic anxiety disorders

439

2156

2.10

44.11

2.3

2.5

66.98

67.55

g/l

0.72

407

2019

Other and unspecified acquired haemolytic anaemias

100

227

5.80

44.06

2.9

2.0

65.34

66.29

g/l

0.38

207

Pyoderma gangrenosum

154

6.97

43.54

2.4

3.2

66.46

67.15

g/l

0.30

139

Trochanteric bursitis

679

3898

1.83

43.49

2.3

2.8

66.42

66.39

g/l

0.04

602

3516

Other symptoms and signs involving the circulatory and respiratory systems

341

1546

2.36

43.42

2.3

2.4

65.82

66.57

g/l

0.83

304

1409

Congenital malformations of the urinary system

316

1393

2.45

43.26

2.4

2.8

64.52

66.54

g/l

4.57

301

1287

Benign neoplasm: Sigmoid colon

1028

6602

1.64

43.18

2.6

66.28

66.22

g/l

0.09

937

5951

Psoriasis

1299

8732

1.54

43.16

2.0

2.6

67.12

66.61

g/l

1.58

1200

7981

Collagenous colitis

487

2538

2.05

43.14

2.8

2.7

65.77

66.37

g/l

0.86

445

2320

Asthma and allergy

402

1902

2.15

42.97

2.1

67.01

67.81

g/l

1.51

371

1743

Internal derangement of knee

1544

10659

1.48

42.94

2.2

2.7

66.81

66.35

g/l

1.77

1402

9759

Polycystic kidney disease

178

598

3.41

42.94

2.6

3.0

64.07

67.00

g/l

5.18

169

550

Radiculopathy

811

4910

1.73

42.76

2.4

2.5

66.57

66.06

g/l

1.11

734

4428

2256

15375

1.39

42.64

2.8

2.5

65.64

66.08

g/l

1.89

2012

13690

Marginal zone B-cell lymphoma

200

6.04

42.62

2.1

1.6

66.98

67.42

g/l

0.18

176

Eosinophilia

132

374

4.25

42.38

2.2

2.8

65.16

66.47

g/l

0.99

119

341

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

735

4201

1.77

42.36

2.2

2.7

64.88

66.62

g/l

7.13

685

3866

Superficial injury of head

1108

7234

1.59

42.16

2.0

2.5

65.98

66.33

g/l

0.81

990

6490

Alcohol use disorder, ICD-based

1875

13532

1.42

42.15

1.8

2.6

66.06

66.70

g/l

2.61

1686

12496

Delirium, not induced by alcohol and other psychoactive substances

702

4119

1.81

42.10

2.3

2.5

64.85

65.94

g/l

2.74

618

3678

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

688

3866

1.80

41.93

2.2

2.7

64.76

66.60

g/l

7.41

644

3573

Drug-induced osteoporosis

120

324

4.67

41.90

1.9

3.1

64.22

67.07

g/l

3.16

111

295

Superficial injury of hip and thigh

757

4528

1.75

41.86

2.0

2.4

65.42

66.19

g/l

1.99

669

4065

Congenital malformations, deformations and chromosomal abnormalities

2523

17521

1.35

41.72

2.2

2.5

66.30

66.79

g/l

2.67

2319

16063

In situ neoplasms

1870

13545

1.42

41.59

2.7

2.5

65.66

66.26

g/l

2.74

1688

12108

Myocarditis

205

743

2.94

41.58

2.6

2.3

64.84

67.81

g/l

5.51

193

676

Hypertrophic cardiomyopathy

273

1161

2.63

41.57

3.0

2.9

64.72

66.34

g/l

2.93

258

1065

Tubulo-interstitial nephritis, not specified as acute or chronic

359

1694

2.27

41.48

2.7

2.3

65.48

66.62

g/l

1.61

323

1521

Oxicams

1184

4376

1.58

41.37

2.2

2.5

66.68

65.70

g/l

3.91

1062

3973

Vitamin deficiency, wide

276

1177

2.56

41.09

2.4

2.7

65.84

66.63

g/l

0.93

247

1073

Vitamin deficiency

276

1177

2.56

41.09

2.4

2.7

65.84

66.63

g/l

0.93

247

1073

Congenital malformations of the urinary system

296

1298

2.46

41.06

2.4

2.8

64.52

66.48

g/l

4.06

284

1197

Panic disorder

503

2663

1.95

40.99

1.9

2.6

66.66

67.29

g/l

1.06

452

2472

Actinic keratosis

2106

14451

1.40

40.82

2.9

2.5

65.56

66.03

g/l

2.02

1882

12832

Non-small cell lung cancer, adenocarcinoma

364

1755

2.26

40.55

1.7

1.6

64.11

66.76

g/l

8.16

338

1554

Unspecified nephritic syndrome

164

546

3.49

40.47

4.3

2.8

63.30

66.68

g/l

5.50

155

493

Other viral diseases, not elsewhere classified

1000

6391

1.60

40.34

3.2

2.4

65.69

66.85

g/l

4.74

937

5895

Other and unspecified urticaria

811

4975

1.69

40.16

2.5

66.77

66.64

g/l

0.19

738

4566

Other demyelinating diseases of the central nervous system

187

663

3.08

40.08

1.7

2.6

68.67

67.98

g/l

0.65

176

622

Acetic acid derivatives and related substances

1315

4550

1.54

40.04

2.3

2.4

66.43

65.77

g/l

2.16

1193

4141

Other crystal arthropathies

154

500

3.66

40.00

2.4

3.2

65.76

65.84

g/l

0.04

139

448

Amiodarone users

591

3371

1.89

39.92

2.2

2.6

64.22

66.11

g/l

7.08

546

3055

Skin changes due to chronic exposure to nonionizing radiation

2144

14741

1.39

39.92

2.9

2.5

65.59

66.04

g/l

1.95

1914

13105

Nonhereditary hypogammaglobulinemia

226

5.29

39.89

3.6

2.8

61.88

67.51

g/l

7.14

212

Bronchiectasis

474

2525

2.03

39.88

2.8

2.6

65.67

66.14

g/l

0.64

426

2268

Cervicobrachial syndrome

917

5802

1.63

39.88

2.5

2.6

67.26

66.47

g/l

2.86

855

5296

Hepatic failure, not elsewhere classified

238

968

2.75

39.78

2.5

2.9

63.89

66.51

g/l

3.51

212

879

Viral and other specified intestinal infections

961

5906

1.61

39.75

2.7

2.3

65.91

67.08

g/l

4.55

902

5413

Spondylolisthesis/Spondylolysis

831

5152

1.68

39.72

2.7

2.6

66.65

66.35

g/l

0.54

760

4694

Pneumonia derived septicemia

219

857

2.85

39.51

5.7

2.7

67.13

66.30

g/l

0.53

193

772

Exclusions for E4_PCOS_CONSORTIUM

2853

13702

1.33

39.48

2.7

2.4

66.37

66.75

g/l

1.82

2558

12438

Drug-induced polyneuropathy

224

5.56

39.19

10.1

2.8

65.01

66.00

g/l

0.61

205

Other viral diseases, not elsewhere classified

753

4548

1.71

39.13

3.6

2.4

65.39

66.68

g/l

4.33

705

4191

Acute pancreatitis (for exclusion)

998

6496

1.60

39.06

2.3

2.5

65.74

66.37

g/l

1.59

915

5892

Rash and other nonspecific skin eruption

483

2590

1.98

39.05

2.2

2.6

66.81

66.43

g/l

0.55

445

2359

Hypoglycaemia, other or unspecified

351

1683

2.23

39.03

2.1

2.6

64.42

66.58

g/l

5.61

323

1546

Poisoning by drugs, medicaments and biological substances

892

5629

1.63

39.01

2.0

2.5

66.30

66.92

g/l

1.56

804

5233

Non-small cell lung cancer

553

3072

1.89

38.98

1.7

1.6

64.78

66.65

g/l

6.10

511

2674

Substance use, excluding alcohol

790

4847

1.69

38.97

1.8

2.6

66.18

66.90

g/l

1.59

692

4508

Other and unspecified effects of external causes

1085

7165

1.56

38.86

2.4

2.5

66.64

66.70

g/l

0.09

1007

6597

Other enthesopathies

1234

8371

1.51

38.84

2.4

2.7

66.74

66.70

g/l

0.07

1122

7639

Essential (haemorrhagic) thrombocythaemia

228

920

2.76

38.64

2.4

1.6

66.57

67.19

g/l

0.55

203

824

Herpesviral [herpes simplex] infections

538

2989

1.89

38.57

3.1

2.5

65.19

66.68

g/l

3.95

497

2738

Drug-induced cataract

164

562

3.36

38.45

3.3

2.9

64.90

66.96

g/l

2.78

156

513

Superficial injury of lower leg

1073

7104

1.56

38.19

2.1

2.5

65.80

66.65

g/l

3.32

951

6453

L04AC Interleukin inhibitors

275

1204

2.45

38.09

1.8

2.7

67.51

67.13

g/l

0.32

259

1119

Secondary thrombocytopenia

109

293

4.58

38.03

5.4

2.8

64.13

66.84

g/l

2.90

104

271

Other overlap syndromes

130

390

3.89

37.95

2.0

3.2

67.69

67.02

g/l

0.37

123

354

COPD-related respiratory insufficiency

680

4088

1.77

37.73

2.2

2.6

64.13

66.14

g/l

8.47

598

3647

Haemorrhoids and perianal venous thrombosis

1510

10687

1.45

37.72

2.5

66.45

66.48

g/l

0.04

1366

9648

Disorders of adult personality and behaviour

993

6468

1.57

37.64

1.8

2.4

66.68

67.07

g/l

0.94

899

6019

Benign neoplasm: Ascending colon

765

4743

1.71

37.62

2.7

2.6

66.29

66.17

g/l

0.16

700

4267

Malignant neoplasm of other connective and soft tissue, including Hilmo

246

1041

2.61

37.53

5.5

1.5

64.98

67.19

g/l

4.31

233

937

Benign neoplasm: Transverse colon

605

3534

1.83

37.50

2.9

2.7

65.76

66.24

g/l

0.81

546

3206

Herpesviral [herpes simplex] infections

974

6338

1.58

37.43

2.8

2.4

66.21

66.91

g/l

1.91

899

5795

Speech therapy

1276

8812

1.50

37.35

2.4

2.5

66.33

g/l

0.01

1216

7922

Generalized anxiety disorder

514

2824

1.87

37.27

1.9

2.6

67.05

67.34

g/l

0.39

471

2618

Inflammatory bowel disease

1310

9065

1.48

37.27

2.2

2.5

66.69

66.72

g/l

0.04

1211

8327

Myositis

166

580

3.23

37.22

1.9

2.9

65.36

66.81

g/l

1.79

160

523

Oter anti-inflammatory and antirheumatic agents, non-steroids

1152

4209

1.56

37.21

2.3

2.5

66.13

65.65

g/l

1.17

1032

3818

Migraine without aura and triptan purchases

519

2863

1.87

37.17

2.0

2.4

67.09

67.25

g/l

0.19

483

2649

Familial hypercholesterolemia

792

4951

1.68

37.13

2.8

2.4

65.70

66.37

g/l

1.60

730

4386

Unstable angina pectoris

1912

11121

1.40

37.06

2.3

2.7

66.08

66.32

g/l

0.70

1721

9912

Psoriatic arthropathies

446

2364

1.98

36.97

1.9

2.8

67.63

66.37

g/l

3.03

409

2183

Migraine with aura and triptan purchases

511

2818

1.87

36.70

1.9

2.4

67.03

67.28

g/l

0.36

477

2593

Coxarthrosis, primary

3060

20435

1.30

36.63

2.3

2.7

66.46

66.25

g/l

0.82

2727

18433

Leukaemia of unspecified cell type

226

5.21

36.58

3.6

2.8

63.57

66.31

g/l

2.51

202

Infection of intervertebral disc (pyogenic)

115

330

4.27

36.55

2.8

2.9

64.38

66.40

g/l

1.64

106

305

Systemic sclerosis (FG)

147

484

3.43

36.51

1.9

3.4

65.54

66.33

g/l

0.52

136

440

Adverse effects, not elsewhere classified

797

4985

1.65

36.51

2.6

2.5

67.00

66.70

g/l

0.56

747

4594

Other diseases of lip and oral mucosa

1770

12971

1.40

36.42

2.7

2.6

66.93

66.53

g/l

1.52

1606

11816

5-aminosalicylic acid

771

4776

1.66

36.39

2.1

2.6

66.98

66.93

g/l

0.06

718

4378

Diplopia

651

3893

1.76

36.33

2.4

2.5

66.20

66.29

g/l

0.11

599

3537

Viral and other specified intestinal infections

712

4213

1.69

36.26

2.9

2.2

65.64

67.13

g/l

4.91

665

3856

Other local infections of skin and subcutaneous tissue

495

2738

1.91

36.21

3.3

2.6

65.75

66.55

g/l

1.42

455

2521

Other encephalitis

167

594

3.14

36.15

2.3

2.9

66.07

66.77

g/l

0.43

151

548

Gastrointestinal stromal tumor and sarcoma

100

264

4.75

35.98

6.2

1.6

64.05

67.03

g/l

4.31

239

Hyperplasia of prostate

1817

7508

1.41

35.92

2.7

2.6

65.93

66.62

g/l

3.33

1656

6930

Injuries to the ankle and foot

2769

19175

1.30

35.79

2.5

66.62

66.73

g/l

0.32

2545

17620

Other abnormal immunological findings in serum

126

382

3.74

35.77

2.1

2.7

68.72

66.63

g/l

2.81

115

347

Other and unspecified local infections of skin and subcutaneous tissue

468

2556

1.94

35.70

3.4

2.7

65.54

66.56

g/l

2.03

432

2350

Amputation of foot

190

738

2.98

35.60

3.4

2.9

63.05

65.94

g/l

4.93

169

671

Traumatic subdural haemorrhage

683

3979

1.72

35.60

2.4

2.7

65.88

g/l

0.00

607

3565

Thyroiditis, ILD-related definition

477

2613

1.91

35.59

2.4

2.6

67.74

66.59

g/l

3.13

441

2380

Microscopic polyangiitis

159

6.66

35.55

1.7

2.9

62.42

66.83

g/l

3.31

142

Cardiac arrest

297

1165

2.30

35.39

2.2

2.5

63.96

67.38

g/l

8.83

276

1042

Dermatophytosis

657

3972

1.74

35.29

2.6

65.94

66.42

g/l

0.80

603

3610

Polyarteritis nodosa and related conditions

105

287

4.31

35.27

2.1

2.7

64.84

66.94

g/l

1.69

258

Benign neoplasm: Stomach

534

3061

1.86

35.26

2.6

65.45

66.28

g/l

1.73

477

2782

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

916

5872

1.58

35.25

2.4

66.19

66.96

g/l

2.17

846

5433

Poisoning by medicine

795

5004

1.64

35.22

2.0

2.5

66.36

66.98

g/l

1.40

716

4650

Diseases of salivary glands

1393

9866

1.45

35.15

2.3

2.6

66.66

66.50

g/l

0.31

1256

8993

Systemic atrophies primarily affecting the central nervous system

265

1199

2.45

34.98

2.2

2.9

67.56

66.41

g/l

2.02

246

1089

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2256

16718

1.34

34.98

2.5

2.6

66.62

66.61

g/l

0.02

2064

15320

Scoliosis

359

1799

2.10

34.95

2.1

2.6

66.16

66.18

g/l

0.02

324

1640

Etanercept

293

1366

2.28

34.86

2.0

2.7

67.58

66.95

g/l

0.72

273

1273

Intestinal malabsorption

248

1086

2.48

34.77

2.2

2.9

65.07

67.00

g/l

3.05

231

996

Clear cell adenocarcinoma of kidney

260

1170

2.44

34.57

3.0

1.6

65.83

66.87

g/l

1.28

240

1060

Raynaud syndrome

394

2055

2.03

34.56

1.7

2.7

67.52

66.70

g/l

1.61

358

1878

Disorders of optic nerve and visual pathways

427

2288

1.97

34.45

2.2

2.7

66.64

66.72

g/l

0.08

398

2112

Iridocyclitis

1020

6844

1.54

34.39

2.8

2.5

67.19

66.50

g/l

2.04

932

6228

Dermatitis due to substances taken internally

277

1274

2.33

34.31

4.3

2.8

65.58

66.47

g/l

1.05

253

1162

Inflammatory diseases of female pelvic organs

2289

12817

1.34

34.28

2.2

2.5

66.72

66.63

g/l

0.22

2037

11599

Diseases of male genital organs

2284

8702

1.35

34.24

2.4

2.6

66.25

66.78

g/l

2.54

2108

8074

Pleural plaque

552

3228

1.83

34.10

2.2

2.6

67.06

66.10

g/l

2.26

490

2865

Cramp and spasm

249

1102

2.45

34.08

2.6

2.7

66.65

66.61

g/l

0.03

231

1016

Encephalitis

173

647

2.97

34.06

2.3

2.9

66.17

66.71

g/l

0.33

156

594

Pneumonia due to Streptococcus pneumoniae

220

920

2.59

34.05

4.5

2.2

67.10

67.00

g/l

0.05

193

824

Early onset COPD

1070

7278

1.53

34.02

2.0

2.6

65.11

66.54

g/l

7.22

987

6646

Fissure and fistula of anal and rectal regions

1036

6979

1.53

34.00

2.5

66.57

66.72

g/l

0.26

927

6369

Pneumococcal septicemia

206

847

2.70

33.63

5.8

2.7

67.36

66.19

g/l

0.81

181

766

Adalimumab

378

1955

2.02

33.62

1.9

2.7

68.39

67.09

g/l

2.68

352

1823

Disorders of vitreous body and globe

2463

18394

1.32

33.62

2.6

2.7

66.23

66.39

g/l

0.49

2241

16663

Other diseases of pancreas

445

2450

1.94

33.60

2.6

65.23

66.47

g/l

2.50

407

2219

Hernia of abdominal wall

2123

16191

1.34

33.54

2.5

2.6

66.12

66.49

g/l

1.41

1942

14729

Ankylosing spondylitis

389

2041

2.00

33.32

1.9

2.6

67.74

66.68

g/l

1.75

359

1892

Bullous disorders

337

1700

2.15

33.32

2.2

2.6

66.40

66.14

g/l

0.26

313

1543

Personality disorders

938

6205

1.55

33.21

1.9

2.4

66.69

67.05

g/l

0.80

854

5777

Other diseases of oesophagus

499

2845

1.85

33.20

2.1

2.6

65.65

66.13

g/l

0.73

449

2570

Polycystic ovarian syndrome, consortium definition

2697

12446

1.30

32.93

2.4

2.5

66.55

66.63

g/l

0.23

2387

11257

Stomatitis and related lesions

842

5474

1.59

32.89

2.8

2.5

66.34

66.53

g/l

0.29

768

4988

Thyrotoxicosis, other and/or unspecified

850

5539

1.59

32.78

2.3

2.6

65.52

66.62

g/l

4.02

772

5027

Disorders of conjunctiva

3457

22408

1.26

32.69

2.6

2.5

66.84

66.56

g/l

1.43

3170

20377

Lesion of lateral popliteal nerve

265

1226

2.34

32.63

2.5

2.6

67.06

66.23

g/l

1.02

245

1132

Follicular lymphoma, hilmo

270

1270

2.36

32.61

2.9

3.0

63.70

66.37

g/l

6.38

256

1159

Other shoulder lesions

401

2140

1.96

32.56

1.8

2.7

66.59

66.63

g/l

0.03

376

1960

Other inflammatory liver diseases

336

1700

2.12

32.52

2.4

2.8

66.62

66.36

g/l

0.21

304

1555

Vitamin D deficiency

116

355

3.70

32.51

1.7

2.5

65.82

67.37

g/l

1.15

106

326

Voice disturbances

1202

8422

1.47

32.49

2.5

2.6

66.33

66.44

g/l

0.20

1094

7625

Fracture of lower leg, including ankle

2418

18641

1.31

32.21

2.2

2.6

66.24

66.64

g/l

1.71

2168

16977

Duodenal ulcer

583

3510

1.75

31.88

2.1

2.6

66.15

66.02

g/l

0.15

539

3128

Cholecystectomy

3271

22772

1.26

31.74

2.6

2.5

66.26

66.45

g/l

0.75

2963

20591

Thyrotoxicosis

1095

7570

1.49

31.70

2.2

2.5

65.50

66.50

g/l

4.32

994

6833

Pneumothorax

357

1861

2.05

31.67

2.4

2.5

64.63

66.65

g/l

4.75

331

1689

Other symptoms and signs involving the urinary system

531

3124

1.79

31.67

2.4

2.7

65.05

66.27

g/l

3.23

506

2832

Lung diseases due to external agents

737

4711

1.64

31.58

2.3

2.5

65.42

65.96

g/l

0.90

649

4216

Psoriasis vulgaris

831

5448

1.58

31.41

2.0

2.6

67.30

66.54

g/l

2.07

758

5008

Benign neoplasm of other and unspecified endocrine glands

632

3902

1.70

31.26

2.3

2.6

66.13

66.43

g/l

0.46

575

3580

Chronic myeloproliferative disease

117

377

3.79

31.26

2.6

3.2

66.01

66.08

g/l

0.03

107

343

Other specified/unspecified inflammatory spondylopathies

205

859

2.54

31.24

2.0

2.7

68.37

66.82

g/l

2.20

185

807

Fitting and adjustment of other devices

1720

11588

1.37

31.23

2.7

2.4

66.16

66.65

g/l

1.73

1504

10251

Other inflammation of eyelid

632

3900

1.69

31.16

3.0

2.5

66.63

66.43

g/l

0.26

555

3545

Acute posthaemorrhagic anaemia

204

863

2.59

31.15

3.0

2.8

65.14

66.42

g/l

1.25

177

773

Disorders of vitreous body

2381

17987

1.31

31.12

2.6

2.7

66.24

66.39

g/l

0.44

2168

16305

Neuromuscular dysfunction of bladder

456

2583

1.87

31.06

2.0

2.7

65.85

66.56

g/l

1.06

408

2341

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

637

3946

1.69

30.85

2.5

1.6

64.90

66.37

g/l

5.26

575

3425

Abscess of lung

114

360

3.69

30.83

2.2

3.0

62.15

66.69

g/l

5.80

108

333

Speech disturbances, not elsewhere classified

474

2728

1.84

30.78

2.1

2.6

66.34

66.16

g/l

0.17

425

2472

Guillain-Barre syndrome

117

376

3.63

30.77

2.5

2.8

67.12

66.67

g/l

0.22

108

344

Other disorders of nervous system

355

1871

2.03

30.72

2.6

2.7

65.59

66.60

g/l

1.48

326

1715

Neuralgia and neuritis, unspecified

247

1135

2.33

30.67

2.6

2.9

66.70

66.52

g/l

0.15

224

1036

Sequelae of other external causes

289

1417

2.19

30.55

3.0

2.7

65.25

66.65

g/l

2.25

274

1295

Acute and subacute iridocyclitis

844

5585

1.56

30.51

3.0

2.5

67.13

66.58

g/l

1.27

778

5101

Faecal incontinence

453

2575

1.86

30.45

2.0

2.4

66.05

66.41

g/l

0.49

409

2283

Inflammatory diseases of the central nervous system

388

2104

1.95

30.34

2.6

66.15

66.48

g/l

0.32

357

1939

Coronary artery bypass grafting

1382

7448

1.43

30.23

1.9

2.6

65.60

66.24

g/l

2.32

1264

6618

Diseases of external ear

1509

11123

1.39

30.11

2.6

2.5

66.72

66.39

g/l

0.89

1290

10122

Enthesopathies of lower limb, excluding foot

872

5824

1.54

29.81

2.4

2.5

66.58

66.56

g/l

0.02

790

5343

Disorders of ocular muscles, binocular movement, accommodation and refraction

1815

13623

1.34

29.72

2.5

66.66

66.65

g/l

0.01

1673

12459

Xerosis cutis

119

397

3.53

29.60

2.1

3.1

65.55

66.49

g/l

0.81

111

363

Nonorganic sleeping disorders

755

4898

1.59

29.53

1.9

2.5

66.51

66.87

g/l

0.67

690

4527

Artificial joint operation, meniscal resection

4306

23278

1.22

29.51

2.4

2.6

66.59

66.43

g/l

0.66

3910

21156

Benign neoplasm: Caecum

581

3584

1.72

29.41

2.8

2.6

66.13

66.16

g/l

0.03

537

3254

Malnutrition

142

522

3.10

29.36

2.4

2.9

62.37

65.93

g/l

3.45

134

468

Specific personality disorders

796

5226

1.56

29.29

1.8

2.5

66.50

67.09

g/l

1.50

721

4863

Anterior Iridocyclitis

892

6024

1.53

29.26

2.9

2.5

67.18

66.52

g/l

1.70

819

5497

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1008

6944

1.48

29.24

2.0

2.4

66.29

66.98

g/l

2.17

922

6450

Abnormal serum enzyme levels

1473

10612

1.39

29.15

2.3

2.6

65.90

66.31

g/l

1.23

1353

9694

Infective dermatitis

525

3144

1.75

29.13

2.2

2.7

66.75

66.38

g/l

0.49

483

2856

Vitamin B12 deficiency anaemia

543

3287

1.74

29.11

2.3

2.5

65.74

66.11

g/l

0.50

490

2938

Coeliac disease

522

3118

1.75

29.07

3.0

2.6

66.94

66.63

g/l

0.40

475

2850

Recurrent aphthous stomatitis , including avohilmo

631

3957

1.66

29.06

3.0

2.5

66.09

66.40

g/l

0.44

577

3611

Other disorders of eyelid

2188

16260

1.31

29.05

2.4

2.6

66.15

66.17

g/l

0.03

1960

14601

Localized swelling, mass and lump of skin and subcutaneous tissue

1368

9988

1.40

28.96

2.5

66.23

66.43

g/l

0.43

1247

9061

Aortic aneurysm

1190

8350

1.45

28.89

2.4

2.6

65.67

66.37

g/l

2.42

1069

7553

Ventral hernia

1130

8006

1.46

28.87

2.5

2.6

65.78

66.42

g/l

2.02

1026

7232

Persistent mood disorders

805

5332

1.56

28.80

2.1

2.5

66.86

66.62

g/l

0.39

724

4872

Lesion of ulnar nerve

627

3935

1.66

28.80

2.2

2.5

66.39

66.55

g/l

0.21

575

3622

Alcohol abuse, main dg, excluding more controls

597

3693

1.67

28.76

1.7

2.7

66.07

66.83

g/l

1.44

538

3443

Malignant neoplasm, without specification of site, including Hilmo

257

1235

2.24

28.68

3.0

1.5

64.03

66.62

g/l

5.02

237

1080

Emphysema

403

2270

1.89

28.29

2.6

2.7

65.27

65.93

g/l

0.86

372

2049

Diabetic maculopathy

645

3870

1.66

28.28

2.6

2.3

65.24

66.69

g/l

4.98

599

3498

Hyperhidrosis

130

456

3.05

28.28

2.0

2.5

67.28

67.45

g/l

0.11

117

412

Fracture of foot, except ankle

950

6525

1.49

28.27

2.8

2.5

66.39

66.73

g/l

0.72

873

6022

Conjunctivitis

2989

20185

1.25

28.11

2.6

2.5

66.93

66.58

g/l

1.83

2735

18359

Acute nephritic syndrome

134

488

3.10

28.07

3.4

2.8

62.94

66.79

g/l

5.01

126

444

Respiratory disorders in diseases classified elsewhere

108

352

3.64

28.03

2.2

3.0

66.26

66.52

g/l

0.11

100

321

Speech and linguistic disorders, excluding more controls

245

1082

2.20

27.76

2.4

2.7

65.93

66.82

g/l

0.96

222

1006

Acidosis

138

516

3.03

27.63

2.4

2.7

65.04

66.74

g/l

1.18

128

474

Parkinson's disease, excluding more controls

655

3948

1.63

27.55

1.8

2.9

66.29

66.11

g/l

0.25

566

3581

Other abnormal uterine and vaginal bleeding

976

4811

1.49

27.50

2.4

2.5

66.32

66.30

g/l

0.02

826

4303

Systemic sclerosis

147

568

2.89

27.43

1.9

2.8

65.54

67.08

g/l

1.41

136

516

Other problems related to primary support group, including family circumstances

368

1955

1.89

27.40

2.7

2.5

65.02

67.22

g/l

5.16

350

1821

Acute generalized exanthematous pustulosis

232

1093

2.29

27.38

4.7

2.9

65.82

66.66

g/l

0.79

211

995

Other bursopathies

601

3781

1.65

27.38

2.7

65.83

66.40

g/l

0.99

550

3423

Cerebral cysts

259

1267

2.17

27.33

2.3

2.6

66.49

66.91

g/l

0.39

241

1168

Disorders of vestibular function (Vertigo)

2183

16887

1.30

27.33

2.4

2.6

66.76

66.32

g/l

2.13

1938

15200

Late syphilis

310

3.75

27.29

4.4

2.8

65.83

67.01

g/l

0.82

280

Gingival hyperplasia

193

846

2.49

27.28

2.7

3.1

64.50

66.37

g/l

2.06

176

776

Malignant neoplasm of breast, including Hilmo

1579

7615

1.37

27.27

2.6

1.5

66.21

67.05

g/l

3.96

1419

6760

Fracture of forearm

2346

17008

1.28

27.24

2.4

2.6

66.07

66.51

g/l

2.10

2090

15386

Cardiomyopathy, Hypertrophic obstructive

117

402

3.29

27.20

2.2

2.9

64.80

67.60

g/l

3.40

110

365

Varicose veins

2885

17618

1.26

27.20

2.5

2.6

66.43

66.50

g/l

0.18

2584

15922

Malignant neoplasm of breast, HER2-negative, including Hilmo

1578

7615

1.37

27.16

2.6

1.5

66.21

67.05

g/l

3.97

1418

6760

Extreme obesity with alveolar hypoventilation

225

1054

2.33

27.13

1.8

2.9

66.38

66.63

g/l

0.18

198

964

Lung transplant status

162

5.18

27.10

1.6

2.8

61.11

66.96

g/l

5.04

154

Lung transplantation

162

5.17

27.08

1.6

2.8

61.11

66.96

g/l

5.04

154

Crohn disease

511

3090

1.71

27.02

1.9

2.6

66.21

66.85

g/l

1.00

478

2846

Atopic dermatitis, strict definition with reimbursement

925

6132

1.48

27.02

2.2

2.4

67.14

67.01

g/l

0.22

857

5695

Primary biliary cholangitis (PBC)

126

452

3.11

26.97

1.6

2.6

68.41

67.49

g/l

0.49

112

413

Organic, including symptomatic, mental disorders

2665

15239

1.27

26.94

2.2

2.6

65.76

66.15

g/l

1.69

2284

13728

Dissociative [conversion] disorders

155

611

2.69

26.92

1.6

2.8

67.68

67.58

g/l

0.05

134

563

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

567

3516

1.66

26.89

2.1

2.6

66.60

67.13

g/l

0.90

514

3279

Metatarsalgia

397

2245

1.85

26.89

2.2

2.7

66.76

66.64

g/l

0.12

361

2051

Artificial opening status

299

1560

2.06

26.86

2.9

2.6

64.80

66.57

g/l

2.93

272

1420

Malignant neoplasm of breast

1553

7551

1.37

26.76

2.6

1.5

66.19

67.04

g/l

4.00

1395

6700

Other condition

599

3782

1.64

26.75

2.7

2.5

66.34

66.75

g/l

0.64

560

3480

Allergic purpura

156

624

2.72

26.74

1.9

2.7

67.07

66.87

g/l

0.11

148

567

Monoarthritis, not elsewhere classified

203

915

2.37

26.48

1.7

3.1

66.95

66.25

g/l

0.64

195

838

Acute gastritis

375

2108

1.88

26.29

2.4

2.7

66.46

66.27

g/l

0.18

339

1912

Adhesive capsulitis of shoulder

726

4810

1.56

26.18

2.0

2.7

66.38

66.41

g/l

0.04

672

4375

Malignant neoplasm of breast, HER2-negative

1537

7512

1.36

26.16

2.6

1.5

66.15

67.05

g/l

4.33

1381

6662

1614

10697

1.35

26.12

2.5

65.83

65.76

g/l

0.15

1409

9456

Other obstructive and reflux uropathy

195

869

2.39

26.02

2.4

64.43

66.78

g/l

3.55

175

796

Other disorders of bladder

599

3824

1.64

25.98

2.0

2.6

66.40

66.35

g/l

0.05

523

3448

Late syphilis

109

372

3.36

25.85

4.2

2.7

66.05

67.17

g/l

0.85

102

336

Thiazolidinediones

586

3739

1.65

25.64

2.1

2.7

66.58

65.98

g/l

1.12

532

3379

Other diseases of stomach and duodenum

334

1830

1.94

25.64

2.3

2.7

65.54

66.40

g/l

1.14

307

1665

Conjunctivitis (acute, non atopic)

1081

7715

1.43

25.55

3.2

2.4

66.78

66.57

g/l

0.40

1003

7062

Agoraphobia

115

398

3.06

25.52

1.6

2.2

67.46

68.60

g/l

0.79

102

374

Other enthesopathy of foot (+metatarsalgia)

414

2405

1.79

25.51

2.2

2.7

66.70

66.60

g/l

0.11

376

2199

Nummular dermatitis

398

2299

1.83

25.50

2.5

2.7

67.12

66.28

g/l

1.52

361

2096

Emotionally unstable personality disorder

375

2108

1.83

25.47

1.7

2.3

66.63

67.52

g/l

1.60

338

1978

Leisure time condition

783

5304

1.52

25.37

2.2

2.5

65.73

66.45

g/l

1.64

672

4815

Parkinson's disease, strict definition, excluding more controls

610

3732

1.62

25.31

1.9

2.9

66.41

66.05

g/l

0.56

526

3382

Suicide or other Intentional self-harm

888

6156

1.48

25.15

2.0

2.5

66.13

66.86

g/l

2.09

810

5718

Ovarian cyst

1321

5573

1.39

25.09

2.3

2.4

66.67

66.54

g/l

0.24

1202

5043

Non-small cell lung cancer, adenocarcinoma, helper endpoint

364

2072

1.89

25.07

1.7

2.7

64.11

66.25

g/l

5.65

338

1884

Hypermobility syndrome

181

791

2.40

25.00

1.9

2.5

67.45

67.31

g/l

0.11

168

740

Dermatographic urticaria

271

1390

2.05

24.98

2.4

2.7

67.52

66.92

g/l

0.79

253

1286

Disease of hard tissues of teeth, NOS

2539

10616

1.27

24.92

2.6

2.4

66.97

66.42

g/l

3.21

2315

9654

Cholecystitis

689

4572

1.57

24.92

2.3

2.5

65.68

66.05

g/l

0.56

612

4052

Atopic dermatitis

1990

12749

1.30

24.86

2.0

2.5

67.30

66.79

g/l

2.49

1823

11707

Unspecified misadventure during surgical and medical care

286

1509

2.03

24.82

2.9

2.8

65.45

66.61

g/l

1.68

262

1384

Other disorders of eye and adnexa

575

3661

1.63

24.79

2.6

66.15

66.66

g/l

0.88

520

3353

Carcinoma in situ of skin of other and unspecified parts of face

494

3066

1.72

24.72

2.4

2.5

65.36

65.90

g/l

0.80

451

2712

Generalized skin eruption due to drugs and medicaments

203

946

2.32

24.70

4.9

2.9

65.42

66.71

g/l

1.42

185

860

Intestinal adhesions without obstruction

415

2447

1.79

24.66

2.8

2.4

64.90

66.35

g/l

2.99

372

2204

Heartburn

455

2739

1.73

24.61

2.2

2.5

66.87

66.74

g/l

0.14

403

2474

Open wound of ankle and foot

443

2654

1.74

24.52

2.6

65.63

66.68

g/l

2.06

405

2448

Sulfonylureas

1819

11266

1.32

24.49

2.1

2.7

65.97

65.80

g/l

0.40

1620

10057

Arterial embolism and thrombosis

317

1734

1.95

24.49

2.3

2.6

63.57

66.28

g/l

7.21

281

1565

Restless leg syndrome

606

3927

1.61

24.49

1.9

2.6

67.17

66.45

g/l

1.72

552

3587

Cervicocranial syndrome

441

2640

1.74

24.39

2.2

2.6

67.32

66.32

g/l

2.36

406

2410

Benign neoplasm: Rectum, anus and anal canal

994

7113

1.45

24.38

2.5

2.6

66.03

66.17

g/l

0.24

910

6394

Other and unspecified nerve root and plexus disorders, also in other diseases

815

5605

1.50

24.37

2.4

2.5

67.33

66.65

g/l

1.91

733

5163

Injuries to unspecified part of trunk, limb or body region

465

2831

1.72

24.35

2.0

2.6

65.35

66.44

g/l

2.17

420

2593

Left bundle-branch block

340

1900

1.89

24.27

1.9

2.6

66.06

66.99

g/l

1.40

294

1697

Visual impairment including blindness (binocular or monocular)

349

1971

1.88

24.23

2.2

2.5

65.83

66.11

g/l

0.28

296

1763

Malignant neoplasm of digestive organs

1670

10140

1.33

24.16

2.4

1.6

64.22

66.82

g/l

28.27

1505

9007

Squamous cell neoplasms and carcinomas of the skin

426

2546

1.76

24.14

2.4

1.6

64.93

66.33

g/l

3.44

388

2189

Retinal vascular occlusion

624

4095

1.60

24.12

2.7

2.6

66.36

66.00

g/l

0.56

564

3638

Disorders of magnesium metabolism

182

4.65

24.11

2.5

2.9

64.17

66.24

g/l

0.89

168

Ankylosing spondylitis, ICD10

371

2130

1.82

24.02

1.9

2.7

67.82

66.88

g/l

1.41

341

1978

Morphin

127

488

2.90

23.99

1.9

2.1

65.74

66.06

g/l

0.17

120

447

Cardiac murmurs and other cardiac sounds

344

1902

1.85

23.94

2.9

2.4

67.01

66.40

g/l

0.77

318

1731

Systemic sclerosis, icd10

146

603

2.70

23.86

1.9

2.7

65.61

67.23

g/l

1.54

135

546

Fibroblastic disorders

1044

7541

1.42

23.81

2.3

2.6

66.45

66.38

g/l

0.10

950

6825

Hallux valgus (acquired)

1341

7181

1.37

23.79

2.4

2.8

66.44

66.15

g/l

0.65

1192

6478

Ulcerative colitis

965

6869

1.44

23.77

2.4

2.5

66.85

66.66

g/l

0.31

893

6314

Retinal vascular disorders

631

4168

1.58

23.64

2.6

66.33

65.99

g/l

0.52

569

3704

Post-traumatic stress disorder

226

1100

2.12

23.60

1.6

2.3

67.92

67.93

g/l

0.00

207

1038

Mixed hyperlipidaemia

218

1065

2.21

23.57

1.8

2.5

66.66

66.68

g/l

0.01

198

975

Other nonthrombocytopenic purpura

212

4.18

23.54

2.2

2.8

66.86

66.09

g/l

0.35

190

Other disorders of optic [2nd] nerve and visual pathways

294

1589

1.96

23.47

2.3

2.9

65.87

66.56

g/l

0.78

272

1463

Other epidermal thickening

223

1099

2.18

23.46

2.6

2.9

65.28

66.53

g/l

1.84

208

1003

ILD-related respiratory insufficiency

209

1016

2.28

23.41

2.4

2.8

65.44

66.11

g/l

0.55

197

911

Special screening examination for infectious and parasitic diseases

661

3183

1.55

23.41

2.1

2.3

67.31

67.26

g/l

0.05

598

2993

Retinal detachments and breaks

1688

13131

1.32

23.38

2.7

2.6

66.26

66.30

g/l

0.06

1523

11879

Diseases of inner ear

2485

19532

1.25

23.29

2.4

2.6

66.68

66.35

g/l

1.48

2206

17653

Other hammer toe(s) (acquired)

769

4868

1.51

23.20

2.1

2.9

65.90

65.82

g/l

0.10

667

4339

Benign neoplasm: Adrenal gland

387

2286

1.80

23.13

2.2

2.8

65.74

66.47

g/l

1.11

349

2097

Mixed and other personality disorders

287

1537

1.94

23.12

2.0

2.5

66.95

67.51

g/l

0.61

262

1438

Other lack of coordination

109

398

3.10

22.88

1.8

3.5

67.05

66.38

g/l

0.37

100

361

6-mercaptopurine

118

440

2.83

22.85

2.1

3.5

66.14

67.43

g/l

0.72

110

407

Hypopituitarism

284

1526

1.95

22.82

2.5

2.9

66.07

66.84

g/l

0.90

267

1431

Alcohol-induced chronic pancreatitis

305

1689

1.92

22.65

1.8

2.8

65.56

66.72

g/l

1.47

279

1565

Disorders of oesophagus in diseases classified elsewhere

136

559

2.73

22.60

3.2

2.9

62.78

66.40

g/l

5.49

119

504

Unknown and unspecified causes of morbidity

275

1464

1.96

22.60

2.5

2.3

66.64

66.99

g/l

0.30

261

1323

Superficial injury of abdomen, lower back and pelvis

606

3987

1.57

22.55

2.3

2.5

66.26

66.55

g/l

0.44

543

3647

Injuries to the neck

867

6121

1.45

22.40

2.4

66.56

66.67

g/l

0.17

785

5623

Temporomandibular joint disorders, including avohilmo

1475

11130

1.33

22.37

2.5

67.28

66.85

g/l

1.67

1358

10225

Transport accidents

1719

11521

1.30

22.37

2.2

2.6

66.75

66.92

g/l

0.40

1574

10701

Other/unspecified reactive arthropathies

291

1591

1.93

22.35

2.7

67.10

66.68

g/l

0.46

267

1468

Other chondrocalcinosis

103

375

3.27

22.34

2.1

2.5

65.38

66.21

g/l

0.51

338

Other postsurgical states

302

1673

1.91

22.29

2.3

2.6

65.32

66.80

g/l

2.86

281

1533

Idiopathic pulmonary fibrosis

430

2646

1.73

22.19

2.0

2.5

66.42

65.97

g/l

0.53

389

2376

Tobacco use

240

1236

2.06

22.16

1.8

2.7

66.63

66.96

g/l

0.26

222

1152

Other or ill-defined heart diseases

226

1135

2.09

22.14

3.0

2.5

64.60

67.17

g/l

4.08

202

1031

Explicit fungal Sepsis

134

5.00

21.91

2.1

2.2

59.83

67.34

g/l

4.80

125

Umbilical hernia

1143

8490

1.38

21.89

2.5

2.6

66.37

66.76

g/l

0.97

1051

7832

Spontaneous rupture of synovium and tendon

376

2231

1.77

21.81

2.2

2.7

66.29

66.36

g/l

0.07

337

2024

Thoracic aortic aneurysm

690

4722

1.52

21.76

2.5

2.7

65.81

66.50

g/l

1.59

621

4303

Viral infections of the central nervous system

303

1689

1.88

21.75

2.5

2.6

65.88

66.69

g/l

0.96

275

1551

Combinations of oral blood glucose lowering drugs

1299

9856

1.35

21.75

2.0

2.8

67.03

66.25

g/l

3.09

1193

9026

Juvenile arthritis (FINNGEN)

146

617

2.47

21.75

2.8

3.1

67.72

66.86

g/l

0.65

137

572

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

540

3488

1.59

21.63

2.4

2.3

67.24

66.93

g/l

0.43

483

3186

Excessive, frequent and irregular menstruation

1383

5706

1.35

21.58

2.3

2.4

66.89

66.54

g/l

0.94

1236

5153

Dermatophytosis

2548

20898

1.24

21.54

2.4

2.5

66.56

66.60

g/l

0.08

2289

19106

Complications of cardiac and vascular prosthetic devices, implants and grafts

137

579

2.66

21.50

2.4

2.8

63.17

66.08

g/l

3.36

128

523

Other disorders of the musculoskeletal system and connective tissue

671

4570

1.52

21.49

2.5

2.6

66.24

66.39

g/l

0.20

612

4147

Other localized connective tissue disorders

114

439

2.89

21.48

3.2

2.9

65.88

67.41

g/l

1.01

104

393

Chronic hepatitis, not elsewhere classified

170

781

2.35

21.47

1.6

3.1

69.25

67.06

g/l

2.19

156

719

Chronic laryngitis and laryngotracheitis

622

4170

1.55

21.43

2.1

2.5

66.65

66.36

g/l

0.40

547

3782

KRA_PSY_EATING, excluding more controls

193

913

2.16

21.38

1.5

2.4

66.34

67.87

g/l

2.20

174

859

Gangrene, not elsewhere classified

188

4.26

21.32

3.3

2.6

64.16

66.98

g/l

1.73

168

Other noninfective disorders of lymphatic vessels and lymph nodes

184

875

2.26

21.31

2.3

2.7

64.45

66.85

g/l

3.45

177

797

Keratitis

1435

11049

1.32

21.22

2.3

2.5

66.70

66.52

g/l

0.41

1305

10064

Syphilis

137

578

2.59

21.19

3.5

2.6

65.88

67.00

g/l

0.94

128

529

Syphilis

137

578

2.59

21.19

3.5

2.6

65.88

67.00

g/l

0.94

128

529

Amputation of ankle bones

137

582

2.62

21.15

3.7

2.9

63.30

65.89

g/l

2.81

125

523

Other and unspecified visual disturbances

448

2802

1.67

21.15

2.4

2.6

66.47

66.43

g/l

0.04

415

2564

Benign neoplasm: Rectum

881

6336

1.44

21.13

2.5

2.6

65.98

66.15

g/l

0.28

805

5705

Malignant neoplasm of other connective and soft tissue

135

568

2.62

21.11

4.7

1.6

64.77

67.16

g/l

2.55

130

513

Alcohol induced polyneuropathy

234

3.78

20.93

1.5

2.9

65.11

66.62

g/l

0.76

213

Anosmia

234

3.42

20.90

2.7

1.4

65.63

68.49

g/l

2.24

211

Corns and callosities

313

1790

1.85

20.85

3.3

2.6

64.81

66.58

g/l

4.09

271

1637

Gonarthrosis, primary, with knee surgery

2798

18513

1.22

20.71

2.2

2.7

66.47

66.21

g/l

1.07

2502

16722

Acute suppurative otitis media

730

4705

1.47

20.69

3.2

2.3

66.89

67.18

g/l

0.47

679

4387

Cyst of kidney

372

2245

1.76

20.68

2.9

2.7

66.33

66.45

g/l

0.12

345

2051

Pemphigoid

172

815

2.34

20.63

1.5

2.7

65.94

65.92

g/l

0.01

159

731

Pain associated with micturition

505

3265

1.61

20.62

2.8

2.6

66.50

66.44

g/l

0.06

452

2963

Synovial cyst of popliteal space [Baker]

340

1995

1.79

20.61

2.3

2.7

66.03

66.35

g/l

0.31

305

1800

Vasomotor and allergic rhinitis

1306

9767

1.33

20.53

2.2

2.5

66.96

66.77

g/l

0.44

1180

8985

Childhood asthma (age<16), excluding more controls

242

982

1.97

20.46

2.0

1.9

67.03

68.84

g/l

2.96

225

928

Injury of unspecified body region

353

2099

1.77

20.40

1.7

2.7

65.47

66.37

g/l

1.24

316

1925

Other immunodeficiencies

226

3.71

20.40

3.7

2.7

66.09

66.81

g/l

0.26

209

Asthma and opportunity respiratory infection

256

1396

1.98

20.38

2.6

2.9

65.37

66.20

g/l

0.93

231

1250

Hypersensitivity angiitis

108

5.52

20.38

1.7

2.9

60.23

66.53

g/l

5.82

Carcinoma in situ of skin of scalp and neck

173

831

2.34

20.32

2.3

2.6

64.38

65.66

g/l

1.38

156

748

Fracture of skull and facial bones

845

6054

1.43

20.17

2.7

2.5

66.26

66.62

g/l

0.67

755

5556

Arthropathic psoriasis

470

3005

1.62

20.15

1.9

2.8

67.33

66.65

g/l

1.17

433

2764

Other follicular disorders

282

1573

1.87

20.14

2.5

2.6

67.61

66.94

g/l

0.83

270

1454

COPD, hospital admissions 1, only main diagnosis

1730

11763

1.29

20.03

2.1

2.6

65.14

66.19

g/l

6.30

1529

10583

Pain and other conditions associated with female genital organs and menstrual cycle

609

3763

1.52

19.88

2.0

2.3

67.10

66.96

g/l

0.20

547

3469

Emotional disorders starting during childhood or adolecense, excluding more controls

334

2.88

19.85

2.0

2.4

67.10

67.80

g/l

0.33

321

Other viral hepatitis

224

1165

2.01

19.83

2.2

2.5

67.42

67.50

g/l

0.04

207

1094

Focal epilepsy

887

6434

1.41

19.76

2.3

2.5

65.92

66.32

g/l

0.73

801

5854

Left ventricular outflow tract obstruction (LVOTO), broad definition

402

2489

1.68

19.70

2.2

2.8

65.97

66.79

g/l

1.24

374

2319

Diseases of tongue

281

1582

1.87

19.67

2.4

66.47

66.39

g/l

0.06

256

1429

Disorders of psychological development

317

1692

1.78

19.65

2.2

2.4

65.89

67.02

g/l

1.56

288

1578

1125

7987

1.37

19.62

2.5

2.4

65.88

65.69

g/l

0.35

970

6995

Malignant melanoma, including Hilmo

737

5193

1.46

19.62

3.0

1.6

66.08

66.80

g/l

1.62

661

4607

Polyarteritis nodosa

127

4.76

19.61

2.1

2.9

64.40

66.06

g/l

0.64

113

Other specified/unspecified soft tissue disorders

225

1185

2.01

19.48

2.4

2.7

66.25

66.26

g/l

0.00

207

1063

Status post-ami

1298

7592

1.34

19.42

2.2

2.6

65.76

66.26

g/l

1.45

1169

6727

Viral hepatitis

266

1474

1.88

19.38

2.1

2.5

67.50

67.20

g/l

0.22

242

1377

Colonic or urogenital fistula

1121

8460

1.36

19.37

2.5

66.61

66.53

g/l

0.13

1005

7723

Other sleep disorders

459

2943

1.61

19.36

2.2

2.7

66.37

66.39

g/l

0.02

411

2692

Other hearing loss

1373

10435

1.32

19.33

2.6

2.5

65.91

66.00

g/l

0.16

1204

9328

Attention to artificial openings

208

1075

2.07

19.29

2.5

64.00

66.78

g/l

4.10

183

976

Viral infections of the central nervous system

311

1810

1.79

19.28

2.5

2.6

66.00

66.67

g/l

0.73

282

1665

Barrett oesophagus

253

1397

1.94

19.23

2.5

2.8

65.28

66.33

g/l

1.19

229

1279

Fall involving bed

192

972

2.16

19.20

2.2

2.9

65.48

65.94

g/l

0.33

160

871

Exfoliative dermatitis

252

3.48

19.11

1.8

3.1

67.07

65.84

g/l

0.80

224

Psychotic depression

236

1265

1.94

19.10

2.0

3.0

67.23

66.58

g/l

0.58

203

1173

Familial hypercholesterolemia, with ischemic heart disease

488

3203

1.60

19.08

2.2

2.6

65.50

66.03

g/l

0.78

455

2824

Other disorders of patella

561

3758

1.53

19.02

2.2

2.8

67.19

66.70

g/l

0.93

510

3501

Malignant neoplasm of breast, ER-positive, including Hilmo

1195

6992

1.34

19.01

2.5

1.5

66.53

67.03

g/l

1.44

1061

6180

Psoriatic arthropathies, ICD10

434

2765

1.63

18.95

1.9

2.8

67.61

66.74

g/l

1.72

398

2540

Need for immunization against other single viral diseases

105

413

2.80

18.94

2.7

2.6

63.47

66.84

g/l

3.99

381

Idiopathic urticaria

100

382

2.84

18.89

2.5

2.6

68.14

67.21

g/l

0.69

350

Other/unspecified synovitis and tenosynovitis

454

2919

1.61

18.88

2.4

2.6

66.37

66.47

g/l

0.10

420

2660

Ulcerative colitis, NAS

526

3499

1.55

18.68

2.2

2.6

66.75

66.78

g/l

0.03

491

3223

Infections with a predominantly sexual mode of transmission

907

6635

1.39

18.64

2.5

2.3

66.54

67.16

g/l

1.59

832

6169

Childhood asthma (age<16)

242

1015

1.91

18.64

2.0

1.9

67.03

68.64

g/l

2.45

225

960

Focal epilepsy, strict definition

830

6023

1.41

18.54

2.3

2.5

65.86

66.32

g/l

0.83

748

5475

Sacroiliitis, not elsewhere classified

157

734

2.23

18.53

1.7

2.4

68.36

67.28

g/l

0.98

140

685

Paraplegia, diplegia of upper limbs

122

521

2.57

18.52

1.9

2.7

65.65

66.58

g/l

0.55

112

478

Other and unspecified haemorrhagic conditions

373

2.90

18.44

3.8

2.5

65.78

66.59

g/l

0.43

340

Personal history of other diseases and conditions

329

1949

1.72

18.43

3.3

2.4

64.98

67.36

g/l

5.45

302

1794

Fall on and from stairs and steps

1084

8203

1.35

18.42

2.3

2.5

66.13

66.41

g/l

0.59

951

7439

Malignant melanoma

610

4211

1.50

18.23

3.1

1.6

66.07

66.78

g/l

1.38

544

3722

Pneumonitis due to solids and liquids

411

2618

1.64

18.20

2.0

2.4

64.71

66.01

g/l

1.98

360

2365

Other forms of systemic lupus erythematosus

172

3.99

18.20

1.9

3.0

65.79

67.22

g/l

0.66

153

Speech and linguistic disorders

251

1329

1.86

18.19

2.4

2.5

65.92

66.78

g/l

0.94

228

1227

Seborrhoeic dermatitis

413

2630

1.63

18.14

2.6

2.7

67.07

66.35

g/l

1.10

365

2404

Primary gonarthrosis, bilateral

2426

17277

1.22

18.08

2.1

2.7

66.61

66.25

g/l

1.65

2171

15604

IBD patients in KELA-register

814

5902

1.41

18.06

2.3

2.5

66.97

66.83

g/l

0.20

765

5469

Other/unspecified enthesopathies of lower limb, excluding foot

265

1501

1.84

17.99

2.1

2.7

66.46

66.48

g/l

0.01

242

1383

Other psoriatic arthropathies

418

2674

1.62

17.96

1.9

2.8

67.62

66.72

g/l

1.71

384

2454

Seborrhoeic keratosis

1027

7759

1.36

17.90

3.0

2.6

65.72

66.27

g/l

1.45

935

6958

Coxarthrosis, primary, with hip surgery

2287

17744

1.23

17.89

2.3

2.7

66.60

66.16

g/l

2.15

2037

15953

Disorders of myoneural junction and muscle in diseases classified elsewhere

185

3.91

17.88

1.9

2.8

64.64

67.21

g/l

1.42

170

Disorders of refraction and accommodation

915

6741

1.38

17.87

2.5

66.75

66.78

g/l

0.05

841

6214

Bacterial, viral and other infectious agents

339

2060

1.71

17.84

2.9

2.6

66.07

66.99

g/l

1.38

317

1920

Molar incisor enamel hypoplasia

351

2.75

17.83

4.3

2.5

63.63

66.24

g/l

1.64

334

Focal epilepsy, mode (most common among epilepsy diagnosis)

777

5614

1.42

17.83

2.3

2.5

66.19

66.36

g/l

0.24

698

5095

Membranous nephropathy

5.81

17.82

6.9

2.4

62.50

67.04

g/l

2.05

malignant neoplasm of male genital organs

1262

5911

1.33

17.81

2.7

1.7

65.76

66.99

g/l

6.57

1143

5372

Obsessive-compulsive disorder

178

884

2.07

17.77

1.7

2.5

66.45

68.06

g/l

2.05

159

832

Malignant neoplasm, without specification of site

166

816

2.18

17.72

2.9

1.5

64.45

66.35

g/l

1.86

150

713

Hyperkinetic disorders, excluding more controls

220

1119

1.91

17.69

1.5

2.3

67.56

67.90

g/l

0.32

204

1069

Overexertion and strenuous or repetitive movements

390

2465

1.64

17.59

2.9

2.7

65.63

66.73

g/l

2.17

355

2280

Ocular pain

323

1948

1.72

17.59

2.6

2.7

66.85

66.83

g/l

0.01

290

1781

Aortic valve malfunction, age under 60 years

372

2327

1.66

17.58

2.2

2.8

66.06

66.82

g/l

1.06

344

2171

Macular pucker

762

5530

1.43

17.56

2.4

2.7

66.02

66.08

g/l

0.07

674

4959

Papilloedema, unspecified

109

451

2.62

17.55

1.7

2.8

65.94

66.84

g/l

0.52

101

415

Malignant neoplasm of breast, HER-positive

1164

6942

1.33

17.54

2.5

1.5

66.52

67.01

g/l

1.39

1034

6138

Carcinoma in situ of skin

446

2930

1.60

17.52

2.5

2.6

65.11

66.20

g/l

2.24

399

2626

Benign paroxysmal vertigo

1288

10058

1.31

17.47

2.5

2.6

66.98

66.22

g/l

3.44

1142

9048

Bullous pemphigoid

139

650

2.39

17.41

1.5

3.0

65.78

65.86

g/l

0.04

129

577

Sequelae of injuries, of poisoning and of other consequences of external causes

914

6800

1.37

17.39

2.6

2.5

66.67

66.70

g/l

0.03

834

6270

Alcohol abuse, main dg

597

4135

1.48

17.37

1.7

2.6

66.07

66.67

g/l

1.03

538

3845

Rosacea

461

3041

1.57

17.23

2.3

2.5

67.24

66.71

g/l

0.81

423

2788

Appendectomy

2450

19569

1.21

17.18

2.8

2.5

66.55

66.73

g/l

0.62

2254

17945

Ulcer of oesophagus

340

2102

1.70

17.15

2.5

2.7

65.81

66.13

g/l

0.31

308

1903

Congenital malformations and deformations of the musculoskeletal system

276

1593

1.78

17.08

1.9

2.6

67.72

66.74

g/l

1.25

264

1477

Viral warts

365

2287

1.65

17.01

2.6

65.38

66.84

g/l

2.80

339

2106

Congenital malformations and deformations of the musculoskeletal system

345

2114

1.67

17.00

1.8

2.6

67.80

66.80

g/l

1.57

324

1958

Social phobias

220

1192

1.89

16.98

1.9

2.5

67.06

67.95

g/l

0.98

208

1123

Cholangitis (primary sclerosing, PSC)

287

1700

1.77

16.97

2.2

2.6

65.99

66.22

g/l

0.17

262

1544

Olecranon bursitis

278

1632

1.79

16.95

3.0

2.7

65.40

66.50

g/l

1.47

259

1491

Trigger finger

546

3742

1.50

16.80

2.0

2.7

66.42

66.57

g/l

0.18

507

3435

Mucosal proctocolitis

450

2965

1.56

16.73

2.2

2.6

67.46

66.94

g/l

0.72

429

2747

Alcohol dependence

1106

8511

1.33

16.67

1.8

2.7

66.05

66.60

g/l

1.34

989

7846

Menorrhagia

1263

5419

1.31

16.58

2.4

66.92

66.44

g/l

1.45

1101

4884

Malignant neoplasm of corpus uteri

360

2274

1.66

16.57

3.7

1.5

65.87

66.58

g/l

1.08

326

1968

Other renal tubulo-interstitial diseases

110

469

2.52

16.56

2.5

2.3

65.85

67.27

g/l

0.97

104

427

Bacterial, viral and other infectious agents

316

1925

1.70

16.53

3.0

2.6

65.93

67.05

g/l

1.72

294

1796

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1174

9048

1.31

16.50

2.5

2.4

67.11

66.97

g/l

0.28

1082

8399

Polycythaemia vera

169

860

2.11

16.49

2.8

1.6

66.40

66.96

g/l

0.45

160

762

Traumatic subarachnoid haemorrhage

165

830

2.11

16.41

2.4

2.5

66.48

66.25

g/l

0.14

144

748

Atopic dermatitis, strict definition

842

6092

1.37

16.41

2.2

2.4

67.13

67.06

g/l

0.11

787

5673

Other and unspecified injuries of head

303

1837

1.72

16.33

1.7

2.7

65.60

66.48

g/l

1.18

264

1673

Cutaneous lupus erythematosus

128

590

2.36

16.30

2.2

3.0

67.52

67.27

g/l

0.14

117

535

Amenorrhoea

194

1025

1.95

16.28

2.1

2.2

67.21

67.32

g/l

0.07

175

948

Malignant neoplasm of corpus uteri, including Hilmo

404

2631

1.60

16.23

3.5

1.5

65.96

66.58

g/l

1.01

365

2287

Erosion of teeth , including avohilmo

825

6100

1.38

16.22

2.5

66.93

66.89

g/l

0.05

757

5648

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1949

15576

1.23

16.20

2.3

2.5

67.04

66.63

g/l

1.81

1765

14199

Other and unspecified rosacea

356

2251

1.65

16.18

2.3

2.7

67.33

66.68

g/l

0.94

326

2061

Malignant neoplasm of bladder, including Hilmo

540

3707

1.50

16.16

2.4

1.6

65.60

66.62

g/l

2.29

478

3288

Malignant neoplasm of prostate, including Hilmo

1274

5906

1.31

16.13

2.7

1.7

65.89

66.97

g/l

5.36

1158

5368

Hemiplegia

227

1276

1.87

16.10

1.8

2.7

65.79

66.66

g/l

0.80

196

1160

Alzheimer disease, excluding more controls

835

4057

1.39

16.09

2.3

3.0

65.44

65.97

g/l

1.10

689

3664

Fall on same level involving ice and snow

2358

19787

1.21

16.05

2.3

2.6

66.52

66.50

g/l

0.04

2097

17990

Crohn's disease NAS

245

1406

1.81

16.02

1.9

2.6

65.49

66.99

g/l

1.93

227

1301

Iridocyclitis in diseases classified elsewhere

104

442

2.58

16.01

2.3

3.0

66.47

66.71

g/l

0.11

403

Algoneurodystrophy

130

602

2.29

16.01

2.0

2.6

67.16

67.46

g/l

0.21

119

561

Calculus of kidney and ureter

1328

10530

1.29

15.93

2.4

2.6

66.58

66.47

g/l

0.22

1207

9596

Infection due to other mycobacteria

384

2.72

15.86

1.7

2.6

64.48

66.70

g/l

1.65

339

Other juvenile arthritis

119

530

2.33

15.85

2.5

3.1

67.84

66.65

g/l

0.87

110

498

Other specified/unspecified bacterial intestinal infections

298

1817

1.72

15.84

3.6

2.6

65.27

66.54

g/l

1.90

267

1659

Propionic acid derivatives

1205

4671

1.32

15.79

2.6

2.5

66.53

65.77

g/l

2.49

1100

4260

Impingement syndrome of shoulder

953

7242

1.34

15.77

2.5

2.8

66.93

66.64

g/l

0.58

859

6647

Cluster headache, wide

147

717

2.15

15.77

1.8

3.0

67.85

67.14

g/l

0.53

141

666

Other blood glucose lowering drugs, excl. Insulins

754

5555

1.40

15.67

2.0

2.6

66.40

65.93

g/l

0.89

690

4965

Viral encephalitis, not elsewhere classified/unspecified

107

465

2.51

15.65

3.5

2.9

65.98

66.74

g/l

0.39

424

Later onset COPD

1496

9590

1.27

15.64

2.1

2.6

65.04

66.02

g/l

4.88

1310

8534

Vascular diseases of the intestine

208

1155

1.92

15.63

2.4

2.6

64.40

66.18

g/l

2.07

193

1038

Inflammatory bowel disease, strict (require KELA)

814

6045

1.37

15.63

2.3

2.5

66.97

66.82

g/l

0.22

765

5602

Strabismus

972

7393

1.34

15.59

2.4

2.5

66.50

66.56

g/l

0.09

897

6765

Postzoster neuralgia

407

2.66

15.57

3.3

2.6

65.17

66.13

g/l

0.57

367

Inguinal hernia

2545

14344

1.20

15.55

2.6

2.5

66.12

66.61

g/l

2.37

2316

13098

Allergic conjunctivitis

2033

16424

1.22

15.54

2.3

2.5

67.05

66.63

g/l

1.93

1842

14998

Malignant neoplasm of prostate

1237

5782

1.31

15.51

2.7

1.7

65.76

66.96

g/l

6.17

1118

5248

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

343

2176

1.65

15.50

3.2

2.6

64.42

66.54

g/l

4.73

309

1983

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

433

2539

1.54

15.46

1.9

2.1

67.06

67.62

g/l

0.84

400

2407

Portal vein thrombosis

383

2.69

15.45

2.6

3.0

65.35

66.87

g/l

0.95

357

Brachial plexus disorders

310

1911

1.67

15.40

2.3

2.7

67.49

66.99

g/l

0.57

284

1790

Total colectomy

181

963

1.99

15.36

2.8

3.0

65.73

66.69

g/l

0.80

173

889

Total colectomy operation

181

963

1.99

15.36

2.8

3.0

65.73

66.69

g/l

0.80

173

889

Oesophagitis

254

1500

1.78

15.27

2.1

2.7

64.95

66.23

g/l

1.87

236

1370

Postprocedural disorders of digestive system, not elsewhere classified

162

836

2.08

15.21

2.5

3.0

65.00

66.43

g/l

1.27

150

764

Allergic contact dermatitis

468

3173

1.51

15.20

2.1

2.6

67.49

66.71

g/l

1.55

425

2912

Mental and behavioural disorders due to sedatives or hypnotics

246

1435

1.78

15.18

1.6

2.6

65.89

67.08

g/l

1.37

221

1335

Status epilepticus

166

862

2.04

15.15

2.0

2.8

65.32

65.92

g/l

0.35

150

785

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

204

1123

1.87

15.15

1.5

2.3

66.70

67.50

g/l

0.61

181

1065

Mental and behavioural disorders due to tobacco

353

2264

1.62

15.12

2.1

2.9

65.74

66.60

g/l

1.17

307

2094

Special screening examination for other diseases and disorders

391

2553

1.57

15.11

2.4

66.94

66.39

g/l

0.80

369

2333

Glaucoma

2659

19496

1.19

15.06

2.5

2.6

66.40

66.21

g/l

0.61

2379

17540

Open wound of forearm

377

2453

1.59

15.06

2.3

2.5

65.77

66.53

g/l

1.06

339

2251

Irregular menses

1447

9147

1.26

15.05

2.6

2.4

66.83

66.96

g/l

0.30

1309

8407

Other and unspecified tonsillitis

929

5911

1.34

15.05

2.3

2.2

67.04

67.32

g/l

0.50

875

5538

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

178

952

1.99

15.02

2.6

2.8

67.07

66.59

g/l

0.34

164

868

CR(E)ST syndrome

377

2.68

14.97

2.1

2.7

65.31

67.09

g/l

1.15

344

Pre-eclampsia or eclampsia

657

4749

1.41

14.92

2.5

66.43

67.18

g/l

1.56

606

4363

Pleural plaque with presence of asbestos

401

2674

1.58

14.87

2.3

2.6

66.99

65.63

g/l

3.08

355

2397

Paralytic strabismus

324

2051

1.65

14.86

2.3

2.6

66.54

66.26

g/l

0.28

293

1885

Procreative management

1028

6605

1.32

14.74

2.4

66.57

67.07

g/l

1.39

959

6131

Smoking dependency

353

2279

1.61

14.71

2.1

2.8

65.74

66.59

g/l

1.16

307

2108

Iron deficiency

375

2.55

14.58

2.0

2.8

65.63

67.42

g/l

1.33

353

Striking against or struck by other objects

1166

9173

1.29

14.56

2.4

2.5

66.43

66.79

g/l

0.91

1048

8472

Other and unspecified disorders of skin and subcutaneous tissue

278

1702

1.71

14.56

2.5

2.7

66.17

66.46

g/l

0.22

222

1551

Monoplegia

351

2.71

14.55

2.3

3.4

67.56

66.92

g/l

0.31

317

Colectomy operation

769

5752

1.38

14.53

2.6

65.53

66.14

g/l

1.22

705

5171

Right bundle-branch block

169

897

2.00

14.50

2.6

2.5

65.34

67.03

g/l

1.75

155

809

Carrier of infectious disease

111

505

2.36

14.46

2.2

2.6

65.76

66.80

g/l

0.65

104

462

Panniculitis, unspecified

220

3.21

14.42

2.2

3.0

65.68

67.06

g/l

0.60

202

Adult respiratory distress syndrome

324

2.80

14.39

3.0

2.6

62.13

66.09

g/l

3.00

289

Nail disorders

319

2021

1.64

14.37

2.4

2.7

65.51

66.68

g/l

2.06

297

1858

Allergic rhinitis

938

7106

1.32

14.35

2.3

2.4

67.18

66.96

g/l

0.45

849

6603

Congenital malformations of heart and great arteries

447

2945

1.51

14.34

2.2

2.7

64.94

66.63

g/l

4.19

411

2736

Acute bronchiolitis

155

710

2.02

14.33

5.6

2.7

65.15

66.05

g/l

0.61

144

657

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

410

2.56

14.27

4.0

1.6

64.91

67.09

g/l

1.72

361

Malignant neoplasm of small intestine, including Hilmo

147

751

2.10

14.26

3.6

1.6

65.12

67.14

g/l

1.93

133

675

Otitis externa

847

6425

1.35

14.24

2.6

2.5

66.94

66.55

g/l

0.78

737

5894

Third [oculomotor] nerve palsy

106

481

2.43

14.22

1.8

3.2

67.00

66.30

g/l

0.43

439

Other diseases of biliary tract

398

2662

1.56

14.22

2.2

2.5

64.50

66.20

g/l

3.79

367

2385

Secondary systemic amyloidosis

5.79

14.22

5.5

2.2

60.26

65.31

g/l

1.79

Superficial injury of thorax

598

4305

1.43

14.19

2.1

2.5

65.83

66.47

g/l

1.25

535

3933

Artificial joint re-operation

343

2232

1.62

14.16

2.0

2.7

66.32

66.23

g/l

0.08

311

2017

Symptoms and signs involving emotional state

120

566

2.24

14.16

2.0

2.7

67.24

66.92

g/l

0.20

108

522

Acute pharyngitis

429

2869

1.51

14.14

3.2

2.4

67.40

67.23

g/l

0.19

397

2682

Cluster headache, strict

132

645

2.15

14.13

1.8

3.0

68.05

67.32

g/l

0.51

126

602

Cerebral aneurysm, nonruptured

365

2400

1.58

14.07

1.9

2.7

66.32

66.49

g/l

0.15

333

2181

Other mental disorders due to brain damage and dysfunction and to physical disease

554

3959

1.45

14.03

2.2

2.6

66.63

66.07

g/l

0.96

468

3564

Infections with a predominantly sexual mode of transmission

1098

8013

1.29

13.98

2.4

2.3

66.71

67.27

g/l

1.59

1012

7448

Benign neoplasm: Small intestine

211

1221

1.85

13.98

2.8

2.9

65.22

66.44

g/l

1.59

197

1111

Juvenile rheumatoid arthirtis

300

2.71

13.89

2.3

3.0

68.11

67.10

g/l

0.59

284

Other specified and unspecified personality disorders

296

1853

1.64

13.88

1.8

2.5

65.90

67.16

g/l

2.07

270

1725

Other erythematous conditions

161

857

2.00

13.78

2.5

2.8

66.81

66.57

g/l

0.14

154

784

Acute alcohol intoxication, ICD10

749

5611

1.36

13.74

1.8

2.6

66.35

66.72

g/l

0.61

676

5203

Benign neoplasm: Descending colon

340

2223

1.61

13.72

2.3

2.7

65.83

66.41

g/l

0.69

306

2039

Other and unspecified vascular occlusions

454

3147

1.50

13.66

2.8

2.6

66.45

65.95

g/l

0.72

409

2803

Viral warts

725

5405

1.37

13.65

2.7

2.4

65.93

66.82

g/l

2.43

670

4977

Autoimmune hyperthyroidism

212

1223

1.80

13.62

2.3

2.8

65.40

67.03

g/l

2.58

195

1112

Other aneurysm

266

1644

1.70

13.58

2.5

2.7

65.82

66.34

g/l

0.54

248

1496

Bell's palsy

468

3255

1.48

13.55

2.6

66.33

66.47

g/l

0.16

428

2973

Congenital malformations of the circulatory system

497

3383

1.46

13.52

2.1

2.7

65.12

66.59

g/l

3.77

462

3128

Inflammatory disease of uterus

421

2863

1.50

13.45

1.8

2.4

66.80

66.97

g/l

0.17

370

2630

Chronic viral hepatitis

169

914

1.92

13.44

2.1

2.3

68.10

67.43

g/l

0.43

155

863

Anti-inflammatory and antirheumatic products, non-steroids

1182

4671

1.29

13.43

2.7

2.5

66.51

65.77

g/l

2.30

1076

4260

Testicular hypofunction

132

661

2.11

13.39

2.0

3.1

68.32

67.15

g/l

1.27

123

621

Abscess of anal and rectal regions

311

1990

1.61

13.37

2.3

2.5

66.13

67.07

g/l

1.17

289

1857

Kyphosis

299

2.77

13.34

2.5

2.7

66.31

66.91

g/l

0.30

274

Other disorders of pigmentation

199

1144

1.84

13.27

2.6

2.7

67.03

66.50

g/l

0.43

185

1038

Pediculosis, acariasis and other infestations

222

1310

1.76

13.26

2.7

2.6

66.81

66.83

g/l

0.01

204

1221

Urolithiasis

1417

11559

1.25

13.26

2.4

2.6

66.54

66.45

g/l

0.16

1287

10537

Endometriosis

1188

5510

1.28

13.25

2.2

2.4

66.51

66.54

g/l

0.05

1072

4985

Respiratory conditions due to other external agents

120

589

2.23

13.25

3.9

2.6

65.22

66.44

g/l

0.95

107

529

Pulmonary oedema

108

508

2.33

13.24

3.2

2.7

64.18

65.66

g/l

1.04

447

Golimumab

123

601

2.15

13.22

1.8

2.8

68.17

67.55

g/l

0.44

116

572

Other/unspecified crystal arthropathies

158

3.71

13.21

2.9

3.0

67.16

66.60

g/l

0.20

142

Crohn's disease of small intestine

245

1484

1.71

13.21

1.8

2.6

64.85

66.98

g/l

3.41

228

1373

Other specified disorders of kidney and ureter

157

842

1.99

13.21

2.5

2.9

65.41

66.57

g/l

0.99

151

768

Psoriasis (vulgaris), strict definition

142

734

2.05

13.20

1.7

2.9

68.30

66.99

g/l

1.08

127

680

Pre-eclampsia

591

4287

1.40

13.20

2.6

2.4

66.41

67.19

g/l

1.51

548

3948

Fenamates

600

2937

1.42

13.19

2.4

2.5

66.55

65.85

g/l

1.41

544

2664

Disorders in reading

158

3.34

13.16

2.5

2.8

65.68

66.60

g/l

0.28

150

Testicular dysfunction

145

755

2.02

13.15

2.0

3.0

68.20

67.09

g/l

1.24

134

710

Allergic urticaria

286

1803

1.64

13.11

3.2

2.7

66.84

66.56

g/l

0.26

261

1659

Thyrotoxicosis with diffuse goitre

494

3487

1.45

13.08

2.1

2.5

65.79

66.79

g/l

2.25

455

3195

Schizophrenia or delusion, excluding more controls

982

7601

1.30

12.97

2.2

2.6

66.01

66.91

g/l

2.83

877

7012

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

637

2938

1.39

12.95

1.9

2.0

67.26

67.81

g/l

1.14

599

2752

Superficial injury of forearm

338

2219

1.57

12.94

2.1

2.5

66.23

66.74

g/l

0.65

296

2048

Other obstetric conditions, not elsewhere classified

659

3063

1.38

12.92

1.9

2.0

67.29

67.79

g/l

0.99

620

2865

Pediculosis, acariasis and other infestations

516

3675

1.43

12.89

2.2

2.5

66.85

66.90

g/l

0.05

478

3419

Benign neoplasm: Duodenum

144

762

2.05

12.88

2.8

2.9

65.55

66.32

g/l

0.57

133

694

Hyperaldosteronism

140

731

2.06

12.85

2.4

3.0

66.49

66.71

g/l

0.13

125

672

Other specified disorders of muscle

126

631

2.12

12.82

1.8

2.9

66.16

67.00

g/l

0.59

116

568

Carcinoma in situ of skin of upper limb, including shoulder

150

809

2.03

12.80

2.4

2.9

63.52

65.80

g/l

3.16

140

724

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

138

713

2.03

12.76

2.0

2.8

67.27

66.98

g/l

0.17

133

657

Mental and behavioural disorders due to opioids

114

547

2.17

12.75

1.8

2.3

67.30

67.90

g/l

0.30

101

516

Degenerative macular diseases

569

4153

1.42

12.75

2.5

66.13

66.00

g/l

0.15

515

3692

Bronchitis, not specified as acute or chronic

345

2287

1.56

12.74

2.4

2.6

66.63

66.53

g/l

0.08

309

2079

Other and unspecified follicular disorders

163

893

1.92

12.68

2.8

2.7

67.55

66.82

g/l

0.75

155

821

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

322

2109

1.59

12.66

2.3

2.6

65.84

66.13

g/l

0.31

297

1890

Thrombotic microangiopathy

125

3.90

12.66

2.9

2.3

60.64

66.27

g/l

3.02

112

Aneurysms, operations, SAH

694

5218

1.36

12.64

2.1

2.6

65.97

66.38

g/l

0.72

619

4692

Other secondary coxarthrosis

162

891

1.93

12.61

1.8

2.8

66.67

66.50

g/l

0.10

144

811

Benign neoplasm: Rectosigmoid junction

207

1227

1.80

12.59

2.6

3.0

66.53

66.32

g/l

0.16

184

1114

Fracture of neck

280

1786

1.64

12.57

2.8

2.5

65.98

66.43

g/l

0.46

255

1631

Optic neuritis

152

815

1.95

12.55

1.8

2.7

68.53

67.44

g/l

1.09

142

755

Nontoxic multinodular goitre

827

6380

1.33

12.52

2.3

2.6

65.96

66.25

g/l

0.49

735

5711

Other nutritional anaemias

239

2.95

12.44

1.9

2.7

65.99

65.75

g/l

0.09

211

Superficial injury of wrist and hand

668

4991

1.36

12.42

2.3

2.4

67.08

66.81

g/l

0.47

610

4618

Alcohol-induced acute pancreatitis

161

890

1.92

12.30

2.1

2.7

66.53

g/l

0.00

140

828

Protein-energy malnutrition of moderate and mild degree

219

3.07

12.27

3.0

2.5

65.22

65.75

g/l

0.16

197

therapeutic use

157

865

1.94

12.27

2.0

2.8

65.64

66.37

g/l

0.48

130

793

Deficiency of other B group vitamins

110

536

2.22

12.26

3.2

2.8

66.21

66.37

g/l

0.09

488

Malignant neoplasm of oesophagus, including Hilmo

167

935

1.89

12.26

1.9

1.6

59.83

66.88

g/l

14.83

159

837

Complications of other internal prosthetic devices, implants and grafts

191

1112

1.81

12.25

2.3

2.6

66.53

66.17

g/l

0.27

175

1011

Moderate visual impairment, binocular

153

836

1.95

12.21

1.9

2.6

65.97

65.94

g/l

0.02

124

741

Other and unspecified injuries of lower leg

267

1686

1.63

12.21

2.1

2.7

65.59

66.94

g/l

1.95

239

1561

Otalgia

295

1909

1.60

12.20

2.7

2.6

67.05

66.53

g/l

0.59

258

1754

Scabies

412

2847

1.48

12.17

2.2

2.5

66.86

67.05

g/l

0.19

380

2650

Other arterial embolism and thrombosis

145

781

1.98

12.12

2.6

2.9

63.92

66.25

g/l

2.92

128

701

Specific development disorders of scholastic skills

105

490

2.18

12.07

3.1

2.4

66.41

67.46

g/l

0.65

467

Other benign neoplasms of skin

1580

13156

1.22

12.02

2.9

2.5

66.52

66.25

g/l

0.71

1391

11876

Orchitis and epididymitis

385

2645

1.50

12.00

2.6

2.5

66.33

66.61

g/l

0.31

355

2420

Dislocation, sprain and strain of joints and ligaments at neck level

471

3346

1.44

12.00

2.2

2.5

67.16

66.99

g/l

0.20

431

3100

Visual field defects

369

2519

1.52

12.00

2.3

2.5

65.79

66.27

g/l

0.56

331

2295

Entropion and trichiasis of eyelid

419

2936

1.48

11.99

2.7

2.5

66.36

66.06

g/l

0.33

375

2622

Spirochaetal infections, other/unspecified

362

2464

1.52

11.95

2.5

2.8

66.85

66.39

g/l

0.61

316

2256

Pre-eclampsia or poor fetal growth

809

6214

1.31

11.94

2.3

66.69

67.27

g/l

1.28

747

5733

Other disorders starting during childhood or adolecense, excluding more controls

395

2.28

11.92

3.2

2.7

65.32

67.00

g/l

0.96

376

Background retinopathy and retinal vascular changes

109

536

2.20

11.89

2.3

2.8

66.68

66.36

g/l

0.17

489

Arterial embolism and thrombosis of lower extremity artery

178

1026

1.84

11.88

2.0

2.9

62.69

66.06

g/l

5.55

157

925

Excessive attrition of teeth

2004

17029

1.19

11.88

2.5

66.96

66.76

g/l

0.54

1823

15680

Other Crohn's disease

235

1449

1.67

11.85

1.8

2.5

65.77

67.25

g/l

1.98

219

1343

Tongue abnormality

265

1692

1.64

11.84

2.5

2.7

66.37

66.41

g/l

0.03

240

1532

Pollen allergy

483

3408

1.42

11.73

2.4

2.5

67.34

67.11

g/l

0.31

430

3196

Hyperfunction of pituitary gland

163

912

1.85

11.71

2.9

2.7

66.26

67.13

g/l

0.72

148

854

Atypical facial pain

207

1244

1.74

11.71

2.5

2.6

67.31

66.70

g/l

0.68

187

1136

Sacrococcygeal disorders, not elsewhere classified

118

596

2.08

11.68

2.0

2.8

67.49

66.99

g/l

0.31

106

550

Acne

227

1383

1.67

11.68

2.3

2.0

67.48

67.72

g/l

0.18

215

1302

Necrosis of pulp, including avohilmo

2059

17513

1.18

11.65

2.6

2.5

66.64

66.82

g/l

0.53

1899

16147

Other disorders of bone density and structure

103

496

2.20

11.64

1.9

2.6

68.30

67.10

g/l

1.08

456

Erythema multiforme

108

532

2.17

11.64

2.8

2.9

65.45

66.74

g/l

0.86

102

484

Ptosis of eyelid

497

3604

1.43

11.62

2.7

2.6

65.88

66.12

g/l

0.32

456

3255

Impacted cerumen

444

3158

1.45

11.62

2.5

2.6

66.51

66.16

g/l

0.40

337

2863

Multifocal fibrosclerosis

154

3.49

11.61

1.7

2.9

66.14

66.47

g/l

0.10

136

Thyroiditis

268

1719

1.61

11.58

2.4

2.7

67.31

66.81

g/l

0.57

242

1573

Other other unspecified disorders of the circulatory system

173

997

1.84

11.57

3.5

2.6

65.37

66.41

g/l

1.04

160

906

Viral meningitis

127

660

2.01

11.55

1.9

2.5

66.47

67.23

g/l

0.50

119

609

Somnolence, stupor and coma

186

1091

1.78

11.54

1.7

2.9

64.72

66.35

g/l

2.03

172

992

Carbimazole or st.post thyroidectomy, condition for graves disease

754

5804

1.32

11.51

2.7

2.6

65.72

66.71

g/l

3.21

693

5286

Suppurative and unspecified otitis media

1068

7572

1.26

11.48

3.0

2.3

67.00

66.85

g/l

0.25

995

6977

Primary adrenocortical insufficiency

237

2.85

11.48

2.0

3.0

64.82

67.22

g/l

1.69

220

Primary coxarthrosis, bilateral

1333

10990

1.24

11.45

2.2

2.6

66.63

65.99

g/l

2.58

1184

9835

Other specified/unspecified spondylopathies

121

625

2.07

11.45

2.8

2.6

66.60

66.38

g/l

0.10

107

569

Astigmatism

217

1323

1.70

11.43

2.5

2.9

66.67

66.51

g/l

0.11

193

1219

Malignant neoplasm of small intestine

105

517

2.19

11.41

4.3

1.6

64.90

67.62

g/l

2.45

465

Nonsuppurative otitis media

661

4306

1.35

11.39

2.8

2.2

66.62

66.77

g/l

0.20

621

3969

Other and unspecified mononeuropathies, also in other diseases

136

732

1.97

11.35

2.4

2.7

66.45

66.61

g/l

0.10

116

663

Scleritis and episcleritis

226

1399

1.68

11.33

2.0

2.6

68.08

66.85

g/l

1.67

212

1295

Other and unspecified psoriasis

281

1835

1.59

11.32

1.9

2.8

66.49

66.62

g/l

0.10

261

1675

Special screening examination for neoplasms

227

1407

1.67

11.31

3.1

2.4

66.35

66.21

g/l

0.09

199

1287

Suggestive for eosinophilic asthma

377

2613

1.49

11.30

2.1

2.6

66.12

66.46

g/l

0.38

347

2386

Wet age-related macular degeneration

871

6663

1.30

11.28

2.4

65.69

65.59

g/l

0.13

763

5831

Chronic iridocyclitis

199

1197

1.74

11.24

2.2

2.7

68.72

66.56

g/l

3.49

176

1098

Plantar fascial fibromatosis

345

2348

1.51

11.21

2.3

2.7

67.28

66.64

g/l

0.93

317

2152

Type 1 diabetes, definitions combined

251

1584

1.61

11.21

2.1

2.4

65.01

67.30

g/l

5.37

231

1496

Other noninflammatory disorders of uterus, except cervix

878

4632

1.30

11.19

2.8

2.6

66.39

66.26

g/l

0.19

784

4141

Emotional disorders and disorders of social functioning with onset specific to childhood

103

489

2.12

11.19

1.9

2.4

67.17

67.24

g/l

0.03

465

Progressive vascular leukoencephalopathy

201

1225

1.75

11.13

2.0

2.6

66.07

65.77

g/l

0.24

172

1078

Crohn disease (strict definition, all UC cases excluded)

178

1039

1.78

11.13

2.0

2.7

65.88

66.98

g/l

1.20

162

966

Biological medicines for asthma

349

2.42

11.10

1.9

2.7

67.88

67.81

g/l

0.03

325

Scabies

165

944

1.82

11.08

3.0

2.5

66.78

66.92

g/l

0.07

150

876

Congenital malformations of cardiac septa

228

1374

1.66

11.06

2.2

2.9

64.99

66.59

g/l

1.93

206

1273

Melanocytic naevi

1063

8572

1.26

11.04

2.9

2.5

66.50

66.63

g/l

0.25

993

7823

Other and unspecified erythematous conditions

142

783

1.92

11.00

2.6

2.8

66.84

66.64

g/l

0.11

136

717

Postprocedural musculoskeletal disorders, not elsewhere classified

318

2150

1.54

10.99

2.7

65.94

66.38

g/l

0.49

289

1962

Periapical abscess

1704

14393

1.20

10.98

2.4

2.6

66.91

66.70

g/l

0.55

1566

13236

Other secondary gonarthrosis

235

1488

1.65

10.93

2.1

3.0

66.00

66.56

g/l

0.47

222

1365

Arthropod-borne viral fevers and viral haemorrhagic fevers

699

5368

1.33

10.93

2.8

2.6

65.78

66.47

g/l

1.55

659

4899

Sequelae of injuries of lower limb

339

2313

1.51

10.93

2.1

2.7

66.65

66.80

g/l

0.15

315

2134

Hepatocellular carcinoma, including Hilmo

135

735

1.95

10.92

2.7

1.5

66.54

66.71

g/l

0.08

122

652

Disorders of tooth development and eruption

506

2977

1.40

10.91

2.6

2.2

66.63

66.83

g/l

0.25

464

2726

Drug-induced hypoglycaemia without coma

373

2.38

10.90

2.0

2.6

64.91

66.25

g/l

0.46

337

Disorders of orbit

182

1079

1.77

10.90

2.9

2.7

66.65

66.79

g/l

0.09

169

985

Biomechanical lesions, not elsewhere classified

216

1342

1.69

10.87

2.3

2.8

67.19

66.58

g/l

0.64

197

1231

Other/unspecified enthesopathies, not elsewhere classified

334

2277

1.51

10.85

2.4

2.6

65.92

66.38

g/l

0.56

301

2063

Viral haemorrhagic fevers, not elsewhere classified/unspecified

614

4637

1.35

10.83

2.8

2.6

65.84

66.47

g/l

1.20

579

4233

Corticotropin deficiency

193

3.05

10.82

2.2

2.6

65.70

67.21

g/l

0.71

180

Malignant neoplasm of anus and anal canal, including Hilmo

294

2.59

10.77

1.9

1.6

66.57

67.17

g/l

0.31

261

Other specified and unspecified retinal disorders

165

959

1.82

10.75

3.1

2.8

67.00

66.38

g/l

0.50

147

877

Other and unspecified trigeminal disorders

324

2.46

10.72

3.4

2.8

67.11

67.05

g/l

0.02

299

Pregnancy hypertension

1182

8642

1.24

10.66

2.4

66.63

67.08

g/l

1.22

1103

7923

Abnormal blood-pressure reading, without diagnosis

172

1008

1.77

10.65

2.5

2.6

66.45

66.55

g/l

0.06

158

916

Hypotension due to drugs

393

2.35

10.60

3.0

2.7

65.50

65.87

g/l

0.16

353

Disorders of optic nerve, not elsewhere classified

110

569

2.09

10.54

2.6

3.1

64.84

66.58

g/l

1.55

101

517

Eating disorder

193

1160

1.69

10.53

1.5

2.1

66.34

67.60

g/l

1.66

174

1091

Type 1 diabetes, strict (exclude DM2)

249

1593

1.59

10.53

2.1

2.4

64.95

67.27

g/l

5.45

229

1504

Flat foot [pes planus] (acquired)

336

2306

1.50

10.50

1.9

3.0

66.71

66.18

g/l

0.67

299

2100

Chondrocostal junction syndrome [Tietze]

154

881

1.84

10.50

2.1

2.7

66.53

66.81

g/l

0.18

139

808

Other and unspecified mood [affective] disorders

193

1165

1.70

10.50

2.0

2.5

66.00

67.43

g/l

1.75

176

1081

Postmenopausal bleeding

1099

4733

1.26

10.44

2.6

66.43

66.28

g/l

0.25

966

4236

Congenital iodine-deficiency syndrome/hypothyroidism

136

754

1.91

10.39

2.5

2.6

64.13

66.45

g/l

2.72

118

684

Specific development disorders of speech and language

171

966

1.75

10.35

2.1

2.8

65.79

66.29

g/l

0.34

158

885

Malignant neoplasm of thymus, including Hilmo

4.41

10.34

2.3

1.9

65.31

66.98

g/l

0.65

Secondary malignant neoplasm of other and unspecified sites

436

2.24

10.32

2.4

1.6

64.75

67.21

g/l

2.16

393

Follicular cysts of skin and subcutaneous tissue

698

5405

1.32

10.31

2.4

2.5

66.29

66.59

g/l

0.47

640

4943

Erythema nodosum

126

683

1.95

10.29

3.2

2.9

67.18

66.88

g/l

0.17

117

624

Exposure to other and unspecified inanimate mechanical forces

259

1695

1.58

10.25

2.6

2.7

66.35

66.70

g/l

0.32

244

1566

Neovascular glaucoma

185

1123

1.73

10.24

2.4

2.7

67.02

66.35

g/l

0.52

171

1011

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

533

3972

1.37

10.24

2.5

2.6

67.40

66.84

g/l

0.89

505

3677

Malignant melanoma of skin, including Hilmo

561

4222

1.36

10.24

2.7

1.6

65.98

66.80

g/l

1.75

502

3740

Lichen simplex chronicus

147

838

1.85

10.20

2.8

3.0

67.06

66.63

g/l

0.33

137

763

Fracture at wrist and hand level

1226

10094

1.23

10.20

2.5

66.33

66.77

g/l

1.31

1096

9257

Certolizumab pegol

267

2.54

10.18

1.5

2.6

69.73

67.96

g/l

1.34

251

Palmar fascial fibromatosis [Dupuytren]

670

5176

1.32

10.17

2.2

2.6

66.16

66.14

g/l

0.01

609

4665

Unspecified/other endometriosis

249

1612

1.58

10.15

2.1

66.82

66.97

g/l

0.12

227

1481

Chondropathies

525

3912

1.37

10.14

2.5

66.71

66.78

g/l

0.08

477

3614

Superficial injury of ankle and foot

364

2549

1.46

10.14

1.9

2.5

66.16

66.92

g/l

1.13

330

2363

Congenital malformations of the respiratory system

397

2.26

10.11

2.7

3.1

66.88

66.42

g/l

0.22

364

!Aliquae complicationes praecoces traumatis

175

1049

1.74

10.08

2.9

2.7

65.93

66.66

g/l

0.55

155

966

Early complications of trauma

175

1049

1.74

10.08

2.9

2.7

65.93

66.66

g/l

0.55

155

966

Hallux rigidus

534

3998

1.37

10.08

2.2

2.9

66.90

66.01

g/l

1.96

469

3609

Unspecified urinary incontinence

369

2606

1.46

10.08

2.0

2.6

66.42

66.23

g/l

0.17

295

2332

Benign neoplasm of mouth and pharynx

441

3213

1.41

10.01

3.6

2.6

66.35

66.41

g/l

0.06

394

2940

Hyperosmolality and hypernatraemia

349

2.38

9.98

3.1

2.4

64.20

66.20

g/l

0.98

310

Presbycusis

687

5299

1.32

9.91

2.6

2.4

65.41

65.67

g/l

0.39

583

4654

Glaucoma secondary to other eye disorders

186

1141

1.71

9.90

2.4

2.8

66.97

66.25

g/l

0.58

172

1037

Monoamine oxidase A inhibitors

447

3265

1.40

9.90

2.0

2.8

66.44

66.60

g/l

0.17

393

2985

Congenital malformations of trachea and bronchus

220

2.79

9.88

2.7

3.4

66.43

66.10

g/l

0.12

196

Cluster headache, wide,, including avohilmo

177

1067

1.72

9.87

1.7

2.7

67.93

67.25

g/l

0.60

169

992

Other and unspecified nonorganic psychotic disorders

568

4292

1.34

9.86

1.9

2.5

66.22

67.13

g/l

1.86

515

3987

Type1 diabetes, definitions combined, early onset

144

812

1.80

9.84

2.0

2.3

64.32

67.77

g/l

7.84

136

776

Other symptoms and signs involving general sensations and perceptions

167

996

1.75

9.83

2.1

2.8

66.46

66.09

g/l

0.20

141

910

Use of teriflunomide

144

3.14

9.83

1.3

2.3

68.78

68.43

g/l

0.17

136

Atrial septal defect

135

751

1.86

9.82

2.1

3.0

65.02

66.42

g/l

0.97

122

692

Sequelae of injuries of neck and trunk

124

679

1.92

9.81

2.9

3.0

66.43

67.00

g/l

0.37

114

629

Panniculitis affecting regions of neck and back

141

801

1.84

9.80

2.0

2.6

66.99

66.73

g/l

0.16

131

737

Pure hyperglyceridaemia

104

539

2.05

9.80

1.9

2.5

66.59

66.38

g/l

0.10

494

Ulcerative colitis (strict definition, require KELA)

548

4130

1.35

9.78

2.5

2.6

67.46

66.82

g/l

1.13

519

3828

Pustular psoriasis

190

1174

1.69

9.78

2.2

2.9

67.15

66.70

g/l

0.35

178

1071

Congenital malformations of the respiratory system

370

2.29

9.77

2.8

3.2

66.70

66.42

g/l

0.12

341

Retinal detachment with retinal break

552

4181

1.36

9.76

2.7

2.6

65.75

66.22

g/l

0.70

496

3796

Abnormality of red blood cells

105

3.73

9.73

1.9

2.5

65.66

66.04

g/l

0.11

Varicella [chickenpox]

151

875

1.79

9.72

5.3

2.5

66.01

67.16

g/l

0.94

142

821

Acquired absence of limb

240

2.68

9.72

3.7

2.5

64.74

66.30

g/l

0.69

217

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

266

1777

1.55

9.71

2.1

1.6

65.86

66.55

g/l

0.64

240

1565

Other diseases of spinal cord

128

711

1.90

9.70

3.0

2.9

65.64

66.98

g/l

1.15

121

656

Otitis externa, unspecified

384

2743

1.43

9.69

2.6

66.85

66.66

g/l

0.20

350

2534

Contact with and exposure to communicable diseases

791

6223

1.28

9.67

2.6

2.4

66.56

67.21

g/l

1.64

739

5812

Pigmented purpuric dermatosis

247

2.66

9.66

2.4

3.6

67.49

66.59

g/l

0.35

227

Melanocytic naevi of trunk

429

3126

1.41

9.65

2.8

2.6

66.53

66.63

g/l

0.12

400

2885

severe traumatic brain injury, does not include concussion

981

7980

1.25

9.64

2.4

66.01

66.14

g/l

0.20

874

7126

Other female pelvic inflammatory diseases

555

4205

1.35

9.62

2.4

2.6

66.20

66.66

g/l

0.74

475

3809

Granulomatous disorders of skin and subcutaneous tissue

104

542

2.02

9.56

3.4

2.8

67.36

67.35

g/l

0.00

493

Ganglion

673

5233

1.30

9.51

2.3

2.6

66.63

66.72

g/l

0.12

612

4783

Glucosamine medication

2250

15672

1.16

9.50

2.5

2.6

66.09

66.12

g/l

0.07

1990

14018

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

183

1102

1.67

9.49

3.2

2.5

66.65

67.16

g/l

0.44

173

1027

Bursitis of shoulder

103

538

2.02

9.43

3.0

2.9

66.44

66.89

g/l

0.23

489

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

593

4545

1.33

9.41

2.5

2.6

67.34

66.81

g/l

0.92

563

4205

Melanoma in situ

210

1349

1.64

9.39

3.1

2.9

66.26

66.24

g/l

0.01

184

1224

Assault

368

2618

1.43

9.38

1.8

2.4

67.10

67.28

g/l

0.16

327

2470

Crohn disease (strict definition, require KELA)

206

1306

1.62

9.38

1.9

2.5

65.79

67.13

g/l

1.65

187

1215

Viral agents as the cause of diseases classified to other chapters

104

547

2.01

9.34

3.4

2.7

65.42

66.87

g/l

1.03

504

Open wound of abdomen, lower back and pelvis

112

602

1.94

9.32

2.1

2.5

66.44

66.79

g/l

0.15

561

Follow-up examination after treatment for malignant neoplasms

404

2934

1.41

9.32

2.8

2.4

66.14

65.87

g/l

0.28

367

2642

D07AA Corticosteroids, weak (group I)

480

3568

1.37

9.29

2.1

2.6

67.15

66.69

g/l

0.67

434

3292

Other and unspecified glaucoma

324

2276

1.48

9.26

2.2

2.6

66.13

66.09

g/l

0.03

285

2019

Salpingitis and oophoritis

605

4665

1.32

9.25

2.1

2.7

66.33

66.75

g/l

0.68

542

4259

Other disorders of electrolyte and fluid balance, not elsewhere classified

203

2.78

9.23

1.6

2.2

65.12

67.22

g/l

1.01

182

Other retinal artery occlusion

121

676

1.92

9.20

2.4

3.0

66.07

65.99

g/l

0.04

107

615

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

218

1407

1.59

9.19

1.9

2.6

65.90

67.19

g/l

1.62

199

1305

Varicella [chickenpox]

165

994

1.71

9.19

5.1

2.5

65.49

67.07

g/l

1.60

156

934

Lateral epicondylitis

429

3148

1.39

9.17

2.2

2.6

67.57

66.77

g/l

1.74

392

2907

Universal erythroderma, KELA reimbursement

322

2.35

9.14

1.8

3.0

66.63

66.45

g/l

0.06

294

Other and unspecified disorders of vitreous body

1769

15032

1.18

9.13

2.5

2.7

66.67

66.36

g/l

1.06

1606

13630

Superficial injury of shoulder and upper arm

412

3011

1.40

9.12

2.1

2.5

66.49

66.51

g/l

0.02

366

2767

Atypical mycobacterium lung infection

318

2.39

9.10

1.8

2.7

64.52

65.90

g/l

0.67

285

Ingrowing nail

188

1177

1.65

9.09

2.1

2.7

65.58

66.84

g/l

1.62

175

1082

Pustulosis palmaris et plantaris

172

1057

1.70

9.08

2.3

2.9

67.34

66.89

g/l

0.34

162

967

Sixth [abducent] nerve palsy

154

923

1.76

9.07

3.0

2.9

66.14

66.29

g/l

0.08

137

837

Other disorders of iris and ciliary body

123

691

1.88

9.06

2.3

3.1

66.93

66.48

g/l

0.26

112

625

Crohn disease (strict definition, require KELA, min 2 HDR)

201

1279

1.62

9.02

1.9

2.5

65.80

67.12

g/l

1.57

182

1189

Implicit parasitic Sepsis

100

3.69

9.02

4.2

2.6

64.64

66.94

g/l

1.11

Emotional disorders starting during childhood or adolescence

487

2.00

9.01

2.0

2.5

67.10

67.23

g/l

0.05

463

Carcinoma in situ of other and unspecified digestive organs

163

996

1.74

9.00

2.4

3.0

65.76

66.33

g/l

0.46

152

911

Nontoxic goitre/thyroid nodule

1198

10007

1.22

9.00

2.3

2.6

66.29

66.25

g/l

0.06

1074

8958

Dislocation, sprain and strain of joint and ligaments of hip

166

1016

1.72

9.00

2.3

2.8

64.60

66.32

g/l

1.87

149

927

Cluster headache, strict, including avohilmo

162

979

1.71

8.99

1.7

2.6

68.10

67.45

g/l

0.54

154

913

Acute alcohol intoxication

978

8004

1.24

8.98

1.8

2.6

66.05

66.57

g/l

1.21

872

7356

Other prurigo

242

2.57

8.97

1.4

3.1

66.67

66.39

g/l

0.09

211

Malignant neoplasm of colon, including Hilmo

746

5929

1.28

8.97

2.6

1.6

64.96

66.62

g/l

6.23

666

5228

Anogenital herpesviral [herpes simplex] infection

167

1015

1.69

8.96

2.6

2.3

65.85

67.72

g/l

2.64

154

945

Impotence

233

1544

1.57

8.95

2.0

2.7

66.34

66.48

g/l

0.09

216

1410

Secondary polycythaemia

101

535

2.00

8.94

2.8

2.9

64.97

66.58

g/l

1.14

487

Secondary parkinsonism, excluding more controls

103

548

1.98

8.93

2.2

2.7

64.54

65.80

g/l

0.83

501

Erythema intertrigo

109

594

1.95

8.90

2.4

3.3

66.14

66.59

g/l

0.25

538

Implicit parasitic Sepsis

111

3.46

8.88

4.1

2.4

64.56

67.18

g/l

1.32

105

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

219

1428

1.58

8.84

2.0

2.6

65.68

66.78

g/l

1.49

197

1322

Carcinoma in situ of skin of ear and external auricular canal

473

2.12

8.84

2.3

2.7

64.92

65.73

g/l

0.31

420

Haemorrhagic disorder due to circulating anticoagulants

396

2.22

8.83

1.8

2.8

64.33

65.83

g/l

0.83

350

Unspecified mental disorder

1377

11641

1.19

8.81

2.0

2.5

66.21

66.87

g/l

2.45

1237

10677

Other congenital malformations

253

1700

1.52

8.79

2.2

2.7

66.40

66.87

g/l

0.40

238

1581

Malignant neoplasm of stomach, including Hilmo

242

1619

1.55

8.79

2.4

1.5

62.36

66.51

g/l

11.51

222

1426

Other bullous disorders

122

691

1.87

8.77

3.3

2.9

67.13

66.51

g/l

0.38

115

628

127

732

1.86

8.74

2.2

2.9

64.91

66.01

g/l

0.80

109

651

Malignant neoplasm of thymus

4.50

8.74

2.5

2.1

65.88

66.67

g/l

0.21

Carcinoma in situ of skin of trunk

167

1039

1.71

8.67

3.5

2.7

63.72

65.90

g/l

3.13

151

935

Acute lymphadenitis

189

1198

1.62

8.65

2.4

2.6

65.73

66.97

g/l

1.19

180

1106

Central retinal artery occlusion

116

653

1.90

8.64

3.4

2.8

67.22

65.75

g/l

1.23

102

589

Nonalcoholic steatohepatitis

180

2.83

8.64

1.7

2.9

68.35

67.59

g/l

0.27

169

Malignant neoplasm of oesophagus

115

643

1.89

8.63

2.0

1.6

59.95

66.83

g/l

9.34

109

585

Acute laryngitis and tracheitis

289

1964

1.47

8.61

2.0

2.4

66.56

67.27

g/l

0.87

267

1834

Benign neoplasm of urinary organs

207

1350

1.60

8.60

2.2

2.9

65.93

66.39

g/l

0.38

187

1229

Crohn's disease of large intestine

175

1092

1.66

8.59

2.0

2.7

66.19

67.23

g/l

0.91

163

1016

Eating disorders

254

1712

1.51

8.57

1.7

2.3

66.34

67.28

g/l

1.33

231

1601

Hereditary ataxia

305

2.35

8.57

1.6

3.1

67.06

66.35

g/l

0.39

278

Prepatellar bursitis

170

1056

1.67

8.57

2.5

2.9

66.70

66.56

g/l

0.08

151

965

Lesion of radial nerve

146

873

1.74

8.56

2.4

2.7

65.36

66.79

g/l

1.39

126

800

Other misadventures during surgical and medical care

109

602

1.93

8.56

2.4

3.2

64.16

66.61

g/l

2.40

102

544

Deviated nasal septum

1277

10757

1.20

8.56

2.7

2.6

66.84

66.60

g/l

0.58

1169

9924

Viral agents as the cause of diseases classified to other chapters

480

2.03

8.52

3.6

2.7

65.02

66.96

g/l

1.37

445

Complications peculiar to reattachment and amputation

147

3.05

8.51

4.5

2.7

65.59

66.22

g/l

0.22

133

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1062

8810

1.22

8.51

2.6

2.5

66.74

66.62

g/l

0.20

964

8076

Acne vulgaris

166

1019

1.66

8.49

2.2

2.0

67.63

67.94

g/l

0.22

158

960

Other strabismus

693

5473

1.28

8.46

2.4

2.5

66.52

66.73

g/l

0.31

643

5038

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1336

9817

1.19

8.44

2.4

2.5

66.67

67.00

g/l

0.85

1247

8969

Hydrocele

491

3738

1.34

8.39

2.5

2.6

65.67

66.48

g/l

1.60

446

3413

Manic episode

108

595

1.89

8.36

2.1

3.1

66.68

67.20

g/l

0.23

552

Blindness, monocular

214

2.63

8.32

3.2

2.7

64.09

66.46

g/l

1.31

191

Behavioural disorders, excluding more controls

197

2.56

8.31

1.8

3.0

67.03

68.06

g/l

0.40

188

Septal defects

204

1302

1.58

8.27

2.2

2.9

65.50

66.50

g/l

0.92

187

1208

Diseases of middle ear and mastoid

1926

13714

1.16

8.25

2.8

2.4

66.71

66.68

g/l

0.07

1777

12518

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

245

2.47

8.24

2.1

2.7

65.07

67.27

g/l

1.49

230

Other bacterial agents as the cause of diseases classified to other chapters

278

2.38

8.20

3.3

2.9

64.72

66.12

g/l

0.76

254

Fasciculation

233

2.50

8.19

1.7

2.6

69.11

67.23

g/l

1.25

220

Gluteal tendinitis

144

868

1.73

8.19

2.0

2.7

66.54

66.38

g/l

0.10

129

800

Asthma mixed form (mode), excluding more controls

150

910

1.69

8.14

1.8

2.0

67.28

67.47

g/l

0.13

135

798

Causalgia

303

2.27

8.13

1.4

2.5

66.88

67.81

g/l

0.54

284

Hyperprolactinaemia

106

585

1.88

8.12

2.9

2.6

66.51

67.44

g/l

0.69

549

Episcleritis

181

1156

1.62

8.11

2.0

2.7

68.31

66.86

g/l

1.79

171

1074

Post-traumatic wound infection, not elsewhere classified

108

603

1.88

8.11

2.8

3.0

67.04

67.01

g/l

0.01

553

Redundant prepuce, phimosis and paraphimosis

696

5495

1.27

8.11

3.1

2.5

67.07

66.94

g/l

0.18

645

5099

Use of disulfiram, acamprosate or naltrexone

294

2073

1.45

8.10

1.7

2.7

66.71

67.12

g/l

0.38

267

1937

Other and unspecified pemphigoid

250

2.51

8.10

1.5

3.1

65.26

66.17

g/l

0.43

224

Medial epicondylitis

130

764

1.77

8.08

2.7

2.8

67.17

66.72

g/l

0.29

119

704

Anogenital herpesviral [herpes simplex] infection

265

1827

1.48

8.08

2.4

2.3

66.10

67.53

g/l

2.25

245

1702

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

195

1271

1.59

8.08

1.9

1.6

65.57

66.36

g/l

0.60

174

1125

Ankylosing spondylitis, strict definition

141

847

1.72

8.06

1.7

2.7

69.00

67.41

g/l

1.43

132

799

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

215

1423

1.54

8.05

2.1

2.8

67.19

66.81

g/l

0.33

197

1323

Chorioretinal inflammation

119

686

1.82

8.04

2.4

2.7

67.14

66.79

g/l

0.23

111

624

Other ill-defined and unspecified causes of mortality

353

2582

1.41

8.04

2.4

2.5

65.16

65.92

g/l

0.88

316

2328

Impetigo

136

809

1.73

8.03

3.1

2.7

67.36

67.12

g/l

0.14

127

749

277

2.29

7.99

2.8

2.6

66.11

68.14

g/l

1.43

257

Other congenital malformations

376

2764

1.38

7.97

2.0

2.7

66.23

66.75

g/l

0.62

347

2550

Other bacterial agents as the cause of diseases classified to other chapters

237

2.49

7.97

3.5

3.1

64.52

66.24

g/l

0.91

216

Other disorders of central nervous system

249

2.42

7.93

2.9

2.4

68.28

67.54

g/l

0.46

229

Carcinoma in situ of colon

102

569

1.93

7.92

2.9

3.2

65.76

66.65

g/l

0.65

515

Malignant neoplasm of endocrine gland

236

1604

1.51

7.92

3.2

1.5

66.49

67.24

g/l

0.79

220

1432

Malignant neoplasm of bladder

286

2019

1.46

7.89

2.2

1.6

65.65

66.37

g/l

0.80

255

1764

Hypogonadotropic hypogonadism

534

1.92

7.89

2.9

2.7

68.55

67.40

g/l

0.88

507

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

274

2.31

7.88

5.1

2.8

63.42

66.78

g/l

1.71

251

Disturbance of activity and attention

216

1409

1.52

7.76

1.5

2.0

67.60

67.58

g/l

0.01

200

1342

Other specified and unspecified disorders of eye and adnexa

150

929

1.68

7.74

2.3

2.9

65.69

66.82

g/l

0.88

133

845

Paralytic ileus

165

1048

1.64

7.71

2.7

2.4

65.10

66.46

g/l

1.10

149

955

Other specified/unspecified disorders of bone/cartilage

107

605

1.85

7.71

2.4

2.5

66.76

66.80

g/l

0.02

568

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

393

2.09

7.69

3.6

1.6

63.73

67.01

g/l

3.02

352

Assault by bodily force

210

1400

1.53

7.65

1.8

2.6

66.54

67.62

g/l

1.06

187

1319

Other ulcerative colitis

196

1292

1.56

7.64

2.1

2.7

67.22

66.92

g/l

0.23

188

1194

Other endocrine disorders

156

932

1.65

7.63

2.7

3.1

65.92

66.28

g/l

0.22

145

861

Nystagmus and other irregular eye movements

266

2.32

7.60

2.2

2.9

64.32

66.74

g/l

1.26

248

Ulcerative colitis (strict definition, all Crohn cases excluded)

459

3506

1.33

7.59

2.6

67.81

66.87

g/l

1.95

432

3242

Oesophageal obstruction

157

991

1.66

7.59

2.6

2.8

63.67

66.22

g/l

2.92

137

902

Malignant neoplasm of liver and intrahepatic bile ducts

123

729

1.77

7.58

1.9

1.6

65.70

66.59

g/l

0.50

107

643

Injuries to the wrist and hand

4009

25327

1.10

7.57

2.4

2.6

66.53

66.58

g/l

0.15

3666

23107

Other dermatomyositis

3.45

7.57

1.2

3.0

64.36

66.66

g/l

0.88

Degeneration of the brain due to alcohol

106

605

1.87

7.57

1.5

2.9

67.25

66.37

g/l

0.47

556

Thyrotoxicosis with toxic multinodular goitre

255

1783

1.48

7.56

2.1

2.7

63.92

66.39

g/l

5.63

225

1603

Pemphigus

163

2.81

7.56

1.9

2.8

66.98

66.18

g/l

0.35

154

Excessive earwax

2326

20182

1.14

7.55

2.6

66.85

66.33

g/l

2.79

2053

18335

Amputation of thigh

146

908

1.69

7.54

2.1

2.6

62.85

65.73

g/l

3.41

131

807

Injury of other and unspecified intrathoracic organs

251

1748

1.48

7.53

2.2

2.5

64.82

66.54

g/l

3.17

226

1605

Type 1 diabetes, strict definition

165

1041

1.61

7.53

1.8

2.3

64.98

67.89

g/l

6.28

154

997

Mental disorders, not otherwise specified

238

1635

1.49

7.50

2.6

2.5

66.30

67.26

g/l

1.24

226

1529

Other specified/unspecified dorsopathies

128

767

1.73

7.48

2.8

2.7

66.36

66.62

g/l

0.15

113

710

Other noninflammatory disorders of vulva and perineum

294

2102

1.43

7.47

1.8

2.4

66.25

66.58

g/l

0.29

262

1907

Degeneration of nervous system due to alcohol

106

608

1.86

7.45

1.5

2.8

67.25

66.35

g/l

0.48

557

Renal agenesis and other reduction defects of kidney

3.41

7.45

2.6

4.4

64.37

66.11

g/l

0.66

Blepharochalasis

1245

10627

1.19

7.42

2.3

2.7

66.09

66.15

g/l

0.11

1108

9535

Abdominal aortic aneurysm (AAA)

462

3525

1.33

7.42

2.0

2.6

65.67

65.93

g/l

0.29

412

3126

Benign neoplasm: Pancreas

132

806

1.74

7.41

2.8

3.1

66.08

66.30

g/l

0.12

124

730

Carcinoma in situ of skin of lower limb, including hip

112

656

1.83

7.41

2.7

3.0

63.92

66.02

g/l

2.41

105

581

Inflammatory diseases of prostate (prostatitis)

509

3966

1.31

7.40

2.4

2.7

66.32

66.64

g/l

0.43

463

3642

Herpesviral keratitis and keratoconjunctivitis

174

1130

1.60

7.39

2.7

65.64

66.66

g/l

1.06

161

1031

Event of undetermined intent

207

1390

1.53

7.38

2.6

2.7

66.75

66.85

g/l

0.07

190

1295

Disorders of speech understanding and production

131

777

1.71

7.31

2.3

2.9

65.58

65.84

g/l

0.14

121

701

Recurrent dislocation and subluxation of joint

182

1189

1.56

7.29

2.1

2.7

67.17

66.91

g/l

0.18

165

1117

Other and unspecified localized connective tissue disorders

4.03

7.29

4.4

3.1

69.98

66.65

g/l

0.76

Diseases of appendix

2806

22745

1.12

7.28

2.6

2.5

66.61

66.66

g/l

0.15

2566

20864

Sleep disorders, other/unspecified

106

606

1.81

7.26

1.9

2.5

67.25

67.24

g/l

0.00

565

Other surgical follow-up care

114

668

1.77

7.21

2.4

2.5

65.49

67.24

g/l

1.31

109

609

Other keratitis

372

2781

1.36

7.20

2.4

2.6

67.16

66.73

g/l

0.50

341

2552

Other otitis externa (chronic)

241

1680

1.48

7.19

2.3

2.8

66.45

66.53

g/l

0.05

192

1542

Lichen planus

505

3950

1.31

7.16

2.4

2.6

67.16

66.24

g/l

1.90

456

3577

Hepatocellular carcinoma

540

1.88

7.16

2.3

1.6

66.24

66.72

g/l

0.20

475

Dystonia

201

1354

1.53

7.16

2.0

2.7

66.83

66.49

g/l

0.22

186

1246

Benign neoplasm: Kidney

150

951

1.65

7.15

2.2

3.0

66.01

66.51

g/l

0.35

135

869

Radial styloid tenosynovitis [de Quervain]

170

1102

1.58

7.13

2.6

2.8

66.11

66.88

g/l

0.74

156

1013

Other specified/unspecified hearing loss

347

2579

1.38

7.12

2.7

2.5

65.94

66.25

g/l

0.33

327

2331

Delayed milestone in childhood

168

2.51

7.11

3.2

4.3

63.49

62.99

g/l

0.12

161

Otitis media, unspecified

288

1900

1.42

7.08

3.4

2.3

66.94

66.90

g/l

0.03

277

1761

Convalescence

183

1210

1.56

7.08

3.0

2.5

66.34

67.22

g/l

0.85

163

1095

Spinal instabilities

103

591

1.82

7.07

1.9

2.8

67.30

66.87

g/l

0.25

556

Acute appendicitis, no complications

1914

16799

1.14

7.05

2.6

2.5

66.72

66.80

g/l

0.18

1760

15497

Behavioural syndromes associated with physiological disturbances and physical factors

3539

22838

1.11

7.04

2.1

2.6

66.82

66.58

g/l

1.06

3196

20849

Other papulosquamous disorders

250

2.33

7.03

2.9

2.6

66.66

66.95

g/l

0.11

228

Other abnormal findings in urine

422

2.01

7.01

3.3

2.4

67.80

65.78

g/l

1.60

378

Trigeminal neuralgia

215

1476

1.50

6.96

2.7

2.6

66.94

66.56

g/l

0.33

201

1348

Endocrine disorders, other/unspecified

428

1.97

6.96

1.9

3.0

67.87

67.10

g/l

0.47

391

Acquired absence of organs, not elsewhere classified

305

2.20

6.95

5.1

2.4

64.43

66.72

g/l

1.08

272

Malignant neoplasm of thyroid gland, including Hilmo

244

1714

1.46

6.94

3.1

1.5

66.88

67.15

g/l

0.22

225

1531

Autonomic disorders

530

1.87

6.92

2.5

2.9

65.76

67.13

g/l

1.00

485

Excessive vomiting in pregnancy

211

1440

1.49

6.89

2.7

2.5

66.35

67.52

g/l

1.63

196

1338

Mouth breathing

1488

12919

1.16

6.89

2.5

2.6

66.72

66.71

g/l

0.01

1370

11918

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

350

2619

1.37

6.89

2.7

2.8

67.07

66.45

g/l

0.83

310

2384

Mental and behavioural disorders due to use of other stimulants, including caffeine

349

2.04

6.87

1.2

2.2

67.75

68.40

g/l

0.27

332

Respiratory tuberculosis, confirmed

482

1.91

6.84

1.7

2.6

66.52

66.09

g/l

0.20

430

Ectropion of eyelid

197

1341

1.53

6.83

1.8

2.5

66.07

65.70

g/l

0.28

172

1184

Atrophic disorders of skin

512

4032

1.29

6.81

2.4

2.5

66.68

66.59

g/l

0.09

473

3643

Achilles tendinitis

352

2635

1.36

6.81

2.7

66.50

66.38

g/l

0.12

317

2440

Retinal haemorrhage

117

708

1.75

6.79

3.6

2.9

65.98

66.02

g/l

0.02

101

642

Melanocytic naevi of lower limb, including hip

155

999

1.61

6.79

2.8

66.45

66.88

g/l

0.30

149

919

Bicipital tendinitis

175

1159

1.56

6.78

2.8

3.0

66.71

g/l

0.00

164

1064

Other eating disorders

105

609

1.76

6.75

1.2

2.3

65.93

67.68

g/l

1.63

576

Appendicitis, broad definition

2766

22584

1.11

6.73

2.6

2.5

66.61

66.68

g/l

0.18

2531

20724

Hypertrophic disorders of skin

171

1126

1.56

6.72

2.9

2.7

67.47

67.16

g/l

0.24

156

1047

Idiopathic hypercalciuria

119

3.00

6.72

1.7

3.4

68.76

66.60

g/l

1.25

109

Corneal ulcer

629

5078

1.26

6.72

2.2

2.5

66.65

66.64

g/l

0.01

574

4652

Intermittent heterotropia

160

1036

1.58

6.71

2.1

2.7

66.16

66.71

g/l

0.41

148

960

Tuberculosis, IBD comorbidity

303

2228

1.40

6.71

2.2

2.4

66.17

65.99

g/l

0.15

260

2002

Other diseases of gallbladder

184

1237

1.54

6.70

2.4

2.7

66.09

66.11

g/l

0.01

168

1104

Localized scleroderma [morphea]

329

2.11

6.70

2.4

2.9

67.22

67.51

g/l

0.10

297

Unspecified visual impairment (binocular)

357

2.06

6.68

1.9

3.1

65.55

66.39

g/l

0.34

321

Other and unspecified mononeuropathies of upper limb

111

662

1.75

6.67

3.6

2.7

67.21

67.01

g/l

0.11

104

616

Maternal care for other conditions predominantly related to pregnancy

457

3475

1.30

6.67

2.4

2.2

67.84

67.54

g/l

0.42

427

3242

Focal brain injury

220

1527

1.47

6.66

2.1

2.7

66.12

66.24

g/l

0.08

197

1387

Lichen ruber planus, wide definition including periferal and oral lichen planus

839

6988

1.22

6.66

2.4

2.6

67.21

66.48

g/l

2.25

763

6336

Use of anticholinesterases

1302

11856

0.85

6.63

1.9

2.5

65.90

65.76

g/l

0.26

1072

10498

N06DA Anticholinesterases

1302

11856

0.85

6.63

1.9

2.5

65.90

65.76

g/l

0.26

1072

10498

Other disorders of penis

350

2631

1.36

6.62

2.0

2.6

66.83

66.57

g/l

0.26

323

2419

Myopia

343

2565

1.36

6.60

2.3

2.5

67.46

67.02

g/l

0.51

323

2378

Use of donepezil

674

7862

0.81

6.59

1.9

2.4

65.72

65.66

g/l

0.07

549

6873

Benign neoplasm of meninges

410

3160

1.33

6.58

2.2

2.6

65.43

66.33

g/l

1.82

363

2843

Other congenital malformations of the digestive system

142

896

1.62

6.58

2.8

3.0

65.26

66.38

g/l

0.95

132

822

Ulcerative ileocolitis

134

841

1.65

6.56

2.2

2.6

68.15

67.22

g/l

0.71

128

783

Other disorders of conjunctiva

575

4622

1.27

6.53

2.4

2.6

66.31

66.14

g/l

0.22

533

4161

Malignant neoplasm of stomach

198

1357

1.51

6.51

2.1

1.5

61.94

66.55

g/l

10.98

182

1200

Complications of genitourinary prosthetic devices, implants and grafts

102

600

1.78

6.50

2.0

2.5

65.18

66.78

g/l

1.10

543

Other and specified injuries of hip and thigh

571

1.81

6.50

1.9

2.6

66.62

66.28

g/l

0.16

520

Malignant neoplasm of eye and adnexa, including Hilmo

382

2.01

6.50

4.8

1.5

65.44

67.10

g/l

0.80

339

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

536

1.85

6.50

2.0

2.9

66.95

66.00

g/l

0.52

480

Malignant neoplasm of colon

568

4558

1.27

6.49

2.5

1.6

65.18

66.54

g/l

3.53

509

3998

Other disorders of binocular movement

408

1.94

6.48

2.5

67.14

67.05

g/l

0.04

374

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

900

7549

1.20

6.48

2.0

2.5

66.94

66.86

g/l

0.12

818

6982

Melanocytic naevi, other sites/unspecified

272

1973

1.41

6.48

3.4

2.6

65.86

66.78

g/l

1.26

256

1829

Acute appendicitis

2565

21609

1.12

6.46

2.6

2.5

66.62

66.70

g/l

0.22

2349

19850

Infectious mononucleosis

179

1197

1.52

6.44

2.8

2.1

68.02

67.94

g/l

0.05

174

1126

Other specified congenital malformation syndromes affecting multiple systems

224

2.28

6.42

1.9

3.4

64.72

66.12

g/l

0.53

212

Nosocomial condition (hospital)

134

2.82

6.41

1.4

3.3

61.43

66.17

g/l

2.46

120

Urethral stricture

249

1789

1.44

6.41

2.3

2.7

66.82

66.38

g/l

0.39

220

1616

Diffuse brain injury

111

667

1.71

6.40

2.7

2.5

67.14

66.64

g/l

0.29

102

611

Sudden idiopathic hearing loss

402

3103

1.33

6.39

2.5

2.6

66.54

66.26

g/l

0.30

352

2831

Use of levodopa decarboxylase inhibitor

617

5020

1.26

6.36

1.9

2.6

66.37

65.95

g/l

0.73

530

4477

Dentofacial anomalies [including malocclusion]

2303

16572

1.12

6.34

2.6

2.5

67.21

66.80

g/l

2.05

2109

15253

Occupational exposure to risk-factors

139

892

1.63

6.33

2.8

2.9

67.41

66.55

g/l

0.68

125

822

Alcoholic gastritis

336

2.06

6.33

1.6

3.2

67.17

66.76

g/l

0.14

307

Hereditary sideroblastic anaemia

3.66

6.32

2.8

2.3

66.55

64.67

g/l

0.53

Rheumatoid lung disease

125

2.97

6.29

1.7

2.4

64.61

65.05

g/l

0.10

109

Ill-defined and unknown causes of mortality

374

2869

1.34

6.28

2.5

65.27

65.86

g/l

0.66

335

2580

Other infective otitis externa

216

1517

1.46

6.26

2.7

67.20

66.39

g/l

0.87

191

1396

Ulcer of vagina/vulva

531

1.81

6.25

2.3

2.7

67.63

66.77

g/l

0.61

488

Sleep disorders

3354

22141

1.10

6.23

2.0

2.6

66.99

66.60

g/l

2.39

3028

20220

Respiratory tuberculosis, bacteriologically and histologically confirmed

504

1.84

6.23

1.7

2.7

66.61

66.02

g/l

0.29

450

Alzheimer’s disease (Early onset)

1403

0.56

6.22

1.8

2.3

65.42

65.67

g/l

0.11

1234

Other and unspecified disorders of orbit

113

2.99

6.20

2.6

2.9

68.51

67.02

g/l

0.52

101

Spinal osteochondrosis

190

2.40

6.20

1.4

2.7

67.14

66.64

g/l

0.16

178

Alzheimer’s disease (Late onset), excluding more controls

658

3516

1.25

6.18

2.3

2.9

65.67

65.88

g/l

0.26

546

3166

Pleural plaque without asbestos

185

1274

1.52

6.18

1.9

2.6

67.14

65.89

g/l

1.52

165

1146

Cytomegaloviral pneumonitis

4.91

6.17

2.4

3.0

66.15

66.08

g/l

0.01

Campylobacter enteritis

102

609

1.75

6.16

2.4

2.8

65.20

66.87

g/l

1.35

554

Adenomyosis (Endometriosis of uterus)

465

3668

1.29

6.14

2.5

66.26

66.31

g/l

0.05

419

3303

Other congenital malformations of the digestive system

164

1086

1.54

6.13

2.4

3.1

65.81

66.40

g/l

0.43

151

997

Other/unspecified disorders of vestibular function

168

1132

1.54

6.13

1.8

2.9

65.89

66.43

g/l

0.50

143

1031

Heterophoria

242

1737

1.42

6.12

2.5

2.7

66.61

g/l

0.00

226

1605

Other orthopaedic follow-up care

195

1349

1.49

6.11

2.1

2.4

66.30

67.00

g/l

0.60

177

1220

Malignant melanoma of skin

399

3093

1.32

6.11

2.9

1.6

65.92

66.76

g/l

1.41

355

2734

Disorder of external ear, unspecified

128

812

1.64

6.11

2.5

3.0

66.11

66.66

g/l

0.35

115

750

Other salmonella infections

137

882

1.61

6.10

3.2

2.6

67.27

67.03

g/l

0.14

125

799

Lichen planus, including avohilmo

717

5939

1.23

6.09

2.3

2.6

67.17

66.42

g/l

1.96

650

5382

Meralgia paraesthetica

127

804

1.64

6.09

1.7

2.6

67.52

66.84

g/l

0.58

116

739

Recurrent dislocation of patella

111

674

1.68

6.09

3.3

2.5

66.66

67.23

g/l

0.38

105

637

Brain meningioma, including Hilmo

185

1270

1.50

6.08

2.4

1.5

65.34

67.07

g/l

2.62

169

1121

Kela-code for severe mental illness

1210

10462

1.17

6.05

1.9

2.5

66.21

66.82

g/l

1.88

1079

9585

Memory loss

391

3035

1.32

6.05

2.1

2.6

65.77

66.23

g/l

0.60

337

2746

Hyphaema and other vascular disorders of iris and ciliary body

509

1.82

6.04

1.7

3.1

66.73

66.34

g/l

0.17

457

Other mycoses, not elsewhere classified/unspecified

377

1.96

6.04

3.2

2.7

64.89

67.09

g/l

1.37

341

Benign neoplasm: Spinal meninges

275

2.17

6.00

1.8

2.7

66.50

66.60

g/l

0.04

246

Inflammatory disorders of male genital organs, not elsewhere classified

308

2.07

5.98

1.3

3.2

65.59

66.67

g/l

0.38

284

Unspecified event, undetermined intent

508

1.80

5.98

2.5

2.9

66.69

67.14

g/l

0.23

467

Injury of intra-abdominal organs

516

1.80

5.96

2.4

2.8

64.31

67.22

g/l

2.32

472

Benign neoplasm: Pituitary gland, craniopharyngeal duct

184

1267

1.50

5.95

2.7

2.8

66.45

66.78

g/l

0.25

177

1164

Malignant neoplasm of thyroid gland

210

1480

1.45

5.95

2.9

1.5

66.81

67.19

g/l

0.32

196

1322

Other and unspecified nail disorders

511

1.81

5.93

2.9

2.7

65.57

67.26

g/l

1.25

471

Dislocation, sprain and strain of joints and ligaments of thorax

121

762

1.65

5.92

2.5

2.6

66.17

66.48

g/l

0.18

114

701

Benign neoplasm of bone and articular cartilage

272

2004

1.39

5.91

2.6

2.7

67.33

66.68

g/l

0.83

249

1844

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

577

1.74

5.90

2.4

2.9

67.37

67.34

g/l

0.02

539

Tinnitus

883

7474

1.20

5.89

2.7

2.6

66.62

66.55

g/l

0.10

806

6834

Unspecified jaundice

196

1370

1.47

5.87

1.9

2.6

63.68

66.40

g/l

3.87

180

1245

Acute nasopharyngitis (common cold)

347

2633

1.33

5.83

2.7

2.4

66.95

67.22

g/l

0.29

320

2458

Behavioural disorders

233

2.17

5.81

1.8

2.6

67.03

67.47

g/l

0.14

219

Noninflammatory disorders of female genital tract

1319

5735

1.16

5.80

2.6

2.4

66.90

66.54

g/l

0.94

1195

5182

177

1208

1.48

5.79

1.4

2.0

67.37

67.98

g/l

0.51

167

1129

Hyperkinetic disorders

220

1529

1.42

5.79

1.5

2.1

67.56

67.42

g/l

0.12

204

1453

Type 1 diabetes, strict definition, subgroup 1

146

956

1.55

5.77

1.7

2.3

64.94

67.83

g/l

5.51

135

914

Disorders of synovium and tendon in diseases classified elsewhere

455

1.84

5.77

2.8

65.82

66.78

g/l

0.53

417

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

107

642

1.66

5.73

3.1

2.6

65.64

67.08

g/l

0.91

102

615

Brain meningioma

176

1212

1.50

5.72

2.3

1.5

65.28

66.98

g/l

2.42

160

1072

Contusion of other and unspecified parts of foot

140

916

1.56

5.72

1.9

2.6

66.29

67.10

g/l

0.62

127

850

Other and unspecified injuries of ankle and foot

127

814

1.60

5.71

1.9

2.8

67.04

67.14

g/l

0.05

121

749

Alcohol withdrawal state with delirium

260

1918

1.39

5.71

1.6

2.7

66.00

66.68

g/l

0.66

229

1781

Crushed, pushed or stepped on by crowd or human stampede

196

1373

1.45

5.68

2.2

2.6

67.19

67.06

g/l

0.10

179

1283

Bulimia nervosa (incl. atypical)

395

1.86

5.68

1.4

2.0

65.97

68.17

g/l

1.93

372

Hypergammalglobulinemia, unspecified

8.78

5.65

4.3

1.7

73.07

67.94

g/l

0.81

Renal cell carcinoma of kidney

132

860

1.60

5.65

2.8

1.6

65.83

66.74

g/l

0.64

123

756

Parapsoriasis

430

1.86

5.61

2.4

3.2

66.63

66.83

g/l

0.08

394

Other superficial mycoses

415

1.86

5.57

2.1

2.9

66.88

67.14

g/l

0.13

388

Orthopaedic devices associated with adverse incidents

547

1.77

5.57

2.1

3.0

66.68

66.40

g/l

0.12

489

Parkinson's disease, including avohilmo

694

5797

1.22

5.53

1.9

2.5

66.18

65.98

g/l

0.30

597

5173

Additional codes for the location of defect, injury or illness

205

1462

1.44

5.51

2.4

2.8

66.75

66.50

g/l

0.19

195

1341

Vulvovaginal ulceration/inflammation in other diseases

153

1028

1.52

5.51

2.4

2.3

66.30

67.29

g/l

0.92

140

957

Endometriosis of pelvic peritoneum

445

3367

1.27

5.50

2.3

2.4

67.35

66.83

g/l

0.90

401

3100

Other bursitis of hip

485

1.79

5.49

2.9

65.40

67.00

g/l

1.09

431

Malignant neoplasm of head and neck

292

2203

1.36

5.49

2.2

1.6

64.96

66.72

g/l

3.30

268

1961

Use of antiglaucoma preparations and miotics

349

2707

1.32

5.46

2.4

2.5

66.73

65.93

g/l

1.14

300

2379

Other and unspecified disorders of pigmentation

132

2.61

5.45

2.4

2.8

67.48

66.88

g/l

0.16

122

Tuberculosis, wide

309

2357

1.34

5.44

2.1

2.5

66.13

65.90

g/l

0.20

265

2121

Other bursitis of knee

290

2.04

5.44

2.3

3.2

66.74

67.07

g/l

0.11

264

Conduct disorder

253

2.07

5.44

1.8

2.7

66.57

67.80

g/l

0.48

236

Autoimmune thyroiditis

353

1.92

5.43

2.4

2.8

68.43

67.83

g/l

0.32

324

Other and unspecified abdominal hernia

166

1145

1.50

5.43

2.3

2.6

66.06

66.48

g/l

0.26

153

1048

Ménière disease

368

2875

1.31

5.41

2.7

66.16

66.42

g/l

0.29

337

2619

Meningitis

171

1185

1.48

5.38

2.6

2.7

66.67

66.88

g/l

0.13

158

1096

Benign neoplasm: Skin of other and unspecified parts of face

417

3316

1.28

5.30

2.8

2.5

66.01

66.32

g/l

0.35

363

2998

Hypertrophic scar

152

1031

1.51

5.28

2.9

2.7

67.22

67.18

g/l

0.02

140

955

Single ventricle heart

7.38

5.27

2.3

1.8

69.39

61.74

g/l

1.27

Other disorders starting during childhood or adolescence

556

1.68

5.25

3.2

2.8

65.25

66.59

g/l

0.72

527

Subacute thyroiditis

125

817

1.58

5.25

2.4

2.8

67.51

67.16

g/l

0.22

113

750

Colorectal cancer

878

7340

1.18

5.24

2.5

1.6

64.98

66.65

g/l

7.57

787

6503

Alzheimer’s disease (undefined)

261

0.22

5.23

1.2

2.1

63.67

65.16

g/l

—

226

Senility

204

2.21

5.21

2.6

2.0

64.74

65.60

g/l

0.34

178

Amblyopia ex anopsia

125

818

1.57

5.18

2.1

3.1

67.11

66.47

g/l

0.40

112

755

Malignant neoplasm of breast, ER-negative, including Hilmo

720

5769

1.20

5.16

2.6

1.5

65.48

66.83

g/l

4.32

644

5056

Other and unspecified epidermal thickening

617

1.67

5.14

2.7

3.0

65.21

66.95

g/l

1.53

568

Polyp of the female genital tract

1052

5219

1.17

5.07

2.6

2.5

66.63

66.40

g/l

0.46

947

4697

Car occupant injured in other and unspecified transport accidents

570

4700

1.23

5.06

2.4

2.5

67.15

66.79

g/l

0.54

532

4325

Lagophthalmos

343

1.93

5.06

3.1

2.8

66.37

66.55

g/l

0.06

315

Dermatitis herpetiformis

430

1.81

5.05

3.9

2.8

67.77

66.50

g/l

0.72

394

Other drug-induced secondary parkinsonism

230

2.16

5.05

1.9

2.8

66.63

66.77

g/l

0.05

208

Lactose intolerance

620

1.65

4.99

2.1

2.3

66.21

66.88

g/l

0.38

568

Oligomenorrhoea

619

1.64

4.98

2.4

2.3

66.56

66.84

g/l

0.14

565

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

136

914

1.52

4.97

2.0

2.9

66.36

66.90

g/l

0.38

124

836

Asthma mixed form (mode)

150

1027

1.49

4.97

1.8

2.0

67.28

67.16

g/l

0.07

135

908

Insomnia

3202

21504

1.09

4.96

2.0

2.6

67.03

66.59

g/l

2.70

2888

19642

Varicose veins of other sites

223

1643

1.39

4.96

2.6

2.8

66.29

66.79

g/l

0.48

196

1518

Malignant neoplasm of renal pelvis, including Hilmo

273

2.03

4.94

3.1

1.5

66.73

66.94

g/l

0.06

240

Carcinoma in situ of skin, other sites/unspecified

437

1.82

4.91

3.1

2.7

64.62

65.80

g/l

0.61

388

Malignant neoplasm of oral cavity, including Hilmo

158

1100

1.48

4.91

2.5

1.6

65.29

66.87

g/l

1.69

150

990

Sequelae of injuries of upper limb

317

2459

1.31

4.90

2.9

2.8

67.00

66.77

g/l

0.22

286

2266

Burns and corrosions

431

3467

1.26

4.90

2.4

2.5

66.49

66.75

g/l

0.29

397

3222

Gestational [pregnancy-induced] hypertension

616

5119

1.21

4.89

2.6

2.3

66.84

67.25

g/l

0.72

583

4701

Perforation of tympanic membrane

347

2726

1.30

4.88

3.1

2.5

65.65

66.42

g/l

1.08

312

2496

Allergic contact dermatitis due to drugs in contact with skin

534

1.70

4.85

2.1

2.9

66.12

66.95

g/l

0.41

490

Sequelae of injuries of head

173

1227

1.45

4.84

2.4

2.9

66.22

66.99

g/l

0.78

157

1137

Other disorders of the genitourinary system

491

4029

1.24

4.75

2.5

2.6

66.40

66.27

g/l

0.14

444

3610

Benign neoplasm: Parathyroid gland

300

1.97

4.73

2.0

3.0

67.88

66.46

g/l

0.64

275

Triptan medication for migraine, min. 3 purchases

1594

10868

1.13

4.72

2.4

67.47

67.01

g/l

1.89

1474

10055

Benign neoplasm: Cerebral meninges

361

2867

1.29

4.72

2.3

2.7

65.24

66.26

g/l

2.03

322

2596

Nonspecific lymphadenitis

179

1282

1.43

4.71

2.5

2.6

65.76

67.13

g/l

1.46

167

1198

Burns and corrosions of external body surface, specified by site

335

2631

1.29

4.70

2.3

2.6

66.37

66.75

g/l

0.41

303

2446

Benign neoplasm: salivary glands, exclude unknown (D119)

333

2621

1.30

4.68

2.2

2.7

66.64

66.40

g/l

0.23

306

2397

Contact with heat and hot substances

168

1192

1.44

4.68

1.9

2.7

65.82

66.87

g/l

1.00

148

1100

Other contact dermatitis

253

1915

1.35

4.68

2.2

2.7

67.28

66.50

g/l

0.83

226

1745

Other congenital malformations of skin

124

831

1.53

4.66

1.9

3.0

67.26

66.67

g/l

0.38

114

766

Injury of muscle and tendon at lower leg level

531

4395

1.23

4.65

2.5

2.6

66.25

66.70

g/l

0.63

491

4072

UC patients in KELA-register (code 208), prior to 1994

162

1148

1.46

4.63

2.7

2.8

66.69

66.77

g/l

0.05

150

1057

Other specified disorders of external ear

152

1067

1.48

4.62

2.9

2.8

66.08

66.40

g/l

0.20

134

992

Examination and encounter for administrative purposes

163

1154

1.45

4.62

3.3

2.6

67.01

66.11

g/l

0.86

150

1052

Corneal scars and opacities

105

685

1.59

4.56

1.9

3.0

66.26

66.51

g/l

0.11

624

Crystalline deposits in vitreous body

247

2.06

4.56

3.2

3.1

64.67

66.12

g/l

0.51

224

Parkinson's disease

655

5548

1.20

4.55

1.8

2.5

66.29

65.96

g/l

0.55

566

4967

Congenital malformations of the nervous system

329

1.85

4.55

2.1

3.2

66.64

66.98

g/l

0.17

307

Benign neoplasm of major salivary glands

372

2978

1.27

4.54

2.1

2.7

66.32

66.28

g/l

0.04

343

2709

Erectile dysfunction

346

2753

1.29

4.54

2.4

2.6

65.26

65.88

g/l

0.75

317

2492

Other salmonella infections

145

1009

1.47

4.53

3.1

2.7

67.24

67.05

g/l

0.11

130

920

Ventricular septal defect, a heart condition

351

1.82

4.51

2.5

3.0

65.65

65.88

g/l

0.06

325

Anisometropia and aniseikonia

112

742

1.56

4.51

2.4

3.1

66.04

66.58

g/l

0.36

100

676

Myocardial infarction, with ST-elevation

748

6406

1.18

4.51

2.1

2.5

64.87

66.04

g/l

3.81

673

5718

Chronic Coagulation defects

466

1.71

4.50

2.7

2.9

66.73

67.20

g/l

0.25

427

Other lesions of median nerve

111

736

1.57

4.49

2.1

2.5

65.05

66.28

g/l

0.99

662

Certain zoonotic bacterial diseases

110

727

1.57

4.49

2.4

2.9

66.18

66.91

g/l

0.46

102

663

Moyamoya

10.49

4.48

1.0

1.4

67.00

66.39

g/l

—

Alzheimer’s disease (undefined), excluding more controls

231

0.24

4.48

1.2

2.0

63.67

64.53

g/l

—

199

Burn and corrosion of ankle and foot

297

1.91

4.45

2.2

2.7

65.33

66.90

g/l

0.63

273

Cysts of oral region, not elsewhere classified

199

1468

1.39

4.45

3.7

2.7

66.16

66.66

g/l

0.41

182

1358

Vertigo of central origin

433

1.75

4.43

1.8

3.1

66.49

66.40

g/l

0.03

387

Injuries involving multiple body regions

122

825

1.52

4.42

3.1

2.6

66.07

66.79

g/l

0.47

105

752

Other degenerative diseases of the basal ganglia

552

1.67

4.41

2.1

3.2

65.64

65.61

g/l

0.01

497

Melanoma in situ of other and unspecified parts of face

391

1.82

4.40

2.7

3.2

65.45

65.81

g/l

0.13

344

Nasal polyp

713

6091

1.19

4.39

2.5

66.77

66.47

g/l

0.51

652

5563

Left hemicolectomy

102

670

1.59

4.37

2.2

2.9

65.40

66.23

g/l

0.46

615

Benign neoplasm: Other and unspecified parts of mouth

129

888

1.50

4.35

3.1

3.0

67.07

66.80

g/l

0.14

115

814

Other predominantly sexually transmitted diseases, not elsewhere classified

403

3259

1.25

4.35

2.4

66.65

67.34

g/l

1.00

369

3021

Other superficial mycoses

282

2189

1.31

4.34

1.9

2.6

67.07

g/l

0.00

252

2026

Other, unspecified and serous retinal detachments

125

856

1.51

4.34

2.6

2.9

67.00

66.52

g/l

0.30

114

785

Juvenile Open Angle Glaucoma

2.66

4.31

3.0

2.8

67.71

68.13

g/l

0.08

Injury of nerves and spinal cord at neck level

536

1.65

4.30

2.4

3.3

65.43

66.64

g/l

0.60

489

Prolonged pregnancy

171

2056

0.72

4.27

2.3

2.1

66.86

67.91

g/l

1.10

158

1921

Atopic conjunctivitis

128

879

1.49

4.27

2.2

2.6

66.80

67.14

g/l

0.23

117

818

Pilonidal cyst

216

1619

1.35

4.27

2.3

66.28

67.39

g/l

1.58

201

1521

Other deformities of toe(s)

124

849

1.50

4.27

2.5

2.9

65.83

66.06

g/l

0.13

107

759

Perioral dermatitis

397

1.75

4.25

2.1

2.7

66.90

67.36

g/l

0.16

365

Ethmoidectomy

422

3447

1.24

4.25

2.4

2.6

66.62

66.74

g/l

0.12

384

3179

Spasmodic torticollis

109

728

1.55

4.24

2.0

2.7

67.47

67.16

g/l

0.16

668

Malignant neoplasm of breast, HER-negative

645

5378

1.19

4.24

2.6

1.5

65.39

66.83

g/l

4.42

578

4698

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

3.30

4.23

1.2

2.3

64.68

66.32

g/l

0.28

Urethritis and urethral syndrome

467

1.69

4.22

3.4

2.8

66.60

67.18

g/l

0.35

429

Personal history of malignant neoplasm

220

1661

1.35

4.22

3.4

2.4

65.77

66.79

g/l

1.29

204

1511

Alopecia areata

521

1.64

4.22

3.4

2.5

66.43

66.79

g/l

0.16

480

Parkinson's disease, strict definition

610

5174

1.20

4.21

1.9

2.5

66.41

65.97

g/l

0.77

526

4628

Other puerperal infections

152

1078

1.43

4.20

2.4

2.1

67.25

67.79

g/l

0.42

141

1014

Injury of eye and orbit

432

3539

1.24

4.19

2.7

2.5

65.59

66.82

g/l

2.86

391

3287

Lichen sclerosus et atrophicus

355

2854

1.27

4.18

2.4

2.5

67.00

66.65

g/l

0.38

325

2550

Atrial septal defect, secundum type

544

1.62

4.17

1.8

3.1

65.85

66.31

g/l

0.18

508

Melanoma in situ of trunk

434

1.73

4.17

3.4

3.1

65.71

66.36

g/l

0.25

394

Benign neoplasm: Parotid gland

295

2326

1.30

4.15

2.1

2.6

66.61

66.39

g/l

0.18

271

2131

Other predominantly sexually transmitted diseases, not elsewhere classified

463

3818

1.22

4.15

2.4

2.3

66.68

67.41

g/l

1.21

425

3556

Other noninflammatory disorders of vagina

244

1873

1.33

4.14

2.5

2.4

66.39

66.46

g/l

0.05

214

1689

Other acantholytic disorders

3.02

4.13

1.6

2.3

66.56

65.71

g/l

0.22

Dislocation, sprain and strain of joints and ligaments of head

115

779

1.51

4.12

2.9

2.7

66.82

67.25

g/l

0.28

103

728

Papillary adenocarcinoma of thyroid gland

155

1112

1.43

4.12

2.8

1.5

66.90

67.43

g/l

0.38

146

1001

Pyoderma

433

1.71

4.11

2.9

3.0

66.76

66.89

g/l

0.05

392

Severe visual impairment, monocular

234

2.01

4.10

1.9

2.7

67.02

66.38

g/l

0.21

213

Granuloma annulare

320

1.83

4.10

1.8

3.1

68.17

67.59

g/l

0.28

290

Nephropathy induced by other drugs, medicaments and biological substances

4.70

4.09

1.8

66.98

66.44

g/l

0.10

Alzheimer’s disease (Atypical or mixed), excluding more controls

352

2252

1.27

4.07

2.1

2.7

64.86

65.62

g/l

0.90

287

2000

Ovarian dysfunction

146

1035

1.43

4.06

2.1

67.62

67.66

g/l

0.02

138

974

Right hemicolectomy

238

1834

1.33

4.05

2.6

2.7

64.94

66.24

g/l

1.58

221

1670

Hordeolum and other deep inflammation of eyelid

184

1363

1.38

4.03

2.8

2.7

67.65

66.74

g/l

0.72

163

1263

Other neurotic disorders

169

1237

1.40

4.02

1.8

2.8

66.36

66.71

g/l

0.24

145

1127

Personal history of risk-factors, not elsewhere classified

220

1.99

3.99

2.0

2.3

65.08

67.22

g/l

0.70

202

Single spontaneous delivery

1164

6945

0.88

3.98

2.7

2.3

66.55

66.33

g/l

0.45

1054

6186

Benign neoplasm: Skin of eyelid, including canthus

594

5049

1.19

3.98

3.0

2.5

66.71

66.22

g/l

0.81

519

4565

FESS (DNB20)

402

3297

1.24

3.93

2.3

2.7

66.78

g/l

0.00

365

3043

Dissection of aorta

130

916

1.47

3.93

2.2

2.8

65.22

66.25

g/l

0.87

113

829

Congenital deformities of feet

102

682

1.53

3.91

1.8

2.6

68.17

67.01

g/l

0.77

631

Residual foreign body in soft tissue

147

1054

1.42

3.91

2.9

65.92

66.86

g/l

0.95

138

963

Superficial injuries involving multiple body regions

548

1.60

3.89

3.8

2.9

66.05

67.04

g/l

0.58

499

Non-small cell lung cancer, squamous

168

1235

1.39

3.89

1.7

1.6

65.80

66.43

g/l

0.42

153

1076

Any dementia, excluding more controls

1663

10387

1.11

3.87

2.2

2.6

65.29

66.01

g/l

3.19

1397

9310

Open wound of hip and thigh

102

685

1.53

3.87

2.0

2.6

64.90

66.83

g/l

1.58

633

Anomalies of dental arch relationship, including avohilmo

508

3836

1.20

3.87

2.8

2.6

67.23

67.06

g/l

0.20

466

3559

Hypermetropia

208

1577

1.34

3.86

3.1

2.8

66.00

66.34

g/l

0.30

186

1447

Endometriosis of ovary

504

4126

1.20

3.83

2.2

2.5

66.85

66.53

g/l

0.40

458

3766

Malignant neoplasm of vulva, including Hilmo

336

1.79

3.82

2.5

1.5

64.53

67.19

g/l

1.62

300

Marasmic kwashiorkor

3.38

3.81

1.5

2.6

59.21

64.90

g/l

1.08

Other acquired deformities of musculoskeletal system and connective tissue

156

1139

1.40

3.80

2.6

2.7

65.38

66.83

g/l

1.57

142

1046

Other disorders of optic disc

284

1.84

3.76

1.7

2.7

65.43

67.27

g/l

0.88

260

Schizophrenia or delusion

982

8681

1.14

3.75

2.2

2.4

66.01

66.80

g/l

2.30

877

7978

Leiomyoma of uterus

2164

11259

1.10

3.73

2.6

2.5

66.35

66.61

g/l

0.82

1910

10146

Haemangioma and lymphangioma, any site

298

2383

1.27

3.72

2.9

2.7

66.93

66.55

g/l

0.39

267

2187

Haemangioma, any site

282

2242

1.28

3.71

2.7

67.03

66.56

g/l

0.50

252

2053

Malignant neoplasm of tongue, including Hilmo

604

1.56

3.71

2.4

1.5

65.43

67.22

g/l

1.19

540

Single delivery by forceps and vacuum extractor

184

1478

0.74

3.70

1.8

1.9

67.52

67.68

g/l

0.10

173

1375

Explicit viral Sepsis

9.80

3.70

1.1

1.4

68.90

69.07

g/l

—

Disorders of eyelid in diseases classified elsewhere

113

784

1.48

3.69

1.7

2.9

65.88

67.02

g/l

0.91

103

712

484

1.62

3.68

2.2

2.8

67.24

67.98

g/l

0.43

448

Contusion of ankle

109

750

1.49

3.66

1.8

2.8

65.94

67.08

g/l

1.00

101

697

Nontoxic single thyroid nodule

241

1889

1.30

3.59

2.3

2.7

67.04

66.57

g/l

0.50

214

1720

Benign neoplasm: Thymus

3.13

3.57

2.1

2.7

65.64

66.75

g/l

0.27

Operations for atrial fibrillation

414

1.68

3.55

1.7

3.2

65.79

66.42

g/l

0.24

376

Palindromic rheumatism

231

1.91

3.54

2.2

3.1

64.99

66.75

g/l

0.94

211

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

491

1.61

3.53

2.3

1.5

65.71

67.30

g/l

0.82

438

Calcific tendinitis of shoulder

175

1316

1.36

3.52

2.5

2.8

66.28

66.85

g/l

0.46

159

1206

Delivery

1180

6952

0.89

3.51

2.7

2.3

66.49

66.32

g/l

0.31

1069

6193

Other and unspecified corneal deformities and disorders

109

760

1.48

3.49

2.3

2.9

67.43

67.13

g/l

0.16

103

691

Drug-induced acute pancreatitis

4.53

3.49

3.7

64.85

66.35

g/l

0.23

Separation of retinal layers (serosa)

140

1020

1.41

3.49

3.0

2.8

67.03

66.94

g/l

0.06

129

943

conjunctival haemorrhage

293

2363

1.27

3.48

2.2

2.6

65.64

66.30

g/l

0.88

273

2155

Fistulae involving female genital tract

399

1.67

3.47

2.4

67.19

67.05

g/l

0.04

361

Left ventricular outflow tract obstruction, narrow definition

148

1088

1.39

3.46

2.3

2.8

63.90

66.52

g/l

3.43

142

1010

Dependent personality disorder

438

1.63

3.45

2.3

2.9

65.32

67.37

g/l

1.28

406

Pyogenic granuloma

368

1.69

3.44

2.4

3.0

65.95

66.82

g/l

0.38

334

Benign neoplasm: Connective and other soft tissue, unspecified

278

1.82

3.44

2.2

2.6

66.21

66.90

g/l

0.22

260

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

321

1.73

3.44

2.8

2.9

65.41

66.66

g/l

0.49

297

Other peripheral vertigo

340

2789

1.24

3.43

1.9

2.7

66.55

66.44

g/l

0.10

298

2545

Subarachnoid haemorrhage

383

3178

1.22

3.42

2.3

2.6

65.59

66.23

g/l

0.88

333

2845

Other vitreous opacities

144

1059

1.40

3.42

2.8

2.9

66.81

66.28

g/l

0.40

129

963

Schizophrenia, schizotypal and delusional disorders

984

8756

1.13

3.42

2.2

2.4

65.98

66.79

g/l

2.47

879

8050

Hypothermia

464

1.61

3.41

1.7

3.0

63.20

66.27

g/l

1.94

426

Benign neoplasm: Other parts of oropharynx

213

1.94

3.40

4.8

2.8

66.94

66.70

g/l

0.07

193

Ulcerative rectosigmoiditis

245

1937

1.28

3.39

2.4

2.6

67.88

66.89

g/l

1.24

228

1798

Presence of other devices

965

8558

1.13

3.39

2.8

2.5

66.16

66.10

g/l

0.09

871

7600

Disorders of breast

1584

13118

1.10

3.38

2.3

2.5

66.83

66.57

g/l

0.75

1422

11821

Mental and behavioural disorders due to cocaine

5.34

3.38

1.3

4.6

66.78

66.63

g/l

—

Tuberculosis of other organs

595

1.54

3.37

2.0

2.9

66.53

65.91

g/l

0.30

531

Alzheimer’s disease, strict definition

939

8685

0.88

3.36

2.1

2.4

65.51

65.71

g/l

0.32

775

7649

Other and unspecified mononeuropathies of lower limb

684

1.49

3.36

1.6

2.6

66.39

66.99

g/l

0.40

626

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.88

3.34

7.5

1.4

66.59

67.01

g/l

—

Endometriosis ASRM stages 1,2

455

3837

1.20

3.33

2.3

2.4

67.23

67.04

g/l

0.24

409

3537

Transient acantholytic dermatosis [Grover]

3.16

3.32

1.3

2.2

66.64

65.16

g/l

0.41

Contracture of muscle

2.66

3.27

1.2

4.3

62.53

66.96

g/l

1.33

Stenosis and insufficiency of lacrimal passages

338

2786

1.23

3.26

2.4

2.6

67.11

66.30

g/l

1.36

309

2501

Follow-up care involving plastic surgery

120

863

1.42

3.24

3.4

2.5

67.07

67.27

g/l

0.10

777

Benign neoplasm: Long bones of lower limb

655

1.49

3.23

2.2

2.8

67.52

67.31

g/l

0.12

604

Tuberculosis of other organs, strict

683

1.49

3.22

2.1

2.8

66.55

65.92

g/l

0.34

609

Haemoglobinuria due to haemolysis from other external causes

13.32

3.19

1.6

2.0

61.62

68.14

g/l

—

Epiphora

586

1.52

3.18

3.2

2.9

66.23

66.87

g/l

0.33

527

Open wound of wrist and hand

1503

13420

1.10

3.17

2.6

2.5

66.58

66.78

g/l

0.50

1397

12389

Burns and corrosions of multiple and unspecified body regions

456

1.58

3.14

2.3

2.9

67.06

66.93

g/l

0.05

421

Haemorrhage in early pregnancy

708

6041

1.15

3.13

2.6

2.5

66.58

67.06

g/l

1.00

654

5556

Striae atrophicae

189

1.93

3.12

1.8

2.7

67.05

67.26

g/l

0.06

176

Tuberculosis

248

1990

1.27

3.12

2.3

2.6

65.82

65.94

g/l

0.09

215

1784

Nontraumatic intracranial haemmorrhage

806

7142

1.14

3.10

2.3

2.5

65.45

66.05

g/l

1.32

708

6344

Inflammation of lacrimal passages (acute and unspecified)

427

1.60

3.10

4.1

2.6

66.45

67.20

g/l

0.35

382

Other disorders of cornea

328

2712

1.23

3.08

2.2

2.5

66.43

66.53

g/l

0.08

297

2487

Other congenital malformations of skin

224

1775

1.28

3.08

1.8

2.7

66.86

66.66

g/l

0.16

202

1635

Primary open-angle glaucoma, strict

1138

10272

1.12

3.06

2.5

66.40

65.87

g/l

1.50

1017

9089

Other melanin hyperpigmentation

591

1.51

3.06

3.0

65.90

66.76

g/l

0.53

531

Benign neoplasm of eye and adnexa

369

3089

1.21

3.06

2.7

2.6

66.21

66.35

g/l

0.13

330

2821

Alport

4.72

3.05

1.7

5.9

63.20

67.29

g/l

—

Perforation of oesophagus

136

2.15

3.04

1.9

3.5

61.97

65.96

g/l

1.53

123

Patent foramen ovale

444

1.58

3.04

1.8

2.9

65.97

66.25

g/l

0.12

414

Alzheimer disease, including avohilmo

1479

11367

0.91

3.03

2.1

2.5

65.53

65.81

g/l

0.68

1225

10069

Congenital malformations of aortic and mitral valves

126

925

1.39

3.03

2.3

2.9

63.27

66.59

g/l

4.37

120

858

Primary open-angle glaucoma

1398

12353

1.10

3.03

2.5

66.36

65.91

g/l

1.34

1238

10935

Hydrocephalus

289

2368

1.24

3.01

2.2

2.6

67.04

66.24

g/l

1.05

254

2132

Hypersensitivity pneumonitis due to organic dust

415

1.61

3.01

2.7

3.3

67.42

66.50

g/l

0.33

380

Lactose intolerance, other/unspecified

558

1.51

3.00

1.6

2.4

66.38

67.07

g/l

0.34

513

Glaucoma suspect

1477

13542

1.10

3.00

2.4

2.6

66.30

66.19

g/l

0.21

1337

12154

Medical abortion

2118

10643

1.08

2.99

2.1

2.6

66.40

66.55

g/l

0.40

1894

9596

Embolic stroke with flimmer

102

726

1.45

2.99

2.0

2.2

65.72

66.15

g/l

0.20

637

Benign neoplasm: Skin of ear and external auricular canal

149

1128

1.36

2.99

1.9

2.8

65.94

66.39

g/l

0.28

127

1029

Neuroendocrine tumor and carcinoma of small intestine

290

1.73

2.99

3.0

1.6

65.24

67.85

g/l

1.40

261

All dysplastic lesions of the vulva

131

972

1.38

2.96

1.6

2.6

65.31

67.15

g/l

1.45

113

894

Rheumatic valve diseases

611

1.49

2.96

2.7

2.5

65.69

65.93

g/l

0.10

539

Other acute skin changes due to ultraviolet radiation

121

888

1.40

2.96

2.0

2.8

66.40

66.84

g/l

0.23

107

808

Maltreatment syndromes

113

818

1.40

2.92

2.1

2.3

67.37

67.78

g/l

0.23

102

776

Benign neoplasm: Liver/bile ducts

563

1.50

2.90

2.4

2.8

66.72

67.30

g/l

0.31

516

Certain zoonotic bacterial diseases

442

1.57

2.90

2.5

2.7

66.00

67.03

g/l

0.51

401

Acute and transient psychotic disorders

332

2763

1.22

2.89

2.0

2.6

66.01

66.90

g/l

1.22

296

2567

Dronedarone medication

106

766

1.43

2.88

2.0

2.7

65.55

66.96

g/l

1.19

692

Other facial nerve disorders

648

1.46

2.86

2.9

2.7

66.06

66.95

g/l

0.56

591

Other and unspecified injuries of abdomen, lower back and pelvis

309

1.68

2.84

2.2

2.5

67.10

66.62

g/l

0.18

283

Disorders of globe

684

1.45

2.83

2.8

2.9

66.52

66.40

g/l

0.05

615

Caries of enamel

3188

21679

1.06

2.83

2.7

2.5

67.16

66.66

g/l

3.50

2910

19936

Other and unspecified injuries of wrist and hand

107

774

1.41

2.83

2.1

2.6

66.57

67.04

g/l

0.28

713

Endovascular or surgical operations to intracerebral aneurysms

212

1692

1.28

2.82

2.0

2.9

65.81

66.65

g/l

0.88

192

1537

Other and unspecified degenerative diseases of nervous system

107

779

1.42

2.81

1.4

3.0

65.91

65.86

g/l

0.02

704

Malignant neoplasm of oral cavity

113

828

1.40

2.80

1.8

1.6

64.80

66.99

g/l

1.90

106

742

Other appendicitis

261

2131

1.24

2.80

2.7

66.35

66.73

g/l

0.37

234

1971

Complications predominantly related to the puerperium

638

5604

1.15

2.80

2.5

2.4

67.26

67.14

g/l

0.15

592

5172

Peritonsillar abscess

582

5084

1.15

2.78

2.6

2.5

67.33

66.84

g/l

0.83

549

4710

Injury of muscle and tendon at hip and thigh level

306

2542

1.22

2.77

2.1

2.7

66.22

66.82

g/l

0.75

290

2354

Delivery, wide proxy

993

5853

0.89

2.76

2.7

2.3

66.65

66.26

g/l

0.86

897

5181

Felty syndrome

134

2.08

2.76

2.0

3.2

63.67

66.37

g/l

0.87

120

Oral lichen planus, including avohilmo , including avohilmo

220

1769

1.27

2.76

2.6

2.9

68.02

66.59

g/l

2.64

203

1605

Other benign neoplasms of connective and other soft tissue

323

2699

1.21

2.75

2.7

2.6

66.40

66.54

g/l

0.13

291

2470

Contusion of toe(s) without damage to nail

422

1.55

2.74

1.5

2.9

66.45

67.47

g/l

0.55

394

Other diseases of peritoneum

152

1169

1.33

2.73

1.8

2.8

66.32

66.43

g/l

0.07

132

1060

Use of rivastigmine

513

5869

0.86

2.73

1.9

2.4

65.85

65.66

g/l

0.23

420

5112

Struck by thrown, projected or falling objec

150

1150

1.33

2.73

2.2

2.6

66.81

66.74

g/l

0.04

139

1068

Secondary parkinsonism+Parkinsonism in other disease

106

776

1.41

2.69

2.3

2.8

64.77

66.39

g/l

1.24

708

Eustachian salpingitis and obstruction

179

1405

1.29

2.68

2.4

66.53

67.49

g/l

0.93

168

1318

Vestibular neuronitis

312

2608

1.21

2.68

2.4

2.7

67.18

66.45

g/l

1.12

279

2396

Unspecified maternal hypertension

155

1.93

2.68

1.7

2.1

66.26

68.01

g/l

0.77

144

Idiopathic progressive neuropathy

3.44

2.67

1.4

3.4

68.68

67.86

g/l

0.13

Small cell lung cancer

582

1.46

2.67

1.7

1.6

65.30

66.63

g/l

0.92

508

Small cell lung cancer, including Hilmo

582

1.46

2.67

1.7

1.6

65.30

66.63

g/l

0.92

508

Oral lichen planus

693

1.43

2.66

3.0

67.82

67.04

g/l

0.52

639

Retinoblastoma

8.36

2.66

24.4

1.0

62.16

63.40

g/l

—

Other and unspecified myoneural disorders

2.35

2.66

1.4

2.6

65.64

67.46

g/l

0.38

Secondary parkinsonism

103

753

1.41

2.64

2.2

2.7

64.54

66.39

g/l

1.48

685

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

200

1601

1.27

2.64

2.0

2.9

67.07

66.55

g/l

0.53

187

1452

Dislocation of lens

404

1.57

2.64

2.7

2.6

66.21

65.63

g/l

0.27

376

Disturbances of smell and taste

139

1062

1.34

2.63

2.5

3.1

66.55

66.78

g/l

0.13

128

972

Ulcerative proctitis

174

1367

1.29

2.63

2.2

2.6

67.25

66.89

g/l

0.24

163

1261

Migraine, single triptan purchase ok & required. ICD-code if available is included

2473

15700

1.07

2.63

2.4

2.5

67.16

66.80

g/l

1.79

2287

14458

Triptan medication for migraine, single purchase ok

2473

15700

1.07

2.63

2.4

2.5

67.16

66.80

g/l

1.79

2287

14458

Vascular dementia

393

3239

1.19

2.61

2.2

2.3

64.59

65.60

g/l

1.62

322

2843

Contact with other hot fluids

592

1.45

2.61

1.5

3.0

65.52

66.81

g/l

0.80

546

Personal history of allergy to drugs, medicaments and biological substances

224

1.76

2.60

2.0

2.3

66.86

67.75

g/l

0.27

210

Other disorders of Eustachian tube

686

1.42

2.60

2.0

2.7

66.24

66.74

g/l

0.22

633

Spinal enthesopathy

709

1.41

2.59

2.9

2.2

66.93

65.15

g/l

1.46

610

Vascular dementia (subcortical)

140

1077

1.34

2.58

2.7

2.5

65.67

65.55

g/l

0.06

121

959

Other effects of reduced temperature

2.83

2.58

1.7

2.2

66.47

66.76

g/l

0.06

Other intracranial haemorrhages

128

972

1.35

2.58

3.0

2.7

65.35

66.00

g/l

0.40

115

873

Use of rasagiline

103

758

1.41

2.58

1.4

3.1

65.40

66.45

g/l

0.82

688

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

156

1210

1.30

2.57

2.3

2.2

65.91

67.81

g/l

2.54

149

1140

Acute otitis externa, noninfective

390

1.57

2.57

2.7

3.1

66.10

67.19

g/l

0.49

358

Injury of muscle and tendon at shoulder and upper arm level

1367

12589

1.09

2.56

2.5

2.6

66.60

66.51

g/l

0.17

1259

11556

L02BA Anti-estrogens

537

4707

1.15

2.52

2.9

2.5

66.22

66.63

g/l

0.64

485

4241

190

1513

1.27

2.52

2.6

2.4

66.08

65.86

g/l

0.15

176

1306

Other diseases of appendix

289

1.66

2.52

1.8

2.5

66.49

67.21

g/l

0.22

266

Exposure to other and unspecified animate mechanical forces

521

1.47

2.51

2.4

2.5

65.06

67.42

g/l

1.44

486

Rheumatic fever incl heart disease

114

854

1.37

2.50

3.6

2.7

65.38

66.09

g/l

0.42

106

761

Vascular syndromes of brain in cerebrovascular disorders

181

1445

1.28

2.49

2.7

66.18

66.12

g/l

0.04

170

1327

Anorexia (incl.atypical)

132

1006

1.33

2.49

2.2

2.3

66.62

67.45

g/l

0.72

123

931

Beta thalassaemia

7.30

2.48

12.6

1.0

67.08

69.04

g/l

—

Unspecified chronic bronchitis

126

959

1.34

2.47

2.0

2.9

66.32

66.28

g/l

0.02

115

860

Retinoblastoma, including Hilmo

7.21

2.47

24.4

1.0

62.16

63.88

g/l

—

Inguinal or femoral hernia, bilateral

419

3620

1.17

2.47

2.5

2.6

66.03

66.27

g/l

0.25

372

3302

Medicines for HER+ breast cancer

1293

11271

1.09

2.47

2.7

2.6

66.46

66.43

g/l

0.06

1152

10091

Schizoaffective disorder

202

1632

1.25

2.43

1.8

2.6

65.18

67.00

g/l

2.64

184

1522

Inguinal hernia, bilateral

411

3552

1.17

2.42

2.5

2.6

66.04

66.28

g/l

0.25

366

3239

Other and unspecified injuries of shoulder and upper arm

704

1.39

2.41

2.2

2.8

66.92

66.97

g/l

0.02

645

Alcohol abuse counselling and surveillance

315

1.60

2.41

1.4

2.6

67.22

66.92

g/l

0.08

298

Apocrine sweat disorders, other sweat gland disorders

2.27

2.40

5.6

2.8

63.54

67.13

g/l

0.95

Congenital dislocation of hip, unilateral

2.18

2.40

1.9

2.7

66.75

65.20

g/l

0.33

Benign neoplasm of middle ear and respiratory system

275

2301

1.21

2.38

2.2

2.7

66.11

66.56

g/l

0.50

253

2108

Sequelae of infectious and parasitic diseases

236

1945

1.23

2.37

3.0

2.5

66.66

66.64

g/l

0.01

212

1777

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

171

1.85

2.36

1.7

1.6

65.61

66.50

g/l

0.27

149

Dissection of cerebral arteries, nonruptured

141

1.93

2.36

2.3

2.6

64.57

68.07

g/l

1.85

129

2.72

2.35

2.2

4.0

67.30

68.99

g/l

0.24

Scar conditions and fibrosis of skin

113

853

1.35

2.34

2.5

2.7

65.87

67.05

g/l

0.72

107

782

Pneumonia due to Haemophilus influenzae

2.43

2.34

5.9

1.9

68.67

67.27

g/l

0.27

Arthropod-borne viral fevers and viral haemorrhagic fevers

313

2654

1.19

2.33

3.0

2.7

65.37

66.59

g/l

1.98

298

2446

Foreign body in alimentary tract

174

1393

1.27

2.32

1.8

2.7

66.01

66.35

g/l

0.22

156

1278

Other disorders of male genital organs

110

829

1.35

2.31

2.9

2.8

66.09

66.93

g/l

0.64

777

Crossbite

148

1070

1.29

2.31

2.9

2.8

66.75

67.06

g/l

0.20

134

1004

Dementia in Alzheimer disease

644

6083

0.89

2.30

2.0

2.4

65.23

65.80

g/l

0.91

502

5369

Thyroiditis, unspecified

319

1.58

2.30

2.0

2.6

66.01

67.67

g/l

0.76

294

Other and unspecified iridocyclitis

139

1084

1.31

2.30

3.1

2.8

68.43

66.78

g/l

1.95

126

993

Malignant neoplasm of vulva

234

1.70

2.29

2.4

1.4

64.85

67.46

g/l

1.21

204

Respiratory tuberculosis, confirmed and not-confirmed

205

1675

1.25

2.29

2.2

2.6

66.20

65.97

g/l

0.16

179

1506

Respiratory tuberculosis

205

1676

1.24

2.28

2.2

2.6

66.20

65.97

g/l

0.16

179

1507

Graves ophthalmopathy, strict

509

1.45

2.27

1.4

2.8

65.96

67.44

g/l

0.89

469

Conductive hearing loss, unspecified

264

2211

1.21

2.27

3.4

2.6

67.16

66.47

g/l

0.79

242

2028

Gonococcal infection

696

1.38

2.24

2.4

2.5

66.40

67.41

g/l

0.53

643

Female genital prolapse

983

5057

1.11

2.24

2.4

2.5

66.74

66.35

g/l

0.86

883

4543

Benign neoplasm: Liver

485

1.46

2.24

2.6

2.9

66.55

67.49

g/l

0.49

443

Dementia, including avohilmo

2137

13814

1.07

2.23

2.1

2.6

65.72

66.01

g/l

0.93

1793

12397

Spontaneous abortion

1121

8231

0.91

2.22

2.5

2.6

67.10

66.81

g/l

0.70

1017

7526

Other infective (teno)synovitis

2.18

2.22

1.3

3.2

65.87

67.46

g/l

0.43

Wilms' tumor, including Hilmo

123

1.97

2.21

4.7

1.8

65.07

66.74

g/l

0.41

106

Serous carcinoma of ovary

183

1.80

2.21

2.6

1.4

63.98

67.22

g/l

1.23

157

Bitten or struck by other mammals

301

2555

1.19

2.20

2.5

2.6

66.88

66.92

g/l

0.03

279

2361

Alzheimer’s disease (Late onset)

884

8156

0.90

2.19

2.1

2.4

65.46

65.61

g/l

0.22

725

7158

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

187

1517

1.25

2.18

2.2

2.6

66.88

67.12

g/l

0.19

173

1404

Tooth eruption problems

262

2140

1.20

2.18

3.0

2.2

66.84

67.41

g/l

0.66

252

2003

Unspecified severe protein-energy malnutrition

2.99

2.18

2.1

1.6

59.62

66.89

g/l

—

Blood alcohol or alcohol intoxication level

429

1.48

2.17

1.7

2.4

64.96

67.18

g/l

1.55

399

Torsion of ovary, ovarian pedicle and fallopian tube

389

1.49

2.14

1.7

2.3

67.50

66.92

g/l

0.31

359

Normotensive glaucoma

346

2989

1.18

2.12

2.1

2.6

66.45

66.07

g/l

0.44

316

2669

Female infertility, associated with anovulation

127

987

1.30

2.11

1.7

1.9

67.65

67.70

g/l

0.02

120

928

Other sexually transmitted chlamydial diseases

102

770

1.34

2.10

1.8

68.33

68.25

g/l

0.04

728

Open bite

103

780

1.34

2.09

1.7

2.5

67.14

67.43

g/l

0.13

732

Ankle and foot

193

1.73

2.09

5.2

2.6

65.86

67.32

g/l

0.47

177

conjunctival degenerations and deposits

561

1.41

2.09

3.0

2.8

67.27

66.72

g/l

0.29

508

Anxious personality disorder

270

1.59

2.07

2.1

2.9

67.65

68.44

g/l

0.37

250

Colon adenocarcinoma

411

3597

1.16

2.07

2.5

1.6

65.16

66.56

g/l

2.78

365

3141

Moderate mental retardation

2.04

2.07

2.5

4.4

69.61

65.45

g/l

1.52

Procedures for purposes other than remedying health state

510

1.42

2.06

2.0

2.3

65.98

67.76

g/l

1.43

468

Disorders of lacrimal system and orbit in diseases classified elsewhere

579

1.40

2.05

1.4

2.7

66.27

67.29

g/l

0.59

531

Other and unspecified acute skin changes due to ultraviolet radiation

683

1.37

2.05

2.1

2.9

65.93

66.62

g/l

0.33

616

Reduction defects of unspecified limb

5.37

2.04

1.2

1.0

65.28

66.76

g/l

—

Female infertility, tubal origin

110

845

1.32

2.04

2.1

2.3

67.79

67.68

g/l

0.06

100

795

Chromophobe cell carcinoma of kidney

120

1.95

2.03

2.5

1.3

67.97

66.88

g/l

0.28

107

Alzheimer’s disease (Early onset), excluding more controls

1026

0.73

2.02

1.8

2.5

65.42

65.55

g/l

0.05

907

Dementia due to Parkinsons disease, excluding more controls

590

1.39

2.02

1.4

2.8

65.25

65.64

g/l

0.16

529

Postmenopausal atrophic vaginitis

931

4695

1.10

1.99

2.3

2.6

67.19

66.35

g/l

2.92

834

4226

Complications of labour and delivery

1674

9945

0.93

1.99

2.7

2.5

67.10

66.73

g/l

1.18

1542

9047

Hand

106

1.98

1.99

2.2

2.1

67.94

67.86

g/l

0.02

Dementia in other diseases classified elsewhere

178

1460

1.24

1.99

1.5

2.7

65.92

66.19

g/l

0.19

145

1325

Pathological resorption of teeth

107

825

1.32

1.98

1.9

2.6

65.44

66.77

g/l

0.98

759

All dysplastic lesions of the cervix uteri, vagina or vulva

664

5897

1.11

1.98

2.2

2.3

66.79

67.14

g/l

0.57

598

5445

Benign neoplasm: Choroid

216

1807

1.22

1.96

3.0

2.8

66.31

66.38

g/l

0.05

192

1649

Benign neoplasm: Skin of trunk

133

1058

1.28

1.94

3.8

2.9

67.29

66.67

g/l

0.54

120

968

Graves disease, strict definition

272

2319

1.18

1.94

2.2

2.6

65.75

67.04

g/l

2.13

248

2124

Alzheimer disease

1285

10099

0.92

1.93

2.2

2.5

65.34

65.75

g/l

1.05

1052

8900

Use of other anti-dementia drugs

1070

9581

0.92

1.93

2.2

2.5

65.45

65.72

g/l

0.50

864

8433

Use of memantine

1070

9581

0.92

1.93

2.2

2.5

65.45

65.72

g/l

0.50

864

8433

Mixed conductive and sensorineural hearing loss

454

4023

1.14

1.93

2.7

2.6

65.36

66.11

g/l

1.17

404

3626

Gonococcal infection

723

1.34

1.93

2.4

2.5

66.47

67.40

g/l

0.48

667

Outcome of delivery

213

1580

0.83

1.91

1.8

2.2

67.54

67.83

g/l

0.23

200

1470

Endometriosis ASRM stages 3,4

663

5997

1.11

1.91

2.3

2.4

66.71

66.66

g/l

0.06

598

5416

Burn and corrosion of wrist and hand

724

1.33

1.90

2.0

2.7

66.73

67.17

g/l

0.26

666

Graves ophthalmopathy

579

1.38

1.90

1.4

2.7

66.19

67.45

g/l

0.79

533

Short stature, not elsewhere classified

211

1.60

1.89

4.1

3.6

62.44

64.31

g/l

0.58

204

Other fall from one level to another

697

6323

1.11

1.89

2.6

2.5

66.31

66.57

g/l

0.43

639

5804

Certain conditions originating in the perinatal period

137

968

1.26

1.88

3.1

2.6

65.49

67.10

g/l

1.28

130

909

Malignant neoplasm of penis, including Hilmo

123

1.87

1.88

4.2

1.8

68.11

67.21

g/l

0.21

107

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

241

2042

1.19

1.87

2.0

2.5

66.27

66.99

g/l

0.76

224

1869

Respiratory tuberculosis, clinically confirmed

320

1.52

1.87

1.9

3.0

67.06

66.04

g/l

0.44

286

Kaposi sarcoma, including Hilmo

3.30

1.86

1.6

1.7

60.59

65.19

g/l

—

Foreign body in respiratory tract

150

1216

1.25

1.85

2.2

2.8

66.50

66.52

g/l

0.01

136

1114

Secondary malignant neoplasm of respiratory and digestive organs

404

1.45

1.85

1.6

1.5

63.89

66.87

g/l

1.62

351

Other osteochondropathies

193

1606

1.22

1.84

3.0

2.7

66.20

66.93

g/l

0.61

176

1490

Diabetes mellitus in pregnancy

604

3474

1.12

1.83

1.8

2.1

67.12

67.67

g/l

1.13

563

3247

HSIL lesion of the vulva

396

1.46

1.83

1.6

2.8

65.22

67.77

g/l

1.10

364

Malignant neoplasm of penis

2.16

1.83

2.7

2.1

67.69

66.57

g/l

0.18

Effects of foreign body entering through natural orifice

769

7025

1.10

1.83

2.6

2.5

66.80

66.65

g/l

0.22

707

6488

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

2.40

1.83

1.8

3.2

66.00

66.87

g/l

0.15

Other porphyria

2.75

1.83

3.0

1.6

69.63

67.35

g/l

—

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

2.74

1.82

1.6

1.3

57.97

65.26

g/l

—

Foreign body in ear

379

1.46

1.82

2.2

3.2

67.20

66.85

g/l

0.14

345

Simple and mucopurulent chronic bronchitis

144

1167

1.25

1.80

1.8

2.7

66.61

65.95

g/l

0.44

127

1046

Scarlet fever

102

1.91

1.80

1.7

2.6

62.84

68.09

g/l

1.92

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

135

1088

1.26

1.79

2.5

2.8

65.17

66.54

g/l

1.45

124

995

Adenocarcinoma and ductal carcinoma of pancreas

893

0.72

1.79

1.8

1.6

62.52

66.68

g/l

3.09

795

Chalazion

345

3017

1.15

1.79

3.2

2.6

66.95

66.60

g/l

0.40

318

2769

Increased muscle tone

140

1.79

4.0

3.8

64.95

66.33

g/l

0.33

129

Use of galantamine

242

2827

0.84

1.78

1.6

2.4

67.11

65.62

g/l

2.49

203

2468

Vasomotor rhinitis (mode)

224

1897

1.20

1.78

2.0

2.8

66.43

66.41

g/l

0.01

199

1740

Malignant neoplasm of larynx, including Hilmo

457

1.41

1.78

2.3

1.6

66.50

67.00

g/l

0.22

406

Benign neoplasm of other and unspecified sites

106

831

1.30

1.78

2.5

2.8

65.55

66.80

g/l

0.95

755

Helminthiases

768

1.31

1.77

3.1

2.7

67.22

66.83

g/l

0.26

711

Foreign body entering into or through eye or natural orifice

231

1963

1.19

1.76

2.6

2.7

65.71

66.66

g/l

1.01

206

1823

Convergent concomitant strabismus

134

1080

1.25

1.74

2.5

2.7

67.13

67.04

g/l

0.05

126

1006

Viral haemorrhagic fevers, not elsewhere classified/unspecified

245

2096

1.18

1.74

3.0

2.7

65.21

66.72

g/l

2.21

234

1944

Macular hole

217

1842

1.20

1.73

2.5

2.8

66.31

66.16

g/l

0.10

197

1674

LSIL lesion of the vulva

614

1.34

1.73

1.6

2.7

65.10

67.63

g/l

1.76

573

Thromboangiitis obliterans

2.05

1.73

1.5

3.1

63.08

66.63

g/l

1.11

Congenital malformations of genital organs

198

1651

1.20

1.72

2.1

2.5

66.68

67.11

g/l

0.38

186

1533

Sequelae of other and unspecified infectious and parasitic diseases

144

1173

1.24

1.72

2.5

2.6

66.99

67.38

g/l

0.24

130

1093

Other and unspecified intracranial injuries

730

1.31

1.70

1.8

2.8

67.07

66.31

g/l

0.42

661

Erythema ab igne [dermatitis ab igne]

4.12

1.69

1.0

1.1

68.32

67.11

g/l

—

Disorders of brain, other and unspecified

213

1.60

1.69

1.3

2.3

63.45

66.92

g/l

1.29

191

Contact with sharp object, undetermined intent

444

1.40

1.69

2.6

2.7

66.65

67.02

g/l

0.15

410

Injury of urinary and pelvic organs

445

1.40

1.68

3.0

2.8

65.50

66.54

g/l

0.45

407

L02BG Aromatase inhibitors

1066

9902

1.08

1.68

2.6

2.7

66.41

66.35

g/l

0.09

950

8861

Ankylosing hyperostosis [Forestier]

320

1.48

1.67

3.9

2.8

67.63

66.46

g/l

0.48

295

Rickettsioses

2.38

1.65

1.5

2.5

62.74

66.69

g/l

0.84

Foreign body or object entering through skin

170

1416

1.21

1.64

2.3

2.7

66.27

67.02

g/l

0.79

157

1310

Aortic stenosis

2.46

1.63

2.5

3.1

64.80

64.63

g/l

—

Pneumoconiosis due to asbestos and other mineral fibres

684

1.32

1.63

1.7

2.4

67.43

65.78

g/l

1.31

615

Non-allergic asthma

268

2320

1.17

1.63

2.4

2.8

67.02

66.25

g/l

0.84

252

2117

Embedded teeth, including avohilmo

174

1452

1.21

1.62

3.1

2.2

66.65

67.56

g/l

1.15

167

1356

Infections of genitourinary tract in pregnancy

231

1978

1.18

1.61

2.6

2.5

66.62

67.04

g/l

0.41

214

1801

Vascular dementia (other)

209

1.61

1.8

2.6

64.55

65.20

g/l

0.16

188

Coalworker pneumoconiosis

3.89

1.60

1.8

2.5

60.20

66.84

g/l

—

Burn and corrosion of trunk

666

1.31

1.60

1.8

2.8

65.95

66.90

g/l

0.54

615

Injury of blood vessels at lower leg level

100

1.89

1.60

1.7

2.8

66.74

67.26

g/l

0.11

Vertical strabismus

772

1.29

1.60

2.2

3.0

65.64

66.66

g/l

0.68

711

169

1.66

1.58

2.6

2.4

66.22

67.93

g/l

0.53

156

Other drug-induced osteomalacia in adults

3.73

1.58

1.0

3.1

67.22

66.12

g/l

—

Sequelae of tuberculosis

529

1.36

1.58

3.2

2.4

66.36

65.35

g/l

0.45

461

Discharge of firework

3.67

1.57

1.8

3.3

61.00

69.96

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

187

1577

1.20

1.57

2.2

2.6

66.88

67.38

g/l

0.45

173

1460

Malignant neoplasm of rectum, including Hilmo

405

3616

1.13

1.57

2.6

1.6

64.67

66.71

g/l

5.47

367

3195

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

2.14

1.56

3.3

3.2

68.58

66.06

g/l

0.60

Polyp of middle ear

2.69

1.56

3.1

1.8

64.37

66.63

g/l

—

Contraceptive management

954

7207

0.92

1.56

2.6

2.4

67.47

67.22

g/l

0.51

890

6736

Pregnancy with abortive outcome

2170

10762

1.06

1.56

2.3

2.6

66.63

66.56

g/l

0.17

1937

9687

Spermatocele

270

2352

1.16

1.55

2.1

2.5

66.20

66.43

g/l

0.20

255

2132

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

377

1.43

1.54

2.3

3.2

65.38

66.17

g/l

0.29

336

Embolic stroke

176

1482

1.20

1.54

1.7

2.6

65.35

65.90

g/l

0.41

159

1332

Femoral hernia

155

1293

1.22

1.53

2.5

2.6

66.52

66.34

g/l

0.11

138

1189

Benign neoplasm: Skin, unspecified

124

1011

1.25

1.52

2.1

2.8

65.98

66.54

g/l

0.35

112

915

Macular cyst

109

880

1.27

1.50

3.1

3.0

65.35

66.24

g/l

0.62

803

Lesion of sciatic nerve

163

1369

1.21

1.50

1.7

2.6

67.15

65.88

g/l

1.20

148

1226

Loose body in joint

515

1.34

1.50

2.3

2.9

66.39

66.23

g/l

0.06

474

Drug-induced autoimmune haemolytic anaemia

2.53

1.50

4.9

1.3

67.74

66.50

g/l

—

Congenital ichthyosis

2.16

1.50

4.5

2.2

65.24

66.95

g/l

0.31

Primary angle-closure glaucoma

162

1361

1.21

1.49

2.1

2.7

66.13

66.07

g/l

0.04

142

1224

Supervision of high-risk pregnancy

397

2127

1.13

1.48

2.0

2.2

67.47

67.64

g/l

0.18

373

1984

Other and/or unspecified nontoxic goitre

263

2297

1.16

1.47

2.2

2.7

66.66

66.44

g/l

0.20

238

2064

Other perinatal haematological disorders

3.31

1.47

1.2

3.3

64.84

59.65

g/l

—

Infections specific to the perinatal period

110

1.76

1.45

1.3

4.1

64.08

63.74

g/l

0.06

102

Other disorders of breast

359

3200

1.13

1.45

2.3

2.5

66.95

66.68

g/l

0.31

310

2903

Endometriosis diagnosis and infertility diagnosis occurring together

223

1924

1.17

1.44

2.3

2.5

67.60

67.42

g/l

0.17

204

1784

Presbyopia

184

1567

1.19

1.43

2.1

2.7

66.62

66.79

g/l

0.11

169

1453

Endometriosis of rectovaginal septum and vagina

225

1947

1.17

1.43

2.2

2.5

66.83

66.17

g/l

0.75

197

1755

Superficial injury of neck

330

1.42

1.4

3.0

66.74

67.18

g/l

0.17

303

Benign neoplasm: Tongue

734

1.28

1.41

3.8

3.0

66.20

66.90

g/l

0.40

668

Acute alcohol intoxication ICD-9

110

895

1.25

1.40

1.5

2.9

65.96

66.32

g/l

0.20

821

Melanocytic naevi of scalp and neck

486

1.34

1.40

3.0

66.49

66.91

g/l

0.17

447

Fourth [trochlear] nerve palsy

593

1.31

1.40

1.7

3.2

67.26

66.62

g/l

0.37

543

Hypertrophy of breast in women and men

542

4947

1.10

1.39

2.2

2.5

66.66

66.82

g/l

0.21

500

4558

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

3.16

1.39

1.8

1.2

68.20

65.86

g/l

—

Disorders of pituitary gland, other and/or unspecified

128

1.71

1.39

2.1

2.2

61.66

67.23

g/l

1.79

117

Preterm labour and delivery

650

5981

1.09

1.38

2.9

2.5

66.92

66.98

g/l

0.07

599

5511

Severe visual impairment, binocular

113

1.76

1.38

3.2

2.7

62.26

65.51

g/l

0.75

100

Benign neoplasm: other/unspecified salivary gland

755

1.27

1.37

2.0

3.0

65.72

66.55

g/l

0.52

686

Acute appendicitis, with complications

651

5999

1.09

1.37

2.6

2.5

66.32

66.58

g/l

0.36

589

5505

Malignant neoplasm of vagina, including Hilmo

1.96

1.37

4.1

1.2

64.71

67.54

g/l

0.47

Abscess of mediastinum

2.29

1.36

1.8

4.1

61.82

66.40

g/l

—

Contact with lifting and transmission devices, not elsewhere classified

394

1.37

1.36

2.1

3.0

67.86

66.92

g/l

0.40

362

Severe combined immunodeficiency [SCID] with reticular dysgenesis

2.00

1.35

1.2

3.1

64.15

66.57

g/l

0.57

Colorectal adenocarcinoma

678

6248

1.09

1.35

2.5

1.6

64.94

66.65

g/l

6.03

601

5521

Underdevelopment of the second kidney

2.70

1.35

2.2

4.6

63.23

65.83

g/l

—

Benign neoplasm: Lip

561

1.31

1.34

3.6

3.0

66.47

66.75

g/l

0.10

505

Glaucoma-related operations

211

1831

1.17

1.34

2.4

2.8

66.05

66.10

g/l

0.03

188

1644

Dementia

1974

12964

1.05

1.34

2.1

2.6

65.63

65.99

g/l

1.19

1646

11625

Iliotibial band syndrome

201

1.53

1.34

3.4

3.3

67.00

67.03

g/l

0.01

189

Benign neoplasm of male genital organs

571

1.31

1.33

3.1

2.8

65.97

65.89

g/l

0.03

526

Rickettsioses

2.21

1.33

1.6

2.1

63.07

66.31

g/l

—

Benign neoplasm: Prostate

203

1.55

1.33

3.8

3.2

64.66

66.09

g/l

0.48

179

Malignant neoplasm of vagina

2.20

1.33

5.3

1.3

64.54

67.67

g/l

—

Poor fetal growth

200

1724

1.17

1.32

1.5

2.1

67.82

67.76

g/l

0.04

184

1614

Benign lipomatous neoplasm of other sites/unspecified

302

2686

1.14

1.32

3.0

2.6

66.00

66.35

g/l

0.35

274

2440

Disorders of muscle tone of newborn

2.93

1.31

1.2

1.9

63.90

59.41

g/l

—

Pedal cyclist injured in noncollision transport accidents

317

2827

1.13

1.30

1.7

2.6

66.35

66.83

g/l

0.57

286

2616

Laparoscopic right hemicolectomy

214

1865

1.16

1.30

2.7

66.26

66.37

g/l

0.07

187

1702

Injury of nerves at wrist and hand level

100

813

1.25

1.29

3.8

2.9

67.21

66.93

g/l

0.13

747

Kela-code for behavioural disturbances in mental retardation

190

0.51

1.29

1.6

2.4

60.76

66.19

g/l

—

174

HSIL lesion of the cervix uteri, vagina or vulva

421

3812

1.11

1.29

2.2

2.3

66.81

67.18

g/l

0.47

379

3511

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

122

1011

1.22

1.29

2.3

2.2

67.20

67.53

g/l

0.23

114

947

Other and unspecified injuries of forearm

123

1.67

1.27

2.1

2.9

65.68

66.27

g/l

0.11

116

Other sexually transmitted chlamydial diseases

143

1203

1.19

1.27

1.7

1.8

68.35

68.04

g/l

0.20

135

1139

Intentional self-harm by sharp object

329

1.38

1.26

1.9

2.6

64.24

67.63

g/l

1.53

306

Bacterial meningitis

102

835

1.24

1.26

2.9

66.25

66.83

g/l

0.27

769

Malignant neoplasm of eye, brain and central nervous system

115

953

1.22

1.25

3.8

1.5

65.58

67.09

g/l

1.03

102

861

Dislocation, sprain and strain of joints and ligaments of knee

1908

16802

1.05

1.25

2.2

2.6

66.66

66.99

g/l

1.19

1739

15527

Carcinoma in situ of larynx

2.20

1.24

1.9

4.4

68.24

66.16

g/l

—

Benign lipomatous neoplasm

1036

9752

1.07

1.24

2.8

2.5

66.34

66.48

g/l

0.25

941

8863

Desensitization to allergens

780

1.24

2.4

2.2

68.34

67.78

g/l

0.37

736

Retinal breaks without detachment

548

5043

1.09

1.24

2.5

2.7

66.59

66.45

g/l

0.18

489

4598

Obstructed labour due to malposition and malpresentation of fetus

361

3735

0.90

1.24

2.0

2.3

67.52

67.41

g/l

0.11

338

3488

Other endophthalmitis

125

1.67

1.23

5.6

3.5

68.46

66.10

g/l

0.74

110

Family history of certain disabilities and chronic diseases leading to disablement

808

1.24

1.23

1.5

2.4

65.46

67.61

g/l

1.82

746

Vascular dementia (undefined)

154

1300

1.19

1.23

1.9

2.2

64.24

65.22

g/l

0.69

119

1127

Purulent endophthalmitis

182

1.55

1.23

3.5

3.2

66.59

66.28

g/l

0.06

162

Maternal care for known or suspected malpresentation of fetus

251

2062

0.88

1.22

2.3

2.0

67.35

67.92

g/l

0.67

240

1924

Abrasion of teeth

1097

10352

1.06

1.21

2.9

2.6

67.05

66.67

g/l

0.95

998

9485

Divergent concomitant strabismus

199

1732

1.16

1.21

2.2

2.6

66.35

66.73

g/l

0.28

186

1593

Polycystic ovarian syndrome, broad definition

172

1478

1.17

1.21

1.6

1.9

67.94

67.91

g/l

0.02

162

1379

Carcinoma in situ of uteri, other/unspecified

127

0.46

1.21

4.3

2.1

67.33

67.42

g/l

—

118

Pedestrian injured in transport accident

200

1743

1.16

1.20

1.9

2.6

66.77

66.49

g/l

0.22

175

1600

Pregnancy, childbirth and the puerperium

913

5088

0.93

1.19

2.3

2.4

66.40

66.23

g/l

0.30

804

4472

Benign neoplasm: Conjunctiva

814

1.24

1.19

2.1

3.1

65.35

66.74

g/l

1.42

748

Benign neoplasm of breast

367

3322

1.11

1.19

2.4

2.5

66.31

66.54

g/l

0.26

323

2983

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

253

2245

1.14

1.18

2.2

2.8

66.42

66.51

g/l

0.08

232

2051

Histrionic personality disorder

111

1.69

1.17

1.3

2.5

67.18

66.96

g/l

0.04

100

Central nervous system disorder causing precocious puberty

2.58

1.16

4.6

5.1

68.78

59.86

g/l

—

Deep bite

257

1998

1.13

1.16

3.5

2.7

67.01

66.82

g/l

0.15

234

1858

Other and unspecified hydrocephalus

476

1.31

1.16

2.1

3.0

66.83

66.27

g/l

0.22

429

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

601

1.27

1.15

3.0

65.55

66.82

g/l

0.80

549

Pedal cyclist injured in transport accident

661

6147

1.08

1.15

2.1

2.5

66.68

66.67

g/l

0.01

595

5651

Family history of malignant neoplasm

273

2436

1.13

1.14

3.3

2.4

66.38

67.18

g/l

1.07

252

2242

Benign neoplasm of brain and other parts of central nervous system

198

1734

1.15

1.14

2.8

66.25

66.60

g/l

0.25

172

1592

Other and unspecified disease of Bartholin gland

701

1.25

1.14

2.5

2.9

65.87

66.69

g/l

0.38

641

Other specified/unspecified deforming dorsopathies

354

1.35

1.13

2.4

2.9

66.62

67.29

g/l

0.22

334

Maternal care related to the fetus and amniotic cavity and possible delivery problems

950

5927

0.94

1.13

2.4

2.3

67.76

67.29

g/l

1.30

892

5474

Malignant neoplasm of nasal cavity and sinuses

128

1.61

1.12

5.0

1.8

65.86

67.17

g/l

0.36

113

Other and unspecified injuries of thorax

381

1.34

1.12

2.3

2.8

65.54

67.05

g/l

0.89

346

Perineal laceration during delivery

230

2175

0.88

1.12

1.9

2.0

67.65

67.71

g/l

0.05

214

2022

Benign neoplasm: Skin of lip

348

1.35

1.11

3.5

2.5

69.20

66.94

g/l

1.14

311

Toxic effects of substances chiefly nonmedicinal as to source

308

2775

1.12

1.10

2.0

2.7

66.48

66.76

g/l

0.25

288

2570

Squamous cell neoplasms and carcinoma of cervix

113

1.64

1.09

3.5

1.6

67.30

67.24

g/l

0.01

106

Use of biperiden

150

1292

1.17

1.09

2.0

2.7

65.21

66.59

g/l

1.17

129

1192

Burn and corrosion of hip and lower limb, except ankle and foot

480

1.29

1.09

1.4

3.0

66.33

66.87

g/l

0.20

435

Benign neoplasm: Skin of scalp and neck

624

1.25

1.08

2.4

3.0

66.61

66.63

g/l

0.01

567

Benign neoplasm: Extrahepatic bile ducts

1.83

1.08

1.3

3.2

67.52

67.53

g/l

0.00

Unspecified lump in breast

473

4356

1.09

1.08

2.2

2.5

66.61

66.55

g/l

0.07

429

3928

Inflammatory disorders of breast

142

1217

1.18

1.08

2.7

2.5

66.79

67.23

g/l

0.30

128

1117

Congenital obstruction of the pelviureteric junction

162

1.52

1.08

3.5

3.0

65.80

67.02

g/l

0.33

148

Generalized epilepsy

786

1.22

1.08

2.7

2.8

66.86

66.92

g/l

0.02

729

Problems related to social environment

633

1.25

1.07

2.6

66.84

66.21

g/l

0.30

574

Neuralgic amyotrophy

2.04

1.07

7.6

3.0

65.42

65.95

g/l

—

Benign neoplasm of ovary

548

5081

1.08

1.07

2.6

65.84

66.51

g/l

1.33

502

4551

Nontoxic diffuse goitre

816

1.22

1.07

2.7

2.8

66.66

66.90

g/l

0.14

734

Urticaria due to cold and heat

146

1.54

1.06

1.7

2.3

68.57

67.52

g/l

0.31

134

Schizotypal disorder

402

1.31

1.06

1.6

2.6

66.99

67.91

g/l

0.34

377

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

148

0.53

1.05

2.1

2.7

64.50

66.63

g/l

—

138

Paranoid personality disorder

350

1.34

1.05

2.7

3.1

68.00

67.22

g/l

0.28

321

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

188

1.48

1.05

2.7

3.6

65.30

66.65

g/l

0.48

174

Assault by drugs, medicaments and biological substances

2.39

1.05

1.4

1.3

65.70

66.87

g/l

—

All dysplastic lesions of the vagina

563

1.26

1.05

2.5

2.7

67.30

67.50

g/l

0.07

526

Acrodermatitis continua

1.99

1.05

1.4

1.6

67.42

66.14

g/l

—

Malignant neoplasm of other and unspecified major salivary glands

1.85

1.05

1.9

1.3

66.44

66.62

g/l

0.03

Disorders of aromatic amino-acid metabolism

1.97

1.05

1.8

2.2

67.73

65.90

g/l

—

Intracerebral haemorrhage

477

4404

1.09

1.04

2.2

2.5

65.27

66.05

g/l

1.29

425

3872

Malignant neoplasm of accessory sinuses, including Hilmo

1.71

1.04

3.4

2.0

67.95

67.49

g/l

0.11

Female infertility

731

4149

1.07

1.04

2.4

67.20

66.97

g/l

0.37

668

3829

Abscess of Bartholin gland

474

1.28

1.04

2.9

2.7

67.68

67.53

g/l

0.04

447

Malignant neoplasm of pancreas

166

1895

0.87

1.01

1.8

1.6

63.73

66.52

g/l

3.90

150

1671

All dysplastic lesions of the cervix uteri

531

4884

1.08

1.01

2.4

2.3

66.92

67.22

g/l

0.41

484

4521

Spirochaetal infections, other/unspecified

1029

9762

1.06

1.00

2.7

2.6

67.13

66.54

g/l

1.95

907

8913

Other spirochaetal diseases

1043

9900

1.06

1.00

2.6

67.13

66.52

g/l

2.04

920

9040

Diseases of thymus

1.88

1.00

2.0

2.8

65.02

66.81

g/l

—

Male infertility

729

1.22

1.00

1.6

2.7

67.48

67.50

g/l

0.01

697

Complications following abortion and ectopic and molar pregnancy

105

887

1.20

0.99

2.2

2.9

66.57

66.82

g/l

0.14

806

Multiple delivery

158

1809

0.87

0.99

3.3

2.2

67.94

66.88

g/l

1.17

151

1656

L02BX Other hormone antagonists and related agents

215

1918

1.14

0.99

3.4

2.6

64.89

65.87

g/l

1.14

186

1753

Labour and delivery complicated by umbilical cord complications

107

904

1.19

0.99

2.8

2.5

67.93

67.48

g/l

0.26

101

840

Undefined dementia

391

3921

0.91

0.99

1.8

2.3

64.39

65.62

g/l

2.26

321

3368

Other disorders of choroid

364

1.32

0.98

2.0

3.1

67.05

66.15

g/l

0.33

330

Unspecific neurodegenerative disorder

1801

12799

0.96

0.98

2.1

2.6

65.61

65.91

g/l

0.88

1483

11430

LSIL lesion of the cervix uteri, vagina or vulva

301

2730

1.11

0.97

2.3

2.4

66.35

67.32

g/l

1.31

272

2515

Benign neoplasm: Brain, supratentorial

338

1.33

0.97

1.8

3.0

68.39

67.01

g/l

0.55

305

Other spirochaetal diseases

1030

9786

1.06

0.96

2.7

2.6

67.13

66.53

g/l

1.97

909

8935

Contact with sharp glass

698

1.21

0.94

2.3

2.6

68.01

67.25

g/l

0.42

653

Congenital mitral valve regurgitation

2.26

0.94

1.8

2.0

69.75

65.30

g/l

—

Transient global amnesia

281

3092

0.90

0.94

2.3

2.6

65.73

66.40

g/l

0.73

246

2808

Pedal cyclist injured in other and unspecified transport accidents

312

2844

1.10

0.93

2.5

2.6

67.01

66.67

g/l

0.33

282

2624

Pituitary-dependent Cushing's disease

1.77

0.93

1.4

3.3

62.05

66.54

g/l

1.09

Seminoma of testis

110

1.58

0.92

2.1

1.9

64.21

68.14

g/l

1.16

Embolism and thrombosis of abdominal aorta

2.02

0.92

1.1

2.5

66.33

67.23

g/l

—

Chronic mastoiditis

711

1.21

0.92

2.0

2.8

66.83

66.18

g/l

0.33

643

Other corneal oedema

220

1.41

0.92

3.8

3.1

66.25

66.81

g/l

0.12

198

Pedestrian injured in collision with car, pick-up truck or van

565

1.24

0.91

1.7

2.9

67.50

66.98

g/l

0.24

514

Abnormal spermatozoa

462

4294

1.08

0.91

2.5

2.7

66.22

66.11

g/l

0.11

419

3902

Inflammatory disease of cervix uteri

187

1663

1.13

0.90

2.3

2.5

66.61

66.57

g/l

0.03

165

1503

Use of ropinirole

124

1074

1.17

0.90

2.0

3.0

66.06

66.44

g/l

0.21

101

985

Seminoma of testis, including Hilmo

127

1.52

0.90

1.9

1.8

64.52

67.73

g/l

1.00

113

Operations 1 for CAVS

1.81

0.90

1.6

3.3

63.12

65.62

g/l

0.54

LSIL lesion of the vagina

298

1.33

0.90

1.7

2.6

66.46

67.40

g/l

0.30

272

Cardiovascular disorders originating in the perinatal period

1.96

0.90

1.4

4.2

65.89

63.20

g/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1162

0.84

0.90

2.5

2.6

68.02

66.84

g/l

1.11

1063

Congenital malformations of spine and bony thorax

1.62

0.90

1.9

2.6

66.21

66.29

g/l

0.01

Other menopausal disorders

770

4598

0.94

0.89

2.3

2.6

66.94

66.49

g/l

1.00

698

4191

Lyme disease

1019

9704

1.05

0.89

2.7

2.6

67.13

66.54

g/l

1.93

898

8859

Cerebral oedema

1.91

0.89

2.0

2.1

60.38

68.14

g/l

—

Vascular dementia (mixed)

578

1.23

0.88

2.2

2.5

64.19

65.43

g/l

0.72

520

Distal bite

500

1.24

0.88

3.4

2.6

66.33

67.02

g/l

0.29

470

Congenital malformation of optic disc

2.07

0.88

1.0

3.8

66.73

65.23

g/l

—

Labour and delivery complicated by fetal stress [distress]

339

2422

0.91

0.88

1.8

2.0

66.92

67.76

g/l

1.37

318

2258

Any dementia

1770

11850

1.04

0.87

2.1

2.5

65.25

65.93

g/l

3.02

1484

10551

Congenital malformations of spine and bony thorax

104

1.57

0.87

1.9

2.7

66.94

66.25

g/l

0.13

Other benign neoplasm of uterus: Corpus uteri

188

1.42

0.87

3.7

2.4

65.07

66.93

g/l

0.43

171

Sickle-cell disorders

1.85

0.87

2.9

2.6

64.61

65.24

g/l

—

Normal-pressure hydrocephalus

186

1662

1.13

0.86

2.4

2.6

67.14

65.99

g/l

1.37

166

1493

Intrahepatic Cholestasis of Pregnancy (ICP)

122

1057

1.16

0.85

2.3

2.2

67.20

67.80

g/l

0.50

114

996

Antepartum haemorrhage, not elsewhere classified

147

1291

1.14

0.85

2.0

2.1

67.99

67.83

g/l

0.10

138

1212

Colour vision deficiencies

1.74

0.84

1.5

2.9

69.95

66.05

g/l

1.23

Contact with nonpowered hand tool

114

986

1.17

0.84

1.9

2.8

67.89

66.69

g/l

1.12

107

918

Thyroid crisis or storm

1.77

0.83

1.0

2.6

64.59

68.93

g/l

—

Chondromalacia

646

1.21

0.82

2.6

2.7

67.25

67.03

g/l

0.11

601

Crowding of teeth, including avohilmo

140

1015

1.14

0.82

3.3

2.4

65.77

67.47

g/l

1.72

132

959

Benign neoplasm: Skin of lower limb, including hip

693

1.20

0.82

3.6

2.9

66.48

67.05

g/l

0.30

635

Congenital musculoskeletal deformities of head, face, spine and chest

181

1.40

0.81

1.6

2.8

69.49

65.50

g/l

2.14

171

Malignant neoplasm of brain, including Hilmo

126

1101

1.15

0.81

3.4

1.5

65.46

67.13

g/l

1.34

113

995

Inhalation and ingestion of food causing obstruction of respiratory tract

225

1.36

0.81

3.0

2.7

69.58

66.14

g/l

1.55

206

Marfan's syndrome

1.60

0.80

1.7

2.9

65.34

67.13

g/l

0.28

Burn and corrosion confined to eye and adnexa

438

1.25

0.80

2.4

2.7

67.03

67.17

g/l

0.05

407

Long labour

425

3907

0.93

0.80

2.3

67.34

67.20

g/l

0.15

400

3627

Burns and corrosions confined to eye and internal organs

520

1.22

0.79

2.7

66.79

67.17

g/l

0.15

480

Maternal care for known or suspected abnormality of pelvic organs

436

3184

0.93

0.77

2.6

2.3

66.85

67.50

g/l

1.13

398

2943

Dislocations, sprains and strains involving multiple body regions

2.20

0.77

1.4

1.5

72.08

64.64

g/l

—

Other mosquito-borne viral fevers

1.92

0.76

1.9

2.5

63.66

66.70

g/l

—

Other disorders of prostate

114

997

1.16

0.76

2.8

2.6

66.58

66.33

g/l

0.14

107

910

Malignant neoplasm of palate

1.75

0.75

2.4

2.0

65.56

66.83

g/l

—

Nightmares

1.91

0.75

2.0

2.9

64.24

66.47

g/l

—

Cholera

2.12

0.75

4.2

3.0

67.60

67.65

g/l

—

Benign lipomatous neoplasm of of intra-abdominal organs

1.65

0.75

4.5

2.3

65.13

66.87

g/l

0.44

L02BB Anti-androgens

365

3396

1.08

0.75

2.9

2.5

65.76

65.79

g/l

0.03

328

3020

Sequelae of inflammatory diseases of the central nervous system

1.68

0.75

4.0

3.6

63.38

67.64

g/l

1.11

Dysplasia of cervi uteri

587

4005

1.06

0.75

2.5

2.3

66.90

66.83

g/l

0.07

533

3671

HSIL lesion of the cervix uteri

352

3265

1.08

0.74

2.2

2.3

67.05

67.31

g/l

0.28

323

3018

Fall on and from ladder

248

2272

1.10

0.73

3.0

2.8

66.46

66.50

g/l

0.03

230

2092

Premature rupture of membranes

347

2678

0.92

0.73

2.2

67.79

67.69

g/l

0.09

321

2492

Huntington disease

2.04

0.73

3.2

1.5

67.26

66.07

g/l

—

Benign mammary dysplasia

448

4202

1.07

0.72

2.5

2.6

66.53

66.35

g/l

0.19

400

3754

Use of amantadine

400

1.24

0.72

1.8

2.5

66.83

66.94

g/l

0.05

363

Communicating hydrocephalus

574

1.20

0.71

2.0

3.2

67.11

66.19

g/l

0.43

523

Acute inflammation of orbit

118

1.47

0.71

5.8

2.2

67.71

67.08

g/l

0.09

113

Accidental poisoning by and exposure to other gases and vapours

110

1.50

0.71

1.3

2.6

64.71

66.96

g/l

0.47

103

HSIL lesion of the vagina

284

1.29

0.70

3.1

2.8

68.38

67.82

g/l

0.15

263

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

760

1.17

0.70

1.8

2.8

68.16

66.53

g/l

1.39

703

Beningn neoplasm: Meninges, unspecified

420

1.23

0.70

2.5

2.9

65.40

66.51

g/l

0.56

379

252

2738

0.91

0.70

1.6

2.6

64.73

66.09

g/l

1.52

223

2490

Pregnancy examination and test

257

1463

1.09

0.69

1.8

2.0

68.30

67.95

g/l

0.38

247

1359

Major anomalies of jaw size

520

1.20

0.69

1.9

2.8

66.29

67.35

g/l

0.55

484

Small cell lung cancer, helper endpoint

718

1.17

0.66

1.7

2.8

65.30

65.78

g/l

0.24

638

Persons encountering health services in circumstances related to reproduction

1559

10849

0.97

0.66

2.6

67.09

67.03

g/l

0.13

1452

10087

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.51

0.66

2.3

3.1

68.46

67.14

g/l

0.30

Rubella [German measles]

737

1.16

0.65

2.6

2.4

67.97

67.19

g/l

0.47

709

Benign neoplasm: Larynx

850

1.15

0.65

2.2

2.8

66.37

66.35

g/l

0.01

774

Malignant neoplasm of gallbladder, including Hilmo

155

1.39

0.65

2.1

1.3

66.73

66.95

g/l

0.04

134

Carcinoma in situ of other and unspecified sites

131

1172

1.13

0.65

2.7

66.42

66.17

g/l

0.15

119

1071

Congenital musculoskeletal deformities of head, face, spine and chest

207

1.32

0.65

1.6

3.2

69.34

65.92

g/l

1.87

195

Female infertility, cervical, vaginal, other or unspecified origin

657

4062

1.05

0.64

2.4

2.3

67.08

66.94

g/l

0.19

599

3749

Benign neoplasm: Brain, infratentorial

139

0.63

1.2

3.5

64.62

66.56

g/l

—

131

Heberden's nodes [with arthropathy]

227

1.31

0.62

1.3

2.7

66.90

67.08

g/l

0.04

205

Puerperal sepsis

341

3192

1.07

0.61

2.7

2.6

67.03

67.04

g/l

0.01

313

2942

Other protozoal intestinal diseases

290

1.26

0.61

2.0

2.7

66.17

66.94

g/l

0.29

268

Carcinoma in situ of oesophagus

1.82

0.60

1.8

2.3

69.22

66.80

g/l

—

Dermatitis due to ingested food

373

1.21

0.60

2.7

3.1

67.16

66.02

g/l

0.43

356

Cyst of Bartholin Gland

752

1.15

0.60

2.2

2.5

65.62

67.37

g/l

1.09

698

Toxic effect of ethanol

772

1.15

0.59

1.9

2.5

64.65

67.00

g/l

2.38

716

Osteitis due to dental implant

203

1.31

0.58

5.9

3.0

66.53

g/l

0.00

182

Congenital malformations of ovaries, fallopian tubes and broad ligaments

110

980

1.13

0.58

1.8

2.3

67.69

67.41

g/l

0.18

105

912

Unspecified dementia

387

3690

0.94

0.58

1.8

2.5

64.44

65.76

g/l

2.55

319

3232

Benign neoplasm: Rectum/anal canal icd-9

266

1.26

0.58

1.6

2.8

66.29

65.85

g/l

0.13

232

Personality and behavioural disorders due to brain disease, damage and dysfunction

347

1.23

0.57

3.3

3.0

65.66

66.44

g/l

0.26

321

Other benign neoplasm of uterus: Other parts/unspecified

144

1307

1.11

0.57

3.2

2.5

66.24

65.92

g/l

0.17

117

1139

Benign neoplasm: Skin of upper limb, including shoulder

467

1.19

0.57

3.9

3.2

64.53

67.01

g/l

1.31

428

Other specified/unspecified disorders of middle ear and mastoid

1.58

0.57

2.1

2.2

71.76

65.73

g/l

—

Obstructed labour due to maternal pelvic abnormality

354

3761

0.94

0.56

3.0

2.5

66.77

66.97

g/l

0.20

324

3462

Exposure to excessive heat of man-made origin

195

1.31

0.56

2.5

2.8

66.62

66.36

g/l

0.05

174

Acute thyroiditis

1.50

0.56

2.8

2.5

66.82

68.51

g/l

0.58

Valgus deformity, not elsewhere classified

142

1.36

0.56

1.2

3.2

67.25

67.02

g/l

0.06

129

Postpartum haemorrhage

437

3886

0.94

0.56

2.2

2.3

67.49

67.29

g/l

0.22

406

3616

Oesophagitis, drug-induced

1.51

0.55

1.2

1.6

66.98

67.16

g/l

—

Dyshidrosis [pompholyx]

294

1.24

0.55

2.2

2.9

67.22

67.05

g/l

0.04

273

Hereditary corneal dystrophies

106

949

1.13

0.55

1.5

3.0

66.68

66.44

g/l

0.12

862

Diving or jumping into water causing injury other than drowning or submersion

1.52

0.54

1.3

3.1

68.70

67.57

g/l

0.28

Corneal degeneration

415

1.20

0.54

1.4

2.8

65.17

66.82

g/l

0.60

374

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.46

0.53

1.3

3.0

66.87

66.43

g/l

—

Small plaque parapsoriasis

1.52

0.53

3.9

2.8

68.99

66.36

g/l

0.61

Postpartum haemorrhage due to anatomy

147

1339

1.10

0.53

1.9

2.0

67.96

67.67

g/l

0.19

137

1257

Unspecified renal colic

135

1.36

0.53

1.7

2.6

64.94

66.61

g/l

0.39

126

Tonsillectomy and adenotomy

1337

9588

0.97

0.53

2.3

67.11

67.04

g/l

0.12

1247

8947

Pterygium

876

1.13

0.53

2.7

2.9

66.63

66.21

g/l

0.24

803

Hip and thigh

1.42

0.52

4.3

3.1

65.24

65.46

g/l

—

Glaucoma, exfoliation

417

3957

1.06

0.52

2.5

2.4

66.28

65.71

g/l

0.74

360

3461

Single delivery by caesarean section

319

1949

0.94

0.52

2.0

1.9

66.75

67.40

g/l

0.81

303

1818

Cicatricial alopecia [scarring hair loss]

180

1.30

0.51

1.5

2.4

67.83

67.33

g/l

0.12

166

Polypectomy (DHB20)

200

1854

1.09

0.51

2.4

2.7

66.39

66.60

g/l

0.15

185

1711

Deep endometriosis

250

2337

1.07

0.50

2.1

2.4

66.76

66.65

g/l

0.09

220

2109

Failed induction of labour

744

1.13

0.50

1.8

66.57

68.13

g/l

1.47

691

Impacted teeth

317

2653

1.06

0.50

2.2

2.1

66.85

67.51

g/l

0.85

304

2492

Mucinous and mucinous cystic tumor, including Hilmo

154

1.33

0.50

5.3

1.4

65.51

67.96

g/l

1.41

140

Other benign neoplasms of uterus

177

1636

1.09

0.50

3.2

2.4

66.04

66.22

g/l

0.10

142

1433

Toxic encephalopathy

1.54

0.49

1.3

1.6

63.83

66.18

g/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

559

1.15

0.49

2.2

2.4

66.89

67.17

g/l

0.11

515

Non-small cell lung cancer, squamous, helper endpoint

168

1552

1.09

0.48

1.7

2.5

65.80

65.86

g/l

0.03

153

1391

Dental pulpitis, including avohilmo

3071

19561

1.02

0.48

2.4

2.5

67.15

66.80

g/l

1.86

2826

18072

Postpolio syndrome

1.47

0.47

9.6

3.8

62.71

64.84

g/l

—

Premenstrual syndrome

155

1.30

0.47

1.2

2.7

69.17

67.95

g/l

0.40

146

Hyperfunction of pituitary gland, other and/or unspecified

1.45

0.47

9.0

2.7

67.83

67.31

g/l

—

Carcinoma in situ, bladder

117

1066

1.11

0.47

2.9

2.8

66.45

66.10

g/l

0.21

105

978

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.43

0.46

1.1

3.2

64.41

68.48

g/l

—

Laparoscopic left hemicolectomy

490

1.16

0.44

2.2

2.7

65.16

66.66

g/l

0.66

442

Carcinoma in situ of middle ear and respiratory system

122

1.34

0.44

1.7

3.2

68.21

66.16

g/l

0.59

110

Carcinoma in situ of breast, other/unspecified

378

1.18

0.44

2.3

2.7

68.81

67.03

g/l

0.72

337

Traumatic amputation of wrist and hand

104

1143

0.90

0.44

1.9

2.7

66.71

66.45

g/l

0.14

1060

Chronic suppurative otitis media, including avohilmo

217

2033

1.07

0.44

2.0

2.7

67.08

66.52

g/l

0.50

198

1861

Malignant neoplasm of pyriform sinus, including Hilmo

1.62

0.43

1.2

3.2

64.14

65.36

g/l

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.62

0.43

2.3

2.9

64.03

65.90

g/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

142

1309

1.09

0.43

2.4

2.5

65.92

66.91

g/l

0.90

130

1216

Arteriovenous malformation of peripheral vessels

0.63

0.43

1.2

2.1

69.03

66.12

g/l

—

Obstructive hydrocephalus

369

1.18

0.43

1.4

3.1

69.66

66.57

g/l

1.86

331

Calculus of lower urinary tract

183

1707

1.08

0.43

2.4

2.7

66.81

66.23

g/l

0.38

164

1556

Malignant neoplasm of gallbladder

105

1.36

0.42

2.4

1.2

65.14

66.57

g/l

0.27

Knuckle pads

1.56

0.42

1.0

5.2

69.70

68.68

g/l

—

Use of selegiline

152

1410

1.09

0.42

1.9

2.8

66.02

66.36

g/l

0.24

122

1285

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

408

3900

1.05

0.42

3.0

2.6

66.36

66.63

g/l

0.31

365

3584

Glanders and melioidosis

0.00

0.41

0.0

1.6

—

65.98

—

Supervision of normal pregnancy

359

2155

0.95

0.41

2.2

68.15

67.69

g/l

0.72

339

2010

Other respiratory conditions originating in the perinatal period

0.00

0.41

0.0

6.4

—

58.56

—

Malignant neoplasm of nasal cavity and middle ear

1.37

0.41

4.9

1.9

63.85

66.28

g/l

0.60

Calcaneal spur

269

1.20

0.41

3.4

3.3

66.27

67.42

g/l

0.38

244

Mucinous and mucinous cystic tumor of rectum

105

0.65

0.40

1.1

1.9

64.49

67.02

g/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

886

0.90

0.40

3.1

2.8

64.93

66.04

g/l

0.64

789

Toxic effect of other gases, fumes and vapours

106

1.34

0.40

1.6

3.4

65.48

67.23

g/l

0.28

Adrenomedullary hyperfunction

1.37

0.39

1.7

3.1

66.03

66.76

g/l

—

Other and unspecified water transport accidents

1.37

0.39

2.8

2.4

64.30

67.03

g/l

—

Bradycardia, unspecified, drug-induced

1.43

0.38

1.3

3.0

65.54

66.06

g/l

—

Oral leukoplakia, including avohilmo

734

1.11

0.38

3.0

2.9

67.18

66.83

g/l

0.17

674

Embedded and impacted teeth

478

3790

1.04

0.38

2.6

2.2

66.82

67.42

g/l

1.10

459

3547

Toxic effect of other noxious substances eaten as food

1.42

0.38

2.4

2.8

68.03

66.47

g/l

—

Other obstetric trauma

778

0.90

0.37

1.9

2.2

68.03

67.91

g/l

0.04

733

Deep bite that required surgery

202

0.78

0.37

1.6

2.1

71.76

68.22

g/l

2.68

190

Other disorders of amniotic fluid and membranes

224

2065

1.06

0.37

2.3

2.0

67.36

67.73

g/l

0.43

209

1927

Chronic diseases of tonsils and adenoids

2539

16310

0.98

0.36

2.4

2.6

67.02

66.69

g/l

1.47

2345

15007

Congenital malformations of oesophagus

108

1.32

0.36

1.9

3.0

67.24

65.65

g/l

0.34

101

Ankyloglossia

161

1.25

0.36

5.7

3.2

66.05

64.57

g/l

0.38

153

Congenital hypothyroidism without goiter

1.34

0.36

1.1

2.7

66.30

66.29

g/l

0.00

Twin gestation

150

1401

1.07

0.35

2.4

2.2

66.89

67.72

g/l

0.82

144

1314

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

264

1.18

0.35

2.8

2.9

66.64

67.16

g/l

0.14

247

Cleft lip

1.38

0.35

3.5

3.2

63.60

67.15

g/l

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

100

1.32

0.34

1.8

3.2

69.26

67.31

g/l

0.18

Benign neoplasm of thyroid gland

854

1.10

0.34

2.5

2.8

68.70

66.89

g/l

1.67

776

Benign neoplasm: Peripheral nerves and autonomic nervous system

406

1.14

0.34

2.6

2.9

66.95

67.08

g/l

0.04

360

Other cestode infections

0.67

0.34

6.3

3.4

65.10

66.37

g/l

—

Gestational diabetes (for exclusion)

669

4510

1.03

0.34

2.1

2.2

67.28

67.49

g/l

0.33

620

4218

Gastric ulcer - Acute with haemorrhage, drug-induced

1.33

0.34

2.3

2.1

65.93

66.91

g/l

—

Malignant neoplasm of brain

701

1.10

0.34

2.7

1.6

66.04

67.34

g/l

0.60

639

Childhood allergy (age < 16)

168

1300

1.07

0.33

1.5

2.0

66.74

67.44

g/l

0.53

157

1235

Other inflammation of vagina/vulva

587

1.11

0.33

1.2

2.5

68.06

67.53

g/l

0.31

550

Other protozoal intestinal diseases

407

1.14

0.33

1.9

2.9

66.22

67.21

g/l

0.51

375

Abnormalities of forces of labour

193

1824

1.06

0.33

2.0

2.3

68.87

67.65

g/l

1.63

175

1717

Exposure to excessive natural heat

1.41

0.32

2.4

2.8

62.33

66.67

g/l

—

Congenital retinoschisis

1.35

0.32

5.7

1.7

74.90

65.54

g/l

—

Malignant neoplasm of larynx

352

1.15

0.32

2.2

1.6

65.89

67.04

g/l

0.47

315

Contact with other specified venomous animals

153

0.77

0.31

1.3

2.7

66.81

67.07

g/l

0.05

141

Vascular dementia (sudden onset)

0.70

0.31

1.6

2.7

63.94

66.16

g/l

—

Chronic suppurative otitis media

179

1692

1.06

0.31

1.9

2.6

66.90

66.48

g/l

0.29

163

1541

Injury of blood vessels at hip and thigh level

1.34

0.31

2.1

2.7

62.93

66.74

g/l

0.73

Inguinal hernia, unilateral

744

1.10

0.31

2.2

2.5

66.23

66.46

g/l

0.12

685

Femoral hernia, unilateral

744

1.10

0.31

2.2

2.5

66.23

66.46

g/l

0.12

685

Inguinal of femoral hernia, unilateral

744

1.10

0.31

2.2

2.5

66.23

66.46

g/l

0.12

685

Uterine polyps

263

2513

1.05

0.31

2.6

2.5

66.93

66.48

g/l

0.52

247

2291

Contact with other sharp object(s)

125

1336

0.93

0.30

2.8

2.6

66.65

67.14

g/l

0.32

117

1248

Accessory breast

106

0.75

0.29

2.5

2.1

67.39

67.95

g/l

—

Erosion and ectropion of cervix uteri

737

1.09

0.29

2.6

2.5

66.16

66.03

g/l

0.05

667

Prophylactic surgery

110

0.72

0.29

2.1

2.3

64.52

69.33

g/l

—

103

Maternal care for known or suspected fetal abnormality and damage

254

2088

1.05

0.29

1.7

2.0

67.26

67.84

g/l

0.73

242

1954

Pedestrian injured in collision with pedal cycle

747

1.09

0.29

2.1

2.8

66.56

66.69

g/l

0.06

679

Esophageal diverticulum (pouch)

1.30

0.29

1.1

3.2

64.35

66.68

g/l

—

Toxic effect of contact with venomous animals

103

960

1.08

0.28

2.6

2.9

67.95

66.66

g/l

0.95

881

Myocardial infarction, unclassifiable

871

7950

0.98

0.28

2.3

2.4

64.85

65.85

g/l

3.37

789

6984

Rheumatic fever with heart involvement

113

1.26

0.27

11.9

3.3

64.22

66.56

g/l

0.44

103

Other disorders affecting eyelid function

225

0.84

0.27

2.3

2.7

65.82

66.76

g/l

0.31

205

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.33

0.27

4.6

2.2

67.91

65.79

g/l

—

Hypertrophy of breast

423

4098

1.03

0.27

2.0

2.4

66.80

66.98

g/l

0.21

387

3771

Multiple gestation

153

1449

1.06

0.26

2.4

2.2

66.88

67.68

g/l

0.79

147

1359

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

158

0.81

0.26

2.8

3.9

60.82

63.03

g/l

0.36

151

Benign leiomyoma with endometriosis

486

4724

1.03

0.26

2.6

2.5

66.05

66.42

g/l

0.50

433

4243

Injury of muscle and tendon at wrist and hand level

386

3738

1.03

0.26

2.8

2.6

67.13

66.73

g/l

0.51

363

3456

Lesion of plantar nerve

176

1677

1.05

0.26

2.2

2.7

66.73

66.45

g/l

0.20

153

1523

Open wound of neck

151

1.20

0.25

1.4

2.7

67.39

67.32

g/l

0.01

143

Rheumatic fever without mention of heart involvement

0.73

0.25

1.2

2.4

64.07

66.54

g/l

—

Qualitative platelet defects

1.18

0.25

1.3

2.7

67.10

66.06

g/l

—

Chromomycosis and phaeomycotic abscess

1.30

0.25

3.1

3.3

65.14

66.66

g/l

—

Malignant neoplasm of rectum

286

2758

1.04

0.24

2.5

1.6

64.50

66.75

g/l

4.75

257

2440

Medical treatment for female infertility

344

3308

1.03

0.24

1.9

2.1

67.50

67.56

g/l

0.05

325

3086

Other specified/unspecified diseases of inner ear

115

1.24

0.24

2.7

2.0

66.12

65.55

g/l

0.14

100

Benign neoplasm: Renal pelvis

1.35

0.24

1.6

3.3

68.40

67.86

g/l

—

Other noninflammatory disorders of cervix uteri

142

1350

1.06

0.23

2.9

2.5

65.86

66.24

g/l

0.24

122

1200

Carcinoma in situ of other and unspecified genital organs

448

1.10

0.23

1.9

2.9

63.77

67.27

g/l

1.39

411

Other complications of labour and delivery, not elsewhere classified

144

1388

0.95

0.22

1.9

1.7

67.56

68.14

g/l

0.51

130

1290

Malignant neoplasm of oropharyng

1.24

0.22

7.4

2.4

61.40

66.81

g/l

—

Other retinal disorders in diseases classified elsewhere

1.23

0.22

1.0

3.6

68.18

65.70

g/l

—

Malignant neoplasm of trachea

0.00

0.22

0.0

2.2

—

68.45

—

Murder, homicide, or other assault by handgun discharge

0.00

0.22

0.0

8.8

—

69.35

—

Other specified air transport accidents

0.00

0.22

0.0

1.1

—

66.95

—

Exposure to vibration

0.00

0.22

0.0

5.0

—

66.17

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1814

14175

1.01

0.22

2.5

66.64

66.65

g/l

0.02

1655

12944

Retained placenta and membranes, without haemorrhage

283

2738

1.04

0.22

2.6

2.4

67.08

67.06

g/l

0.02

261

2521

Schizophrenia

392

4029

0.97

0.21

2.1

2.6

65.14

66.93

g/l

4.29

349

3741

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1231

9442

0.98

0.21

2.4

66.80

66.92

g/l

0.24

1120

8630

Carcinoma in situ of penis

1.28

0.21

1.2

3.0

63.55

65.96

g/l

—

Niacin deficiency [pellagra]

0.00

0.21

0.0

2.4

—

67.29

—

Complications following myocardial infarction

221

1.14

0.21

1.5

2.4

66.66

65.73

g/l

0.28

187

Psoriatic arthropathies, strict definition

0.00

0.20

0.0

7.7

—

66.69

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

179

1863

0.96

0.20

2.6

2.7

66.29

66.64

g/l

0.29

164

1716

Other abnormal products of conception

615

3983

1.02

0.20

2.0

2.3

67.70

67.49

g/l

0.32

580

3725

Deaf mutism, not elsewhere classified

115

0.77

0.20

2.2

2.3

68.01

67.10

g/l

—

109

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

109

1148

0.95

0.20

3.0

2.9

67.19

66.78

g/l

0.25

102

1049

Carcinoma in situ of cervix uteri

169

1621

1.04

0.20

2.3

66.94

67.24

g/l

0.23

154

1502

Traumatic amputation of ankle and foot

1.21

0.20

1.7

3.0

64.03

67.92

g/l

—

Alzheimer’s disease (Atypical or mixed)

372

3788

0.97

0.20

2.0

2.3

64.68

65.56

g/l

1.24

303

3285

Unspecified abortion

107

1016

1.06

0.19

1.7

2.7

67.37

67.31

g/l

0.03

100

948

Burn and corrosion of shoulder and upper limb, except wrist and hand

426

0.91

0.19

3.6

3.3

65.44

66.81

g/l

0.43

387

Caught, crushed, jammed or pinched in or between objects

114

1086

1.05

0.19

1.5

2.7

66.41

66.73

g/l

0.17

105

1014

Eccrine sweat disorders

1.25

0.19

1.6

3.2

69.20

67.57

g/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

279

2865

0.97

0.17

2.6

1.6

64.67

66.75

g/l

3.87

247

2536

Otosclerosis

215

2217

0.97

0.17

2.1

2.9

66.37

66.46

g/l

0.07

189

2030

Noise effects on inner ear

102

1068

0.95

0.16

2.0

2.8

65.76

66.37

g/l

0.32

995

Prolapse and hernia of ovary and fallopian tube

127

1208

1.04

0.16

2.1

2.2

65.48

65.28

g/l

0.11

108

1016

Benign neoplasm: Vulva

514

0.93

0.16

2.8

65.33

67.09

g/l

0.63

467

Congenital malformations of eye, ear, face and neck

131

1259

1.04

0.16

3.0

2.7

67.39

66.93

g/l

0.24

118

1170

Cleft lip and cleft lip and palate

111

1.18

0.16

2.5

2.6

64.26

67.12

g/l

0.90

105

Antenatal screening

409

2247

1.02

0.15

2.1

2.2

67.87

67.67

g/l

0.23

390

2099

Melanocytic naevi of other and unspecified parts of face

145

1399

1.04

0.15

3.2

2.7

67.38

66.65

g/l

0.58

136

1279

Other abortion

150

0.86

0.15

1.4

2.3

65.64

66.99

g/l

0.17

137

Respiratory tuberculosis, not confirmed

128

1234

1.04

0.14

2.6

2.7

65.77

65.99

g/l

0.12

114

1105

Other congenital malformations of female genitalia

103

1.17

0.14

2.3

2.9

67.28

67.09

g/l

0.03

Malignant neoplasm of rectosigmoid junction

374

1.07

0.13

3.7

1.5

63.99

66.89

g/l

1.13

329

Foreign body on external eye

382

3891

0.98

0.13

3.2

2.6

67.23

66.83

g/l

0.49

356

3632

Other congenital malformations of face and neck

540

1.06

0.13

2.0

2.6

66.70

67.15

g/l

0.16

501

Disorders of acoustic nerve

717

1.05

0.13

3.0

2.8

65.85

66.84

g/l

0.43

655

LSIL lesion of the cervix uteri

208

2029

1.03

0.12

2.7

2.4

66.43

67.48

g/l

1.10

187

1884

Malignant neoplasm of pancreas, including Hilmo

251

2456

1.02

0.12

2.0

1.6

64.17

66.63

g/l

4.67

227

2154

Postpartum care and examination

205

1268

1.02

0.11

2.2

2.0

66.76

68.18

g/l

2.14

197

1176

Postprocedural disorders of ear and mastoid process, not elsewhere classified

218

0.91

0.10

1.3

2.5

62.19

66.36

g/l

1.46

196

Ototoxic hearing loss

1.15

0.10

15.0

2.7

63.26

65.06

g/l

—

Glaucoma secondary to eye trauma

166

0.90

0.10

3.3

2.8

65.45

66.43

g/l

0.28

148

Carcinoma in situ of breast, intraductal

244

2397

1.02

0.09

2.4

2.6

66.51

66.63

g/l

0.08

216

2167

Inflammation of lacrimal passages (chronic)

439

1.05

0.09

2.3

2.7

67.11

66.61

g/l

0.19

389

Degenerative diseases of the nervous system

1521

11240

0.99

0.08

2.1

2.5

65.49

65.84

g/l

0.95

1265

9959

Benign neoplasm: Connective and other soft tissue of abdomen

1.04

0.08

2.8

1.9

61.18

67.32

g/l

—

False labour

524

3303

0.99

0.08

2.1

2.2

68.03

67.63

g/l

0.74

491

3086

Postpartum hemorraghe, parous women as controls

437

3763

0.99

0.08

2.2

2.3

67.49

67.33

g/l

0.17

406

3509

Other maternal disorders predominantly related to pregnancy

1467

9251

0.99

0.08

2.4

2.5

66.93

66.97

g/l

0.08

1352

8503

Other congenital malformations of tongue, mouth and pharynx

165

1.09

0.08

6.2

3.1

65.39

65.45

g/l

0.01

154

Explosion of other materials

0.81

0.08

2.0

2.8

64.12

65.71

g/l

—

Injury of muscle and tendon at ankle and foot level

500

1.04

0.08

2.3

2.9

67.69

67.05

g/l

0.21

459

Recurrent cholesteatoma of postmastoidectomy cavity

1.04

0.07

1.0

1.7

62.04

66.76

g/l

—

Congenital lens malformations

0.84

0.07

4.3

2.3

64.09

65.32

g/l

—

Chloasma

1.02

0.07

1.0

2.7

69.34

67.12

g/l

—

Cleft lip and palate

0.87

0.07

1.6

2.3

65.36

68.01

g/l

—

Contact with machinery

316

3197

0.99

0.06

3.0

2.6

66.30

66.51

g/l

0.18

288

2947

Use of levodopa decarbox-comt-inhibitor

1013

0.98

0.06

1.2

2.9

65.70

66.23

g/l

0.32

923

Vascular dementia (multiple infarctions)

365

0.96

0.06

2.3

2.4

63.73

65.34

g/l

0.66

326

Pedal cyclist injured in collision with motor vehicle

647

0.97

0.05

1.7

2.8

67.25

66.99

g/l

0.11

595

Mucinous and mucinous cystic tumor

100

1.11

0.05

8.4

1.2

65.93

67.64

g/l

0.57

Defect, injury or illness of neck

100

1.11

0.05

1.5

2.4

67.28

66.57

g/l

0.13

Other obstructed labour

152

1542

0.99

0.05

2.5

67.30

67.22

g/l

0.05

139

1432

Maternal care for other known or suspected fetal problems

368

2350

0.99

0.05

1.6

2.1

67.59

67.86

g/l

0.29

349

2197

Frontotemporal dementia, wide, incl. Pick's disease

179

1.07

0.05

2.0

2.8

67.42

66.75

g/l

0.17

162

Adenocarcinoma and papilloma adenocarcinoma of rectum

272

2745

0.99

0.04

2.7

1.6

64.67

66.72

g/l

3.67

240

2428

Dementia due to Parkinson's disease

784

1.02

0.04

1.4

2.7

65.25

65.68

g/l

0.18

700

Ectopic pregnancy

393

3959

0.99

0.04

2.1

2.6

67.29

67.00

g/l

0.42

353

3675

Frontotemporal dementia

160

1.07

0.04

2.1

2.9

67.34

66.80

g/l

—

144

Benign neoplasm of other and unspecified female genital organs

111

1127

0.98

0.04

2.7

2.6

66.41

66.78

g/l

0.18

1016

Carcinoma in situ of breast, lobular

180

1.06

0.04

5.1

2.5

66.42

67.23

g/l

0.24

167

Habitual aborter

210

0.95

0.03

4.4

2.3

64.83

68.22

g/l

0.98

198

Abnormal findings on antenatal screening of mother

955

0.98

0.03

2.0

1.8

67.29

68.04

g/l

0.39

892

Persistent delusional disorders

204

2059

0.99

0.03

2.7

2.6

65.66

66.36

g/l

0.65

183

1879

Open bite that required surgery (Lefort1 or BSSO)

131

1.07

0.03

1.1

2.0

68.93

67.83

g/l

0.42

122

Benign neoplasm: Cranial nerves

773

0.98

0.03

3.4

2.9

65.36

66.77

g/l

0.67

699

Benign neoplasm: Short bones of lower limb

209

0.95

0.03

6.0

2.9

65.23

67.51

g/l

0.53

192

Malignant neoplasm of rectosigmoid junction, including Hilmo

728

1.02

0.03

3.4

1.6

63.04

66.82

g/l

3.16

652

Postpartum haemorrhage due to retained placenta

189

1903

0.99

0.02

2.0

2.1

67.91

67.59

g/l

0.21

171

1775

Cholesteatoma of middle ear

151

1522

0.99

0.02

2.2

2.6

66.24

66.30

g/l

0.03

139

1387

Postpartum hemorraghe, all women as controls

437

4316

1.00

0.02

2.2

67.49

67.41

g/l

0.08

406

4023

Circumscribed brain atrophy

619

0.98

0.02

1.9

2.9

66.59

65.93

g/l

0.31

562

Left side

127

0.94

0.01

1.5

2.8

69.33

66.32

g/l

0.81

120

Maternal care for cervical incompetence

862

1.01

0.01

4.0

2.7

66.18

67.00

g/l

0.57

786

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

104

1.06

0.01

1.8

2.2

68.05

66.19

g/l

0.53

Acquired stenosis of external ear canal

254

1.03

0.00

2.0

2.7

65.88

66.15

g/l

0.07

236

Motorcycle rider injured in other and unspecified transport accidents

104

1034

1.01

0.00

1.9

2.5

66.27

67.35

g/l

1.14

973

Mandibular retrognathia

113

1125

1.00

0.00

3.8

2.5

67.44

67.25

g/l

0.10

107

1060

Brain glioblastoma and astrocytoma

335

1.02

0.00

1.8

1.6

65.38

67.82

g/l

0.85

302

Impacted maxillary canine

112

0.98

0.00

1.8

2.9

68.45

64.55

g/l

1.32

106

Malignant neoplasm of floor of mouth

114

0.96

0.00

1.4

1.8

62.73

66.95

g/l

0.82

101

Other specified and unspecified disorders of lens

273

0.99

0.00

3.0

2.6

65.17

65.63

g/l

0.13

248

Thyrotoxicosis with toxic single thyroid nodule

194

0.98

0.00

2.8

2.5

67.64

67.40

g/l

0.05

175

Handgun discharge, undetermined intent

0.00

0.0

6.4

—

64.57

—

Malignant neoplasm of other and ill-defined sites

0.97

0.00

1.3

1.4

62.62

67.50

g/l

—

Acute necrotizing ulcerative gingivitis

0.00

0.0

1.0

—

67.08

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

1.2

—

69.50

—

Anthrax

0.00

0.0

2.8

—

66.36

—

Familial erythrocytosis

0.92

-0.00

2.8

2.7

67.58

67.53

g/l

—

Androgen resistance syndrome

0.00

-0.00

0.0

12.4

—

64.17

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.1

—

65.36

—

Corneal pigmentations and deposits

0.93

-0.00

1.1

2.9

69.70

66.24

g/l

—

Benign neoplasm: Respiratory system, unspecified

0.94

-0.00

1.2

1.9

72.02

67.27

g/l

—

Benign neoplasm: Retina

120

1.00

-0.00

2.2

2.5

65.70

66.63

g/l

0.20

108

Status migrainosus, drug-induced

0.00

-0.00

0.0

10.8

—

67.70

—

Exposure to unspecified type of radiation

0.00

-0.00

0.0

1.0

—

66.43

—

Keratoderma in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

62.70

—

Systemic sclerosis induced by drugs and chemicals

0.00

-0.00

0.0

1.6

—

67.40

—

Foreign object accidentally left in body during surgical and medical care

0.92

-0.00

5.3

3.4

67.42

66.04

g/l

—

Relapsing panniculitis [Weber-Christian]

0.00

-0.00

0.0

1.8

—

64.95

—

Moderate visual impairment, monocular

100

1.00

-0.00

1.8

2.6

71.05

67.36

g/l

—

Peutz-Jeghers syndrome

0.00

-0.00

0.0

1.0

—

68.06

—

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

-0.00

0.0

1.3

—

70.26

—

Down's syndrome

1.00

-0.00

5.8

3.4

67.14

66.30

g/l

—

Monkeypox

0.00

-0.00

0.0

1.3

—

63.35

—

Gottron papules

0.00

-0.00

0.0

1.0

—

68.76

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

1.0

—

63.50

—

Malignant neoplasm of lip, including Hilmo

250

1.00

-0.00

2.4

1.6

65.38

66.87

g/l

0.48

217

Enophthalmos

0.00

-0.00

0.0

8.8

—

67.97

—

Smallpox

0.00

-0.00

0.0

1.0

—

67.41

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS